{"protocolSection": {"identificationModule": {"nctId": "NCT00121667", "orgStudyIdInfo": {"id": "CV181-014"}, "organization": {"fullName": "AstraZeneca", "class": "INDUSTRY"}, "briefTitle": "Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone", "officialTitle": "\"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial to Evaluate the Efficacy and Safety of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone\""}, "statusModule": {"statusVerifiedDate": "2015-03", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2005-08"}, "primaryCompletionDateStruct": {"date": "2006-10", "type": "ACTUAL"}, "completionDateStruct": {"date": "2010-02", "type": "ACTUAL"}, "studyFirstSubmitDate": "2005-07-18", "studyFirstSubmitQcDate": "2005-07-20", "studyFirstPostDateStruct": {"date": "2005-07-21", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2011-03-15", "resultsFirstSubmitQcDate": "2011-03-15", "resultsFirstPostDateStruct": {"date": "2011-04-08", "type": "ESTIMATED"}, "dispFirstSubmitDate": "2009-07-30", "dispFirstSubmitQcDate": "2010-08-13", "dispFirstPostDateStruct": {"date": "2010-08-18", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2015-04-08", "lastUpdatePostDateStruct": {"date": "2015-04-29", "type": "ESTIMATED"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "AstraZeneca", "class": "INDUSTRY"}}, "descriptionModule": {"briefSummary": "The purpose of this clinical research study is to learn whether Saxagliptin added to Metformin therapy is more effective than Metformin alone as a treatment for type 2 diabetic subjects who are not sufficiently controlled with Metformin alone", "detailedDescription": "All subjects will participate in a lead-in period, and qualifying subjects will continue into a short-term randomized treatment period. Subjects who complete the short-term period will be eligible to enter the long term extension period. Also, subjects in the short-term period who have an elevated blood sugar that requires additional medication for blood sugar control will be eligible to enter the long-term treatment extension period where they will receive pioglitizone added onto their blinded study medication"}, "conditionsModule": {"conditions": ["Diabetes Mellitus, Type 2"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE3"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "DOUBLE", "whoMasked": ["PARTICIPANT", "INVESTIGATOR"]}}, "enrollmentInfo": {"count": 1462, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Saxagliptin + Metformin (A)", "type": "EXPERIMENTAL", "description": "Pioglitazone 15-45 mg (as needed for rescue)", "interventionNames": ["Drug: Saxagliptin + Metformin", "Drug: Pioglitazone"]}, {"label": "Saxagliptin + Metformin (B)", "type": "EXPERIMENTAL", "description": "Pioglitazone 15-45 mg (as needed for rescue)", "interventionNames": ["Drug: Saxagliptin + Metformin", "Drug: Pioglitazone"]}, {"label": "Saxagliptin + Metformin (C)", "type": "EXPERIMENTAL", "description": "Pioglitazone 15-45 mg (as needed for rescue)", "interventionNames": ["Drug: Saxagliptin + Metformin", "Drug: Pioglitazone"]}, {"label": "Placebo+ Metformin (D)", "type": "PLACEBO_COMPARATOR", "description": "Pioglitazone 15-45 mg (as needed for rescue)", "interventionNames": ["Drug: Placebo + Metformin", "Drug: Pioglitazone"]}], "interventions": [{"type": "DRUG", "name": "Saxagliptin + Metformin", "description": "Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT)", "armGroupLabels": ["Saxagliptin + Metformin (A)"], "otherNames": ["BMS-477118"]}, {"type": "DRUG", "name": "Saxagliptin + Metformin", "description": "Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT)", "armGroupLabels": ["Saxagliptin + Metformin (B)"], "otherNames": ["BMS-477118"]}, {"type": "DRUG", "name": "Saxagliptin + Metformin", "description": "Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT)", "armGroupLabels": ["Saxagliptin + Metformin (C)"], "otherNames": ["BMS-477118"]}, {"type": "DRUG", "name": "Placebo + Metformin", "description": "Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT)", "armGroupLabels": ["Placebo+ Metformin (D)"]}, {"type": "DRUG", "name": "Pioglitazone", "description": "Tablets, Oral, 15 - 45 mg (as needed for rescue)", "armGroupLabels": ["Placebo+ Metformin (D)", "Saxagliptin + Metformin (A)", "Saxagliptin + Metformin (B)", "Saxagliptin + Metformin (C)"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Baseline and Change From Baseline in Hemoglobin A1c (A1C) at Week 24", "description": "Mean change from baseline is adjusted for baseline value.", "timeFrame": "Baseline, Week 24"}], "secondaryOutcomes": [{"measure": "Baseline and Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24", "description": "Mean change from baseline is adjusted for baseline value.", "timeFrame": "Baseline, Week 24"}, {"measure": "Percentage of Participants Achieving Therapeutic Glycemic Response (A1C < 7.0%) at Week 24", "timeFrame": "Week 24"}, {"measure": "Baseline and Change From Baseline at Week 24 in Postprandial Glucose (PPG) Area Under the Curve (AUC)", "description": "Mean change from baseline is adjusted for baseline value.", "timeFrame": "Baseline, Week 24"}], "otherOutcomes": [{"measure": "Overall Summary of Adverse Events During ST+LT Treatment Period", "description": "AE=any new untoward medical occurrence or worsening of a pre-existing medical condition which does not necessarily have a causal relationship with this treatment. SAE=any untoward medical occurrence that at any dose: results in death, is life-threatening, requires inpatient hospitalization or causes prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, results in development of drug dependency or drug abuse, is an important medical event. Related events=relationship of certain, probable, possible, or missing.", "timeFrame": "AEs: up to last treatment day + 1 day or last visit day in the ST+LT period; SAEs: up to last treatment day + 30 days or last visit day + 30 days in the LT+ST period. Mean duration of exposure: 124, 118, 130, 95 wks respectively for 2.5mg, 5mg, 10 mg, pla"}, {"measure": "Marked Laboratory Abnormalities - During ST + LT Treatment Period", "description": "A laboratory value was considered a marked abnormality if it is outside the pre-defined criteria for marked abnormality and the on-treatment value was more extreme (farther from the limit) than the baseline value. Pre-Rx=pretreatment; ULN=upper limit of normal; ALP=alkaline phosphatase; AST=aspartate aminotransferase; ALT=alanine aminotransferase; unspec=unspecified; sodium serum low: \\<0.9 x Pre-Rx \\& \\<=130mEq/L / high: \\>1.1 x Pre-Rx \\& \\>=150mEq/L; potassium, serum low: \\<=0.8 x Pre-Rx \\& \\>=6.0mEq/L / high: 1.2 x Pre-Rx \\& \\>=6.0mEq/L; LLN=lower limit of normal.", "timeFrame": "Lab assessments taken during and up to 14 days after the last dose of study drug during the ST + LT Treatment Period. Mean duration of exposure: 124, 118, 130, 95 weeks, respectively, for 2.5mg, 5mg, 10 mg, placebo."}, {"measure": "Baseline and Changes From Baseline in Hemoglobin During the ST + LT Period", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206"}, {"measure": "Baseline and Changes From Baseline in Hematocrit During the ST + LT Period", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206"}, {"measure": "Baseline and Changes From Baseline in Red Blood Cell Counts (x 10^6 c/\u00b5L) During the ST + LT Period", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206"}, {"measure": "Baseline and Changes From Baseline in Platelet Counts (x 10^9 c/L) During the ST + LT Period", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206"}, {"measure": "Baseline and Changes From Baseline in White Blood Cell Counts (x 10^3 c/\u00b5L) During the ST + LT Period", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206"}, {"measure": "Baseline and Changes From Baseline in Absolute Neutrophil Counts (x 10^3 c/\u00b5L) During the ST + LT Period", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206"}, {"measure": "Baseline and Changes From Baseline in Absolute Lymphocyte Counts (x 10^3 c/\u00b5L) During the ST + LT Period", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206"}, {"measure": "Baseline and Changes From Baseline in Absolute Monocyte Counts (x 10^3 c/\u00b5L) During the ST + LT Period", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206"}, {"measure": "Baseline and Changes From Baseline in Absolute Basophil Counts (x 10^3 c/\u00b5L) During the ST + LT Period", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206"}, {"measure": "Baseline and Changes From Baseline in Absolute Eosinophil Counts (x 10^3 c/\u00b5L) During the ST + LT Period", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206"}, {"measure": "Changes From Baseline in Systolic Blood Pressure During the ST + LT Period", "timeFrame": "Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206"}, {"measure": "Changes From Baseline in Diastolic Blood Pressure During the ST + LT Period", "timeFrame": "Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206"}, {"measure": "Changes From Baseline in Heart Rate During the ST + LT Period", "timeFrame": "Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206"}, {"measure": "Electrocardiogram (ECG) Tracings - Shift Table From Baseline (BL) to Selected Visits During ST + LT Treatment Period", "description": "The normality/abnormality of the ECG tracing was determined by the investigator.", "timeFrame": "Baseline, Weeks 12, 24, 76, 102, 154, 206,"}, {"measure": "All Reported Hypoglycemic Adverse Events During the ST + LT Treatment Period", "description": "Hypoglycemic Events are based upon the Saxagliptin Predefined List of Events, which are hypoglycemia, blood glucose decreased, and hypoglycemic unconsciousness.", "timeFrame": "AEs: up to last treatment day + 1 day or last visit day in the ST+LT period; SAEs: up to last treatment day + 30 days or last visit day + 30 days in the LT+ST period. Mean duration of exposure: 124, 118, 130, 95 wks respectively for 2.5mg, 5mg, 10 mg, pla"}, {"measure": "Confirmed Hypoglycemia During the ST + LT Treatment Period", "description": "'Confirmed' = recorded on the hypoglycemia AE case report form with a fingerstick glucose \\<= 50 mg/dL and associated symptoms.", "timeFrame": "AEs: up to last treatment day + 1 day or last visit day in the ST+LT period; SAEs: up to last treatment day + 30 days or last visit day + 30 days in the LT+ST period. Mean duration of exposure: 124, 118, 130, 95 wks respectively for 2.5mg, 5mg, 10 mg, pla"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Type 2 diabetes mellitus requiring treatment with at least 1500 mg but not greater than 2550 mg of a maximum tolerated dose of Metformin therapy for at least 8 weeks prior to screening.\n* HbA1c \\>= 7.0% and \\<= 10.0 %\n* Body mass index \\<= 40 kg/m2\n* Fasting C-peptide \\>= 1 ng/dL\n\nExclusion Criteria:\n\n* Symptomatic poorly controlled diabetes\n* Recent cardiac or cerebrovascular event\n* Serum creatinine \\>= 1.5 mg/dL for males and \\>= 1.4 mg/dL for females", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "maximumAge": "77 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"locations": [{"facility": "Local Institution", "city": "Anniston", "state": "Alabama", "country": "United States", "geoPoint": {"lat": 33.65983, "lon": -85.83163}}, {"facility": "Local Institution", "city": "Birmingham", "state": "Alabama", "country": "United States", "geoPoint": {"lat": 33.52066, "lon": -86.80249}}, {"facility": "Local Institution", "city": "Calera", "state": "Alabama", "country": "United States", "geoPoint": {"lat": 33.1029, "lon": -86.7536}}, {"facility": "Local Institution", "city": "Haleyville", "state": "Alabama", "country": "United States", "geoPoint": {"lat": 34.22649, "lon": -87.62141}}, {"facility": "Local Institution", "city": "Mesa", "state": "Arizona", "country": "United States", "geoPoint": {"lat": 33.42227, "lon": -111.82264}}, {"facility": "Local Institution", "city": "Phoenix", "state": "Arizona", "country": "United States", "geoPoint": {"lat": 33.44838, "lon": -112.07404}}, {"facility": "Local Institution", "city": "Jonesboro", "state": "Arkansas", "country": "United States", "geoPoint": {"lat": 35.8423, "lon": -90.70428}}, {"facility": "Local Institution", "city": "Little Rock", "state": "Arkansas", "country": "United States", "geoPoint": {"lat": 34.74648, "lon": -92.28959}}, {"facility": "Local Institution", "city": "Sherwood", "state": "Arkansas", "country": "United States", "geoPoint": {"lat": 34.81509, "lon": -92.22432}}, {"facility": "Local Institution", "city": "Encino", "state": "California", "country": "United States", "geoPoint": {"lat": 34.15917, "lon": -118.50119}}, {"facility": "Local Institution", "city": "Fountain Valley", "state": "California", "country": "United States", "geoPoint": {"lat": 33.70918, "lon": -117.95367}}, {"facility": "Local Institution", "city": "Fresno", "state": "California", "country": "United States", "geoPoint": {"lat": 36.74773, "lon": -119.77237}}, {"facility": "Local Institution", "city": "Los Angeles", "state": "California", "country": "United States", "geoPoint": {"lat": 34.05223, "lon": -118.24368}}, {"facility": "Local Institution", "city": "Mission Viejo", "state": "California", "country": "United States", "geoPoint": {"lat": 33.60002, "lon": -117.672}}, {"facility": "Local Institution", "city": "Northridge", "state": "California", "country": "United States", "geoPoint": {"lat": 34.22834, "lon": -118.53675}}, {"facility": "Local Institution", "city": "Orange", "state": "California", "country": "United States", "geoPoint": {"lat": 33.78779, "lon": -117.85311}}, {"facility": "Local Institution", "city": "Roseville", "state": "California", "country": "United States", "geoPoint": {"lat": 38.75212, "lon": -121.28801}}, {"facility": "Local Institution", "city": "Sacramento", "state": "California", "country": "United States", "geoPoint": {"lat": 38.58157, "lon": -121.4944}}, {"facility": "Local Institution", "city": "Spring Valley", "state": "California", "country": "United States", "geoPoint": {"lat": 32.74477, "lon": -116.99892}}, {"facility": "Local Institution", "city": "Tustin", "state": "California", "country": "United States", "geoPoint": {"lat": 33.74585, "lon": -117.82617}}, {"facility": "Local Institution", "city": "Castle Rock", "state": "Colorado", "country": "United States", "geoPoint": {"lat": 39.37221, "lon": -104.85609}}, {"facility": "Local Institution", "city": "Colorado Springs", "state": "Colorado", "country": "United States", "geoPoint": {"lat": 38.83388, "lon": -104.82136}}, {"facility": "Local Institution", "city": "Denver", "state": "Colorado", "country": "United States", "geoPoint": {"lat": 39.73915, "lon": -104.9847}}, {"facility": "Local Institution", "city": "Golden", "state": "Colorado", "country": "United States", "geoPoint": {"lat": 39.75554, "lon": -105.2211}}, {"facility": "Local Institution", "city": "Loveland", "state": "Colorado", "country": "United States", "geoPoint": {"lat": 40.39776, "lon": -105.07498}}, {"facility": "Local Institution", "city": "Altamonte Springs", "state": "Florida", "country": "United States", "geoPoint": {"lat": 28.66111, "lon": -81.36562}}, {"facility": "Local Institution", "city": "Chipley", "state": "Florida", "country": "United States", "geoPoint": {"lat": 30.78186, "lon": -85.53854}}, {"facility": "Local Institution", "city": "Cocoa Beach", "state": "Florida", "country": "United States", "geoPoint": {"lat": 28.32045, "lon": -80.60947}}, {"facility": "Local Institution", "city": "Coral Gables", "state": "Florida", "country": "United States", "geoPoint": {"lat": 25.72149, "lon": -80.26838}}, {"facility": "Local Institution", "city": "Fort Lauderdale", "state": "Florida", "country": "United States", "geoPoint": {"lat": 26.12231, "lon": -80.14338}}, {"facility": "Local Institution", "city": "Jacksonville", "state": "Florida", "country": "United States", "geoPoint": {"lat": 30.33218, "lon": -81.65565}}, {"facility": "Local Institution", "city": "Kissimmee", "state": "Florida", "country": "United States", "geoPoint": {"lat": 28.30468, "lon": -81.41667}}, {"facility": "Local Institution", "city": "Marianna", "state": "Florida", "country": "United States", "geoPoint": {"lat": 30.77436, "lon": -85.22687}}, {"facility": "Local Institution", "city": "Miami", "state": "Florida", "country": "United States", "geoPoint": {"lat": 25.77427, "lon": -80.19366}}, {"facility": "Local Institution", "city": "New Port Richey", "state": "Florida", "country": "United States", "geoPoint": {"lat": 28.24418, "lon": -82.71927}}, {"facility": "Local Institution", "city": "Ocala", "state": "Florida", "country": "United States", "geoPoint": {"lat": 29.1872, "lon": -82.14009}}, {"facility": "Local Institution", "city": "Tallahassee", "state": "Florida", "country": "United States", "geoPoint": {"lat": 30.43826, "lon": -84.28073}}, {"facility": "Local Institution", "city": "Tampa", "state": "Florida", "country": "United States", "geoPoint": {"lat": 27.94752, "lon": -82.45843}}, {"facility": "Local Institution", "city": "Decatur", "state": "Georgia", "country": "United States", "geoPoint": {"lat": 33.77483, "lon": -84.29631}}, {"facility": "Local Institution", "city": "Chicago", "state": "Illinois", "country": "United States", "geoPoint": {"lat": 41.85003, "lon": -87.65005}}, {"facility": "Local Institution", "city": "Vernon Hills", "state": "Illinois", "country": "United States", "geoPoint": {"lat": 42.21947, "lon": -87.97952}}, {"facility": "Local Institution", "city": "Elkhart", "state": "Indiana", "country": "United States", "geoPoint": {"lat": 41.68199, "lon": -85.97667}}, {"facility": "Local Institution", "city": "Lafayette", "state": "Indiana", "country": "United States", "geoPoint": {"lat": 40.4167, "lon": -86.87529}}, {"facility": "Local Institution", "city": "Iowa City", "state": "Iowa", "country": "United States", "geoPoint": {"lat": 41.66113, "lon": -91.53017}}, {"facility": "Local Institution", "city": "Waterloo", "state": "Iowa", "country": "United States", "geoPoint": {"lat": 42.49276, "lon": -92.34296}}, {"facility": "Local Institution", "city": "Topeka", "state": "Kansas", "country": "United States", "geoPoint": {"lat": 39.04833, "lon": -95.67804}}, {"facility": "Local Institution", "city": "Lexington", "state": "Kentucky", "country": "United States", "geoPoint": {"lat": 37.98869, "lon": -84.47772}}, {"facility": "Local Institution", "city": "Munfordville", "state": "Kentucky", "country": "United States", "geoPoint": {"lat": 37.27228, "lon": -85.89108}}, {"facility": "Local Institution", "city": "New Orleans", "state": "Louisiana", "country": "United States", "geoPoint": {"lat": 29.95465, "lon": -90.07507}}, {"facility": "Local Institution", "city": "West Monroe", "state": "Louisiana", "country": "United States", "geoPoint": {"lat": 32.51848, "lon": -92.14764}}, {"facility": "Local Institution", "city": "Baltimore", "state": "Maryland", "country": "United States", "geoPoint": {"lat": 39.29038, "lon": -76.61219}}, {"facility": "Local Institution", "city": "Chester", "state": "Maryland", "country": "United States", "geoPoint": {"lat": 38.97539, "lon": -76.2894}}, {"facility": "Local Institution", "city": "Prince Frederick", "state": "Maryland", "country": "United States", "geoPoint": {"lat": 38.5404, "lon": -76.5844}}, {"facility": "Local Institution", "city": "Boston", "state": "Massachusetts", "country": "United States", "geoPoint": {"lat": 42.35843, "lon": -71.05977}}, {"facility": "Local Institution", "city": "Kansas City", "state": "Missouri", "country": "United States", "geoPoint": {"lat": 39.09973, "lon": -94.57857}}, {"facility": "Local Institution", "city": "St. Louis", "state": "Missouri", "country": "United States", "geoPoint": {"lat": 38.62727, "lon": -90.19789}}, {"facility": "Local Institution", "city": "Kalispell", "state": "Montana", "country": "United States", "geoPoint": {"lat": 48.19579, "lon": -114.31291}}, {"facility": "Local Institution", "city": "Omaha", "state": "Nebraska", "country": "United States", "geoPoint": {"lat": 41.25626, "lon": -95.94043}}, {"facility": "Local Institution", "city": "Las Vegas", "state": "Nevada", "country": "United States", "geoPoint": {"lat": 36.17497, "lon": -115.13722}}, {"facility": "Local Institution", "city": "Toms River", "state": "New Jersey", "country": "United States", "geoPoint": {"lat": 39.95373, "lon": -74.19792}}, {"facility": "Local Institution", "city": "Albuquerque", "state": "New Mexico", "country": "United States", "geoPoint": {"lat": 35.08449, "lon": -106.65114}}, {"facility": "Local Institution", "city": "Charlotte", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 35.22709, "lon": -80.84313}}, {"facility": "Local Institution", "city": "Greensboro", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 36.07264, "lon": -79.79198}}, {"facility": "Local Institution", "city": "Morehead City", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 34.72294, "lon": -76.72604}}, {"facility": "Local Institution", "city": "Salisbury", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 35.67097, "lon": -80.47423}}, {"facility": "Local Institution", "city": "Sparta", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 36.50541, "lon": -81.12092}}, {"facility": "Local Institution", "city": "Wilmington", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 34.22573, "lon": -77.94471}}, {"facility": "Local Institution", "city": "Winston Salem", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 36.09986, "lon": -80.24422}}, {"facility": "Local Institution", "city": "Athens", "state": "Ohio", "country": "United States", "geoPoint": {"lat": 39.32924, "lon": -82.10126}}, {"facility": "Local Institution", "city": "Columbus", "state": "Ohio", "country": "United States", "geoPoint": {"lat": 39.96118, "lon": -82.99879}}, {"facility": "Local Institution", "city": "Lyndhurst", "state": "Ohio", "country": "United States", "geoPoint": {"lat": 41.52005, "lon": -81.48873}}, {"facility": "Local Institution", "city": "Oklahoma City", "state": "Oklahoma", "country": "United States", "geoPoint": {"lat": 35.46756, "lon": -97.51643}}, {"facility": "Local Institution", "city": "Tulsa", "state": "Oklahoma", "country": "United States", "geoPoint": {"lat": 36.15398, "lon": -95.99277}}, {"facility": "Local Institution", "city": "Eugene", "state": "Oregon", "country": "United States", "geoPoint": {"lat": 44.05207, "lon": -123.08675}}, {"facility": "Local Institution", "city": "Portland", "state": "Oregon", "country": "United States", "geoPoint": {"lat": 45.52345, "lon": -122.67621}}, {"facility": "Local Institution", "city": "Carlisle", "state": "Pennsylvania", "country": "United States", "geoPoint": {"lat": 40.20148, "lon": -77.18887}}, {"facility": "Local Institution", "city": "Langhorne", "state": "Pennsylvania", "country": "United States", "geoPoint": {"lat": 40.17455, "lon": -74.92267}}, {"facility": "Local Institution", "city": "Levittown", "state": "Pennsylvania", "country": "United States", "geoPoint": {"lat": 40.15511, "lon": -74.82877}}, {"facility": "Local Institution", "city": "Philadelphia", "state": "Pennsylvania", "country": "United States", "geoPoint": {"lat": 39.95233, "lon": -75.16379}}, {"facility": "Local Institution", "city": "Pittsburgh", "state": "Pennsylvania", "country": "United States", "geoPoint": {"lat": 40.44062, "lon": -79.99589}}, {"facility": "Local Institution", "city": "Charleston", "state": "South Carolina", "country": "United States", "geoPoint": {"lat": 32.77657, "lon": -79.93092}}, {"facility": "Local Institution", "city": "Duncan", "state": "South Carolina", "country": "United States", "geoPoint": {"lat": 34.9379, "lon": -82.14511}}, {"facility": "Local Institution", "city": "Bristol", "state": "Tennessee", "country": "United States", "geoPoint": {"lat": 36.59511, "lon": -82.18874}}, {"facility": "Local Institution", "city": "Austin", "state": "Texas", "country": "United States", "geoPoint": {"lat": 30.26715, "lon": -97.74306}}, {"facility": "Local Institution", "city": "Bryan", "state": "Texas", "country": "United States", "geoPoint": {"lat": 30.67436, "lon": -96.36996}}, {"facility": "Local Institution", "city": "Carrollton", "state": "Texas", "country": "United States", "geoPoint": {"lat": 32.95373, "lon": -96.89028}}, {"facility": "Local Institution", "city": "Dallas", "state": "Texas", "country": "United States", "geoPoint": {"lat": 32.78306, "lon": -96.80667}}, {"facility": "Local Institution", "city": "Houston", "state": "Texas", "country": "United States", "geoPoint": {"lat": 29.76328, "lon": -95.36327}}, {"facility": "Local Institution", "city": "San Antonio", "state": "Texas", "country": "United States", "geoPoint": {"lat": 29.42412, "lon": -98.49363}}, {"facility": "Local Institution", "city": "Temple", "state": "Texas", "country": "United States", "geoPoint": {"lat": 31.09823, "lon": -97.34278}}, {"facility": "Local Institution", "city": "Salt Lake City", "state": "Utah", "country": "United States", "geoPoint": {"lat": 40.76078, "lon": -111.89105}}, {"facility": "Local Institution", "city": "Hampton", "state": "Virginia", "country": "United States", "geoPoint": {"lat": 37.02987, "lon": -76.34522}}, {"facility": "Local Institution", "city": "Virginia Beach", "state": "Virginia", "country": "United States", "geoPoint": {"lat": 36.85293, "lon": -75.97799}}, {"facility": "Local Institution", "city": "Olympia", "state": "Washington", "country": "United States", "geoPoint": {"lat": 47.03787, "lon": -122.9007}}, {"facility": "Local Institution", "city": "Spokane", "state": "Washington", "country": "United States", "geoPoint": {"lat": 47.65966, "lon": -117.42908}}, {"facility": "Local Institution", "city": "Mar Del Plata", "state": "Buenos Aires", "country": "Argentina", "geoPoint": {"lat": -38.00228, "lon": -57.55754}}, {"facility": "Local Institution", "city": "Rosario", "state": "Santa Fe", "country": "Argentina", "geoPoint": {"lat": -32.94682, "lon": -60.63932}}, {"facility": "Local Institution", "city": "Buenos Aires", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Local Institution", "city": "Cordoba", "country": "Argentina", "geoPoint": {"lat": -31.4135, "lon": -64.18105}}, {"facility": "Local Institution", "city": "Sydney", "state": "New South Wales", "country": "Australia", "geoPoint": {"lat": -33.86785, "lon": 151.20732}}, {"facility": "Local Institution", "city": "Woollongong", "state": "New South Wales", "country": "Australia"}, {"facility": "Local Institution", "city": "Brisbane", "state": "Queensland", "country": "Australia", "geoPoint": {"lat": -27.46794, "lon": 153.02809}}, {"facility": "Local Institution", "city": "Kippa Ring", "state": "Queensland", "country": "Australia", "geoPoint": {"lat": -27.22586, "lon": 153.0835}}, {"facility": "Local Institution", "city": "Meadowbrook", "state": "Queensland", "country": "Australia", "geoPoint": {"lat": -27.66401, "lon": 153.14465}}, {"facility": "Local Institution", "city": "Adelaide", "state": "South Australia", "country": "Australia", "geoPoint": {"lat": -34.92866, "lon": 138.59863}}, {"facility": "Local Institution", "city": "Woodville South", "state": "South Australia", "country": "Australia", "geoPoint": {"lat": -34.88186, "lon": 138.53477}}, {"facility": "Local Institution", "city": "Perth", "state": "Western Australia", "country": "Australia", "geoPoint": {"lat": -31.95224, "lon": 115.8614}}, {"facility": "Local Institution", "city": "Fortaleza", "state": "Ceara", "country": "Brazil", "geoPoint": {"lat": -3.71722, "lon": -38.54306}}, {"facility": "Local Institution", "city": "Belem", "state": "Para", "country": "Brazil", "geoPoint": {"lat": -1.45583, "lon": -48.50444}}, {"facility": "Local Institution", "city": "Porto alegre", "state": "Rio Grande Do Sul", "country": "Brazil", "geoPoint": {"lat": -30.03306, "lon": -51.23}}, {"facility": "Local Institution", "city": "Campinas", "state": "Sao Paulo", "country": "Brazil", "geoPoint": {"lat": -22.90556, "lon": -47.06083}}, {"facility": "Local Institution", "city": "Marilia", "state": "Sao Paulo", "country": "Brazil", "geoPoint": {"lat": -22.21389, "lon": -49.94583}}, {"facility": "Local Institution", "city": "Sao Paulo", "country": "Brazil", "geoPoint": {"lat": -23.5475, "lon": -46.63611}}, {"facility": "Local Institution", "city": "Calgary", "state": "Alberta", "country": "Canada", "geoPoint": {"lat": 51.05011, "lon": -114.08529}}, {"facility": "Local Institution", "city": "Coquitlam", "state": "British Columbia", "country": "Canada", "geoPoint": {"lat": 49.28297, "lon": -122.75262}}, {"facility": "Local Institution", "city": "Kelowna", "state": "British Columbia", "country": "Canada", "geoPoint": {"lat": 49.88307, "lon": -119.48568}}, {"facility": "Local Institution", "city": "Surrey", "state": "British Columbia", "country": "Canada", "geoPoint": {"lat": 49.10635, "lon": -122.82509}}, {"facility": "Local Institution", "city": "Brandon", "state": "Manitoba", "country": "Canada", "geoPoint": {"lat": 49.84692, "lon": -99.95306}}, {"facility": "Local Institution", "city": "Portage La Prairie", "state": "Manitoba", "country": "Canada", "geoPoint": {"lat": 49.97282, "lon": -98.29263}}, {"facility": "Local Institution", "city": "Winnipeg", "state": "Manitoba", "country": "Canada", "geoPoint": {"lat": 49.8844, "lon": -97.14704}}, {"facility": "Local Institution", "city": "Bathurst", "state": "New Brunswick", "country": "Canada", "geoPoint": {"lat": 47.61814, "lon": -65.65112}}, {"facility": "Local Institution", "city": "Mount Pearl", "state": "Newfoundland and Labrador", "country": "Canada", "geoPoint": {"lat": 47.51659, "lon": -52.78135}}, {"facility": "Local Institution", "city": "St. John's", "state": "Newfoundland and Labrador", "country": "Canada", "geoPoint": {"lat": 47.56494, "lon": -52.70931}}, {"facility": "Local Institution", "city": "St. Johns", "state": "Newfoundland and Labrador", "country": "Canada", "geoPoint": {"lat": 47.56494, "lon": -52.70931}}, {"facility": "Local Institution", "city": "Aylmer", "state": "Ontario", "country": "Canada", "geoPoint": {"lat": 42.76679, "lon": -80.98302}}, {"facility": "Local Institution", "city": "London", "state": "Ontario", "country": "Canada", "geoPoint": {"lat": 42.98339, "lon": -81.23304}}, {"facility": "Local Institution", "city": "Oakville", "state": "Ontario", "country": "Canada", "geoPoint": {"lat": 43.45011, "lon": -79.68292}}, {"facility": "Local Institution", "city": "Sarnia", "state": "Ontario", "country": "Canada", "geoPoint": {"lat": 42.97866, "lon": -82.40407}}, {"facility": "Local Institution", "city": "Thornhill", "state": "Ontario", "country": "Canada"}, {"facility": "Local Institution", "city": "Toronto", "state": "Ontario", "country": "Canada", "geoPoint": {"lat": 43.70011, "lon": -79.4163}}, {"facility": "Local Institution", "city": "Woodstock", "state": "Ontario", "country": "Canada", "geoPoint": {"lat": 43.13339, "lon": -80.7497}}, {"facility": "Local Institution", "city": "Charlottetown", "state": "Prince Edward Island", "country": "Canada", "geoPoint": {"lat": 46.23899, "lon": -63.13414}}, {"facility": "Local Institution", "city": "Drummondville", "state": "Quebec", "country": "Canada", "geoPoint": {"lat": 45.88336, "lon": -72.48241}}, {"facility": "Local Institution", "city": "Fleurimont", "state": "Quebec", "country": "Canada", "geoPoint": {"lat": 45.41455, "lon": -71.84873}}, {"facility": "Local Institution", "city": "Longueuil", "state": "Quebec", "country": "Canada", "geoPoint": {"lat": 45.53121, "lon": -73.51806}}, {"facility": "Local Institution", "city": "St. Leonard", "state": "Quebec", "country": "Canada", "geoPoint": {"lat": 45.58773, "lon": -73.59501}}, {"facility": "Local Institution", "city": "Saskatoon", "state": "Saskatchewan", "country": "Canada", "geoPoint": {"lat": 52.13238, "lon": -106.66892}}, {"facility": "Local Institution", "city": "Santiago De Chile", "state": "Metropolitana", "country": "Chile", "geoPoint": {"lat": -33.45694, "lon": -70.64827}}, {"facility": "Local Institution", "city": "Santiago", "state": "Metropolitana", "country": "Chile", "geoPoint": {"lat": -33.45694, "lon": -70.64827}}, {"facility": "Local Institution", "city": "Celaya", "state": "Guanajuato", "country": "Mexico", "geoPoint": {"lat": 20.52353, "lon": -100.8157}}, {"facility": "Local Institution", "city": "Guadalajara", "state": "Jalisco", "country": "Mexico", "geoPoint": {"lat": 20.66682, "lon": -103.39182}}, {"facility": "Local Institution", "city": "Morelia", "state": "Michioacan", "country": "Mexico", "geoPoint": {"lat": 19.70078, "lon": -101.18443}}, {"facility": "Local Institution", "city": "Monterrey", "state": "Nuevo Leon", "country": "Mexico", "geoPoint": {"lat": 25.67507, "lon": -100.31847}}, {"facility": "Local Institution", "city": "Hermosillo", "state": "Sonora", "country": "Mexico", "geoPoint": {"lat": 29.1026, "lon": -110.97732}}, {"facility": "Local Institution", "city": "Merida", "state": "Yucatan", "country": "Mexico", "geoPoint": {"lat": 20.97537, "lon": -89.61696}}, {"facility": "Local Institution", "city": "Distrito Federal", "country": "Mexico", "geoPoint": {"lat": 16.59, "lon": -93.02694}}, {"facility": "Local Institution", "city": "Durango", "country": "Mexico", "geoPoint": {"lat": 24.02032, "lon": -104.65756}}, {"facility": "Local Institution", "city": "Carolina", "country": "Puerto Rico", "geoPoint": {"lat": 18.38078, "lon": -65.95739}}, {"facility": "Local Institution", "city": "Ponce", "country": "Puerto Rico", "geoPoint": {"lat": 18.01108, "lon": -66.61406}}, {"facility": "Local Institution", "city": "Rio Pieoras", "country": "Puerto Rico"}, {"facility": "Local Institution", "city": "San Juan", "country": "Puerto Rico", "geoPoint": {"lat": 18.46633, "lon": -66.10572}}, {"facility": "Local Institution", "city": "Hualien", "country": "Taiwan"}, {"facility": "Local Institution", "city": "Taichung", "country": "Taiwan", "geoPoint": {"lat": 24.1469, "lon": 120.6839}}, {"facility": "Local Institution", "city": "Taipei", "country": "Taiwan", "geoPoint": {"lat": 25.04776, "lon": 121.53185}}]}, "referencesModule": {"references": [{"pmid": "19478198", "type": "BACKGROUND", "citation": "DeFronzo RA, Hissa MN, Garber AJ, Luiz Gross J, Yuyan Duan R, Ravichandran S, Chen RS; Saxagliptin 014 Study Group. The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with metformin alone. Diabetes Care. 2009 Sep;32(9):1649-55. doi: 10.2337/dc08-1984. Epub 2009 May 28."}, {"pmid": "31364269", "type": "DERIVED", "citation": "Bailey CJ, Del Prato S, Wei C, Reyner D, Saraiva G. Durability of glycaemic control with dapagliflozin, an SGLT2 inhibitor, compared with saxagliptin, a DPP4 inhibitor, in patients with inadequately controlled type 2 diabetes. Diabetes Obes Metab. 2019 Nov;21(11):2564-2569. doi: 10.1111/dom.13841. Epub 2019 Aug 26."}, {"pmid": "27402391", "type": "DERIVED", "citation": "Perl S, Cook W, Wei C, Iqbal N, Hirshberg B. Saxagliptin Efficacy and Safety in Patients With Type 2 Diabetes and Moderate Renal Impairment. Diabetes Ther. 2016 Sep;7(3):527-35. doi: 10.1007/s13300-016-0184-9. Epub 2016 Jul 11."}, {"pmid": "27033025", "type": "DERIVED", "citation": "Bonora E, Bryzinski B, Hirshberg B, Cook W. A post hoc analysis of saxagliptin efficacy and safety in patients with type 2 diabetes stratified by UKPDS 10-year cardiovascular risk score. Nutr Metab Cardiovasc Dis. 2016 May;26(5):374-9. doi: 10.1016/j.numecd.2015.11.004. Epub 2015 Dec 1."}, {"pmid": "23802840", "type": "DERIVED", "citation": "Rosenstock J, Gross JL, Aguilar-Salinas C, Hissa M, Berglind N, Ravichandran S, Fleming D. Long-term 4-year safety of saxagliptin in drug-naive and metformin-treated patients with Type 2 diabetes. Diabet Med. 2013 Dec;30(12):1472-6. doi: 10.1111/dme.12267. Epub 2013 Jul 19."}, {"pmid": "23795975", "type": "DERIVED", "citation": "Karyekar CS, Frederich R, Ravichandran S. Clinically relevant reductions in HbA1c without hypoglycaemia: results across four studies of saxagliptin. Int J Clin Pract. 2013 Aug;67(8):759-67. doi: 10.1111/ijcp.12212. Epub 2013 Jun 24."}, {"pmid": "21680990", "type": "DERIVED", "citation": "Karyekar C, Donovan M, Allen E, Fleming D, Ravichandran S, Chen R. Efficacy and safety of saxagliptin combination therapy in US patients with type 2 diabetes. Postgrad Med. 2011 Jul;123(4):63-70. doi: 10.3810/pgm.2011.07.2305."}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "1462 participants were enrolled, and 787 entered the lead-in period. 45 discontinued the during the lead-in period. 19 subjects no longer met study criteria, 10 subjects withdrew consent, and 2 subjects were randomized but not treated.", "groups": [{"id": "FG000", "title": "Saxagliptin 2.5 mg + Metformin", "description": "Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "FG001", "title": "Saxagliptin 5 mg + Metformin", "description": "Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "FG002", "title": "Saxagliptin 10 mg + Metformin", "description": "Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "FG003", "title": "Placebo+ Metformin", "description": "Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}], "periods": [{"title": "Short Term (ST) Period", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "192"}, {"groupId": "FG001", "numSubjects": "191"}, {"groupId": "FG002", "numSubjects": "181"}, {"groupId": "FG003", "numSubjects": "179"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "148"}, {"groupId": "FG001", "numSubjects": "143"}, {"groupId": "FG002", "numSubjects": "140"}, {"groupId": "FG003", "numSubjects": "112"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "44"}, {"groupId": "FG001", "numSubjects": "48"}, {"groupId": "FG002", "numSubjects": "41"}, {"groupId": "FG003", "numSubjects": "67"}]}], "dropWithdraws": [{"type": "Lack of Efficacy", "reasons": [{"groupId": "FG000", "numSubjects": "25"}, {"groupId": "FG001", "numSubjects": "22"}, {"groupId": "FG002", "numSubjects": "27"}, {"groupId": "FG003", "numSubjects": "44"}]}, {"type": "Subject Withdrew Consent", "reasons": [{"groupId": "FG000", "numSubjects": "8"}, {"groupId": "FG001", "numSubjects": "13"}, {"groupId": "FG002", "numSubjects": "4"}, {"groupId": "FG003", "numSubjects": "11"}]}, {"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "5"}, {"groupId": "FG001", "numSubjects": "6"}, {"groupId": "FG002", "numSubjects": "5"}, {"groupId": "FG003", "numSubjects": "3"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "4"}, {"groupId": "FG002", "numSubjects": "4"}, {"groupId": "FG003", "numSubjects": "3"}]}, {"type": "Poor / Non-compliance", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "1"}, {"groupId": "FG003", "numSubjects": "2"}]}, {"type": "Subject No Longer Meets Study Criteria", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "2"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "2"}]}, {"type": "Other Reason", "reasons": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}]}, {"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "1"}]}, {"type": "Pregnancy", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "1"}]}]}, {"title": "Short Term (ST) + Long Term (LT) Period", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "192"}, {"groupId": "FG001", "numSubjects": "191"}, {"groupId": "FG002", "numSubjects": "181"}, {"groupId": "FG003", "numSubjects": "179"}]}, {"type": "Completed Study Without Being Rescued", "achievements": [{"groupId": "FG000", "numSubjects": "14"}, {"groupId": "FG001", "numSubjects": "18"}, {"groupId": "FG002", "numSubjects": "23"}, {"groupId": "FG003", "numSubjects": "7"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "64"}, {"groupId": "FG001", "numSubjects": "58"}, {"groupId": "FG002", "numSubjects": "68"}, {"groupId": "FG003", "numSubjects": "39"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "128"}, {"groupId": "FG001", "numSubjects": "133"}, {"groupId": "FG002", "numSubjects": "113"}, {"groupId": "FG003", "numSubjects": "140"}]}], "dropWithdraws": [{"type": "Lack of Efficacy", "reasons": [{"groupId": "FG000", "numSubjects": "54"}, {"groupId": "FG001", "numSubjects": "51"}, {"groupId": "FG002", "numSubjects": "42"}, {"groupId": "FG003", "numSubjects": "65"}]}, {"type": "Subject Withdrew Consent", "reasons": [{"groupId": "FG000", "numSubjects": "38"}, {"groupId": "FG001", "numSubjects": "34"}, {"groupId": "FG002", "numSubjects": "26"}, {"groupId": "FG003", "numSubjects": "30"}]}, {"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "12"}, {"groupId": "FG001", "numSubjects": "18"}, {"groupId": "FG002", "numSubjects": "13"}, {"groupId": "FG003", "numSubjects": "10"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "11"}, {"groupId": "FG001", "numSubjects": "11"}, {"groupId": "FG002", "numSubjects": "13"}, {"groupId": "FG003", "numSubjects": "16"}]}, {"type": "Other Reason", "reasons": [{"groupId": "FG000", "numSubjects": "5"}, {"groupId": "FG001", "numSubjects": "7"}, {"groupId": "FG002", "numSubjects": "6"}, {"groupId": "FG003", "numSubjects": "3"}]}, {"type": "Subject No Longer Meets Study Criteria", "reasons": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "6"}, {"groupId": "FG002", "numSubjects": "5"}, {"groupId": "FG003", "numSubjects": "9"}]}, {"type": "Poor / Non-compliance", "reasons": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "5"}, {"groupId": "FG002", "numSubjects": "8"}, {"groupId": "FG003", "numSubjects": "4"}]}, {"type": "Pregnancy", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "1"}]}, {"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "2"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Saxagliptin 2.5 mg + Metformin", "description": "Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "BG001", "title": "Saxagliptin 5 mg + Metformin", "description": "Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "BG002", "title": "Saxagliptin 10 mg + Metformin", "description": "Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "BG003", "title": "Placebo+ Metformin", "description": "Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "BG004", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "192"}, {"groupId": "BG001", "value": "191"}, {"groupId": "BG002", "value": "181"}, {"groupId": "BG003", "value": "179"}, {"groupId": "BG004", "value": "743"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "54.66", "spread": "10.08"}, {"groupId": "BG001", "value": "54.69", "spread": "9.62"}, {"groupId": "BG002", "value": "54.18", "spread": "10.14"}, {"groupId": "BG003", "value": "54.76", "spread": "10.18"}, {"groupId": "BG004", "value": "54.57", "spread": "9.98"}]}]}]}, {"title": "Age, Customized", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "< 65 years", "categories": [{"measurements": [{"groupId": "BG000", "value": "159"}, {"groupId": "BG001", "value": "159"}, {"groupId": "BG002", "value": "155"}, {"groupId": "BG003", "value": "153"}, {"groupId": "BG004", "value": "626"}]}]}, {"title": ">= 65 years", "categories": [{"measurements": [{"groupId": "BG000", "value": "33"}, {"groupId": "BG001", "value": "32"}, {"groupId": "BG002", "value": "26"}, {"groupId": "BG003", "value": "26"}, {"groupId": "BG004", "value": "117"}]}]}, {"title": ">= 75 years", "categories": [{"measurements": [{"groupId": "BG000", "value": "3"}, {"groupId": "BG001", "value": "2"}, {"groupId": "BG002", "value": "5"}, {"groupId": "BG003", "value": "3"}, {"groupId": "BG004", "value": "13"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "109"}, {"groupId": "BG001", "value": "88"}, {"groupId": "BG002", "value": "86"}, {"groupId": "BG003", "value": "83"}, {"groupId": "BG004", "value": "366"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "83"}, {"groupId": "BG001", "value": "103"}, {"groupId": "BG002", "value": "95"}, {"groupId": "BG003", "value": "96"}, {"groupId": "BG004", "value": "377"}]}]}]}, {"title": "Race/Ethnicity, Customized", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "White", "categories": [{"measurements": [{"groupId": "BG000", "value": "153"}, {"groupId": "BG001", "value": "159"}, {"groupId": "BG002", "value": "144"}, {"groupId": "BG003", "value": "150"}, {"groupId": "BG004", "value": "606"}]}]}, {"title": "Black / African American", "categories": [{"measurements": [{"groupId": "BG000", "value": "8"}, {"groupId": "BG001", "value": "11"}, {"groupId": "BG002", "value": "14"}, {"groupId": "BG003", "value": "7"}, {"groupId": "BG004", "value": "40"}]}]}, {"title": "Asian", "categories": [{"measurements": [{"groupId": "BG000", "value": "8"}, {"groupId": "BG001", "value": "3"}, {"groupId": "BG002", "value": "5"}, {"groupId": "BG003", "value": "4"}, {"groupId": "BG004", "value": "20"}]}]}, {"title": "Other", "categories": [{"measurements": [{"groupId": "BG000", "value": "23"}, {"groupId": "BG001", "value": "18"}, {"groupId": "BG002", "value": "18"}, {"groupId": "BG003", "value": "18"}, {"groupId": "BG004", "value": "77"}]}]}]}, {"title": "Race/Ethnicity, Customized", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "Hispanic / Latino", "categories": [{"measurements": [{"groupId": "BG000", "value": "27"}, {"groupId": "BG001", "value": "25"}, {"groupId": "BG002", "value": "29"}, {"groupId": "BG003", "value": "27"}, {"groupId": "BG004", "value": "108"}]}]}, {"title": "Not Hispanic / Latino", "categories": [{"measurements": [{"groupId": "BG000", "value": "64"}, {"groupId": "BG001", "value": "62"}, {"groupId": "BG002", "value": "54"}, {"groupId": "BG003", "value": "49"}, {"groupId": "BG004", "value": "229"}]}]}, {"title": "Not Reported", "categories": [{"measurements": [{"groupId": "BG000", "value": "101"}, {"groupId": "BG001", "value": "104"}, {"groupId": "BG002", "value": "98"}, {"groupId": "BG003", "value": "103"}, {"groupId": "BG004", "value": "406"}]}]}]}, {"title": "Age Characterization Female Only", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "=< 50 years", "categories": [{"measurements": [{"groupId": "BG000", "value": "33"}, {"groupId": "BG001", "value": "34"}, {"groupId": "BG002", "value": "24"}, {"groupId": "BG003", "value": "21"}, {"groupId": "BG004", "value": "112"}]}]}, {"title": "> 50 years", "categories": [{"measurements": [{"groupId": "BG000", "value": "76"}, {"groupId": "BG001", "value": "54"}, {"groupId": "BG002", "value": "62"}, {"groupId": "BG003", "value": "62"}, {"groupId": "BG004", "value": "254"}]}]}]}, {"title": "Weight", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "kg", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "85.97", "spread": "17.57"}, {"groupId": "BG001", "value": "87.26", "spread": "17.04"}, {"groupId": "BG002", "value": "87.83", "spread": "18.90"}, {"groupId": "BG003", "value": "87.14", "spread": "17.75"}, {"groupId": "BG004", "value": "87.04", "spread": "17.79"}]}]}]}, {"title": "Body Mass Index", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "kg/m^2", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "31.68", "spread": "5.15"}, {"groupId": "BG001", "value": "31.23", "spread": "4.67"}, {"groupId": "BG002", "value": "31.12", "spread": "4.79"}, {"groupId": "BG003", "value": "31.57", "spread": "4.80"}, {"groupId": "BG004", "value": "31.40", "spread": "4.85"}]}]}]}, {"title": "Body Mass Index Categorization", "paramType": "NUMBER", "unitOfMeasure": "Participants", "classes": [{"title": "< 30", "categories": [{"measurements": [{"groupId": "BG000", "value": "75"}, {"groupId": "BG001", "value": "84"}, {"groupId": "BG002", "value": "82"}, {"groupId": "BG003", "value": "76"}, {"groupId": "BG004", "value": "317"}]}]}, {"title": ">= 30", "categories": [{"measurements": [{"groupId": "BG000", "value": "117"}, {"groupId": "BG001", "value": "107"}, {"groupId": "BG002", "value": "99"}, {"groupId": "BG003", "value": "103"}, {"groupId": "BG004", "value": "426"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Baseline and Change From Baseline in Hemoglobin A1c (A1C) at Week 24", "description": "Mean change from baseline is adjusted for baseline value.", "populationDescription": "Randomized participants with both a baseline and post-baseline value (up to Week 24)", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "percentage of glycosylated hemoglobins", "timeFrame": "Baseline, Week 24", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg + Metformin", "description": "Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg + Metformin", "description": "Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg + Metformin", "description": "Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo+ Metformin", "description": "Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "186"}, {"groupId": "OG001", "value": "186"}, {"groupId": "OG002", "value": "180"}, {"groupId": "OG003", "value": "175"}]}], "classes": [{"title": "Baseline Mean", "categories": [{"measurements": [{"groupId": "OG000", "value": "8.08", "spread": "0.07"}, {"groupId": "OG001", "value": "8.07", "spread": "0.06"}, {"groupId": "OG002", "value": "7.98", "spread": "0.08"}, {"groupId": "OG003", "value": "8.06", "spread": "0.07"}]}]}, {"title": "Adjusted Mean Change from Baseline", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.59", "spread": "0.07"}, {"groupId": "OG001", "value": "-0.69", "spread": "0.07"}, {"groupId": "OG002", "value": "-0.58", "spread": "0.07"}, {"groupId": "OG003", "value": "0.13", "spread": "0.07"}]}]}], "analyses": [{"groupIds": ["OG000", "OG003"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<.0001", "pValueComment": "Between-group comparisons significant at alpha = 0.019, significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.", "statisticalMethod": "ANCOVA", "statisticalComment": "Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF). Adjusted for baseline.", "paramType": "Mean Difference (Final Values)", "paramValue": "-0.73", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.92", "ciUpperLimit": "-0.53", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.10", "estimateComment": "ANCOVA model: difference between week t and baseline values = baseline values + treatment"}, {"groupIds": ["OG001", "OG003"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<.0001", "pValueComment": "Between-group comparisons significant at alpha = 0.019, significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.", "statisticalMethod": "ANCOVA", "statisticalComment": "Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF). Adjusted for baseline.", "paramType": "Mean Difference (Final Values)", "paramValue": "-0.83", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-1.02", "ciUpperLimit": "-0.63", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.10", "estimateComment": "ANCOVA model: difference between week t and baseline values = baseline values + treatment"}, {"groupIds": ["OG002", "OG003"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<.0001", "pValueComment": "Between-group comparisons significant at alpha = 0.019, significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.", "statisticalMethod": "ANCOVA", "statisticalComment": "Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF) .Adjusted for baseline.", "paramType": "Mean Difference (Final Values)", "paramValue": "-0.72", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.91", "ciUpperLimit": "-0.52", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.10", "estimateComment": "ANCOVA model: difference between week t and baseline values = baseline values + treatment"}]}, {"type": "SECONDARY", "title": "Baseline and Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24", "description": "Mean change from baseline is adjusted for baseline value.", "populationDescription": "Randomized Participants with measurement at timepoint. Last Observation Carried Forward (LOCF).", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "mg/dL", "timeFrame": "Baseline, Week 24", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg + Metformin", "description": "Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg + Metformin", "description": "Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg + Metformin", "description": "Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo+ Metformin", "description": "Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "188"}, {"groupId": "OG001", "value": "187"}, {"groupId": "OG002", "value": "181"}, {"groupId": "OG003", "value": "176"}]}], "classes": [{"title": "Baseline Mean", "categories": [{"measurements": [{"groupId": "OG000", "value": "173.57", "spread": "3.23"}, {"groupId": "OG001", "value": "179.03", "spread": "3.44"}, {"groupId": "OG002", "value": "175.86", "spread": "3.73"}, {"groupId": "OG003", "value": "174.94", "spread": "3.27"}]}]}, {"title": "Adjusted Mean Change from Baseline", "categories": [{"measurements": [{"groupId": "OG000", "value": "-14.31", "spread": "2.48"}, {"groupId": "OG001", "value": "-22.03", "spread": "2.49"}, {"groupId": "OG002", "value": "-20.50", "spread": "2.53"}, {"groupId": "OG003", "value": "1.24", "spread": "2.56"}]}]}], "analyses": [{"groupIds": ["OG000", "OG003"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<.0001", "pValueComment": "Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.", "statisticalMethod": "ANCOVA", "statisticalComment": "Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF). Adjusted for baseline.", "paramType": "Mean Difference (Final Values)", "paramValue": "-15.55", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-22.55", "ciUpperLimit": "-8.55", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "3.56", "estimateComment": "ANCOVA model: difference between week t and baseline values = baseline values + treatment"}, {"groupIds": ["OG001", "OG003"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<.0001", "pValueComment": "Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.", "statisticalMethod": "ANCOVA", "statisticalComment": "Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF) .Adjusted for baseline.", "paramType": "Mean Difference (Final Values)", "paramValue": "-23.28", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-30.29", "ciUpperLimit": "-16.27", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "3.57", "estimateComment": "ANCOVA model: difference between week t and baseline values = baseline values + treatment"}, {"groupIds": ["OG002", "OG003"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<.0001", "pValueComment": "Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.", "statisticalMethod": "ANCOVA", "statisticalComment": "Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF) .Adjusted for baseline.", "paramType": "Mean Difference (Final Values)", "paramValue": "-21.74", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-28.81", "ciUpperLimit": "-14.68", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "3.60", "estimateComment": "ANCOVA model: difference between week t and baseline values = baseline values + treatment"}]}, {"type": "SECONDARY", "title": "Percentage of Participants Achieving Therapeutic Glycemic Response (A1C < 7.0%) at Week 24", "populationDescription": "Randomized Participants with measurement at time point, Last Observation Carried Forward (LOCF)", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage of participants", "timeFrame": "Week 24", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg + Metformin", "description": "Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg + Metformin", "description": "Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg + Metformin", "description": "Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo+ Metformin", "description": "Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "186"}, {"groupId": "OG001", "value": "186"}, {"groupId": "OG002", "value": "180"}, {"groupId": "OG003", "value": "175"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "37.1"}, {"groupId": "OG001", "value": "43.5"}, {"groupId": "OG002", "value": "44.4"}, {"groupId": "OG003", "value": "16.6"}]}]}], "analyses": [{"groupIds": ["OG000", "OG003"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<.0001", "pValueComment": "Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.", "statisticalMethod": "Fisher Exact", "statisticalComment": "The exact 95% CIs is based on the standardized statistic and inverting the one 2-sided test.", "paramType": "Difference in Proportions", "paramValue": "20.5", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "10.6", "ciUpperLimit": "30.5"}, {"groupIds": ["OG001", "OG003"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<.0001", "pValueComment": "Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.", "statisticalMethod": "Fisher Exact", "statisticalComment": "The exact 95% CIs is based on the standardized statistic and inverting the one 2-sided test.", "paramType": "Difference in Proportions", "paramValue": "27.0", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "17.0", "ciUpperLimit": "36.7"}, {"groupIds": ["OG002", "OG003"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<.0001", "pValueComment": "Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.", "statisticalMethod": "Fisher Exact", "statisticalComment": "The exact 95% CIs is based on the standardized statistic and inverting the one 2-sided test.", "paramType": "Difference in Proportions", "paramValue": "27.9", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "17.7", "ciUpperLimit": "37.7"}]}, {"type": "SECONDARY", "title": "Baseline and Change From Baseline at Week 24 in Postprandial Glucose (PPG) Area Under the Curve (AUC)", "description": "Mean change from baseline is adjusted for baseline value.", "populationDescription": "Randomized Participants with measurement at timepoint. Last Observation Carried Forward (LOCF).", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "mg*min/dL", "timeFrame": "Baseline, Week 24", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg + Metformin", "description": "Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg + Metformin", "description": "Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg + Metformin", "description": "Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo+ Metformin", "description": "Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "150"}, {"groupId": "OG001", "value": "146"}, {"groupId": "OG002", "value": "148"}, {"groupId": "OG003", "value": "131"}]}], "classes": [{"title": "Baseline Mean", "categories": [{"measurements": [{"groupId": "OG000", "value": "48224", "spread": "869.70"}, {"groupId": "OG001", "value": "49021", "spread": "876.17"}, {"groupId": "OG002", "value": "44931", "spread": "889.85"}, {"groupId": "OG003", "value": "47407", "spread": "1071.9"}]}]}, {"title": "Adjusted Mean Change from Baseline", "categories": [{"measurements": [{"groupId": "OG000", "value": "-8891", "spread": "797.97"}, {"groupId": "OG001", "value": "-9586", "spread": "810.46"}, {"groupId": "OG002", "value": "-8137", "spread": "807.88"}, {"groupId": "OG003", "value": "-3291", "spread": "853.24"}]}]}], "analyses": [{"groupIds": ["OG000", "OG003"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<.0001", "pValueComment": "Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.", "statisticalMethod": "ANCOVA", "statisticalComment": "Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF). Adjusted for baseline.", "paramType": "Mean Difference (Final Values)", "paramValue": "-5599", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-7894", "ciUpperLimit": "-3305", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "1168.2", "estimateComment": "ANCOVA model: difference between week t and baseline values = baseline values + treatment"}, {"groupIds": ["OG001", "OG003"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<.0001", "pValueComment": "Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.", "statisticalMethod": "ANCOVA", "statisticalComment": "Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF). Adjusted for baseline.", "paramType": "Mean Difference (Final Values)", "paramValue": "-6294", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-8606", "ciUpperLimit": "-3983", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "1176.8", "estimateComment": "ANCOVA model: difference between week t and baseline values = baseline values + treatment"}, {"groupIds": ["OG002", "OG003"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<.0001", "pValueComment": "Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.", "statisticalMethod": "ANCOVA", "statisticalComment": "Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF). Adjusted for baseline.", "paramType": "Mean Difference (Final Values)", "paramValue": "-4845", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-7153", "ciUpperLimit": "-2537", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "1175.1", "estimateComment": "ANCOVA model: difference between week t and baseline values = baseline values + treatment"}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Overall Summary of Adverse Events During ST+LT Treatment Period", "description": "AE=any new untoward medical occurrence or worsening of a pre-existing medical condition which does not necessarily have a causal relationship with this treatment. SAE=any untoward medical occurrence that at any dose: results in death, is life-threatening, requires inpatient hospitalization or causes prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, results in development of drug dependency or drug abuse, is an important medical event. Related events=relationship of certain, probable, possible, or missing.", "populationDescription": "All treated participants", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "AEs: up to last treatment day + 1 day or last visit day in the ST+LT period; SAEs: up to last treatment day + 30 days or last visit day + 30 days in the LT+ST period. Mean duration of exposure: 124, 118, 130, 95 wks respectively for 2.5mg, 5mg, 10 mg, pla", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg + Metformin", "description": "Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg + Metformin", "description": "Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg + Metformin", "description": "Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo+ Metformin", "description": "Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "192"}, {"groupId": "OG001", "value": "191"}, {"groupId": "OG002", "value": "181"}, {"groupId": "OG003", "value": "179"}]}], "classes": [{"title": "At Least 1 AE", "categories": [{"measurements": [{"groupId": "OG000", "value": "177"}, {"groupId": "OG001", "value": "155"}, {"groupId": "OG002", "value": "161"}, {"groupId": "OG003", "value": "142"}]}]}, {"title": "At Least 1 Related AE", "categories": [{"measurements": [{"groupId": "OG000", "value": "53"}, {"groupId": "OG001", "value": "57"}, {"groupId": "OG002", "value": "65"}, {"groupId": "OG003", "value": "56"}]}]}, {"title": "Deaths", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "2"}]}]}, {"title": "At Least 1 SAE", "categories": [{"measurements": [{"groupId": "OG000", "value": "23"}, {"groupId": "OG001", "value": "27"}, {"groupId": "OG002", "value": "22"}, {"groupId": "OG003", "value": "15"}]}]}, {"title": "At Least 1 Related SAE", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "3"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "1"}]}]}, {"title": "Discontinuations Due to SAEs", "categories": [{"measurements": [{"groupId": "OG000", "value": "4"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "6"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Discontinuations Due to AEs", "categories": [{"measurements": [{"groupId": "OG000", "value": "11"}, {"groupId": "OG001", "value": "18"}, {"groupId": "OG002", "value": "13"}, {"groupId": "OG003", "value": "9"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Marked Laboratory Abnormalities - During ST + LT Treatment Period", "description": "A laboratory value was considered a marked abnormality if it is outside the pre-defined criteria for marked abnormality and the on-treatment value was more extreme (farther from the limit) than the baseline value. Pre-Rx=pretreatment; ULN=upper limit of normal; ALP=alkaline phosphatase; AST=aspartate aminotransferase; ALT=alanine aminotransferase; unspec=unspecified; sodium serum low: \\<0.9 x Pre-Rx \\& \\<=130mEq/L / high: \\>1.1 x Pre-Rx \\& \\>=150mEq/L; potassium, serum low: \\<=0.8 x Pre-Rx \\& \\>=6.0mEq/L / high: 1.2 x Pre-Rx \\& \\>=6.0mEq/L; LLN=lower limit of normal.", "populationDescription": "Number of Participants Analyzed=Treated participants; n=number of treated subjects with baseline value and at least one value during the ST + LT treatment period", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "Lab assessments taken during and up to 14 days after the last dose of study drug during the ST + LT Treatment Period. Mean duration of exposure: 124, 118, 130, 95 weeks, respectively, for 2.5mg, 5mg, 10 mg, placebo.", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg + Metformin", "description": "Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg + Metformin", "description": "Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg + Metformin", "description": "Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo+ Metformin", "description": "Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "192"}, {"groupId": "OG001", "value": "191"}, {"groupId": "OG002", "value": "181"}, {"groupId": "OG003", "value": "179"}]}], "classes": [{"title": "Hemoglobin < 8 g/dL (n=189, 190, 181, 179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Hematocrit < 0.75 x pre-Rx (n=189, 190, 181, 179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "5"}, {"groupId": "OG002", "value": "5"}, {"groupId": "OG003", "value": "2"}]}]}, {"title": "Platelets < 50 x 10^9 c/L (n=189, 188, 181, 178)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Platelets > 1.5 x ULN (n=189, 188, 181, 178)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "4"}, {"groupId": "OG003", "value": "1"}]}]}, {"title": "Leukocytes < 2 x 1000 c/\u00b5L (n=189, 190, 181, 179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Neutrophils+Bands <1x1000 c/\u00b5L (n=189,190,181,179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "1"}]}]}, {"title": "Eosinophils >0.9x1000 c/\u00b5L (n=189, 190, 181, 179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "12"}, {"groupId": "OG001", "value": "12"}, {"groupId": "OG002", "value": "18"}, {"groupId": "OG003", "value": "9"}]}]}, {"title": "Lymphocytes <=0.75x1000 c/\u00b5L (n=189,190,181,179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "4"}, {"groupId": "OG002", "value": "4"}, {"groupId": "OG003", "value": "2"}]}]}, {"title": "ALP >3 x pre-Rx and >ULN (n=190, 190, 181, 179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "ALP >1.5 x ULN (n=190, 190, 181, 179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "3"}]}]}, {"title": "AST >3 x ULN (n=190, 190, 181, 179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "6"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "3"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "AST >5 x ULN (n=190, 190, 181, 179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "AST >10 x ULN (n=190, 190, 181, 179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "AST >20 x ULN (n=190, 190, 181, 179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "ALT >3 x ULN (n=190, 190, 181, 179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "4"}, {"groupId": "OG001", "value": "4"}, {"groupId": "OG002", "value": "4"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "ALT >5 x ULN (n=190, 190, 181, 179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "ALT >10 x ULN (n=190, 190, 181, 179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "ALT >20 x ULN (n=190, 190, 181, 179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Bilirubin Total >2mg/dL (n=190,190,181,179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "1"}]}]}, {"title": "Bilirubin Total >1.5xULN (n=190,190,181,179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "1"}]}]}, {"title": "Bilirubin Total >2xULN (n=190,190,181,179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "BUN >2 x pre-Rx and >ULN (n=190,190,181,179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "12"}, {"groupId": "OG001", "value": "9"}, {"groupId": "OG002", "value": "6"}, {"groupId": "OG003", "value": "9"}]}]}, {"title": "Creatinine >2.5 mg/dL (n=190,190,181,179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "1"}]}]}, {"title": "Glucose, Serum Fasting < 50 mg/dL (n=0, 0, 0, 0)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Glucose, Serum Fasting > 500 mg/dL (n=0, 0, 0, 0)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Glucose, Serum Unspec. < 50 mg/dL (n=0,0,0,0)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Glucose, Serum Unspec. > 500 mg/dL (n=0,0,0,0)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Glucose, Plasma Fasting<50mg/dL(n=189,189,181,179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "3"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "3"}]}]}, {"title": "Glucose,Plasma Fasting>500mg/dL(n=189,189,181,179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Glucose, Plasma Unspec.<50mg/dL(n=192,191,181,179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "19"}, {"groupId": "OG001", "value": "7"}, {"groupId": "OG002", "value": "9"}, {"groupId": "OG003", "value": "9"}]}]}, {"title": "Glucose,Plasma Unspec.>500mg/dL(n=192,191,181,179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "1"}]}]}, {"title": "Sodium,Serum Low (*) (n=190,190,181,179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "2"}, {"groupId": "OG002", "value": "4"}, {"groupId": "OG003", "value": "1"}]}]}, {"title": "Sodium,Serum High (*) (n=190,190,181,179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Potassium, Serum Low (*) (n=190,190,181,179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "1"}]}]}, {"title": "Potassium, Serum High (n=190,190,181,179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "4"}, {"groupId": "OG001", "value": "5"}, {"groupId": "OG002", "value": "5"}, {"groupId": "OG003", "value": "7"}]}]}, {"title": "Chloride < 90 mEq/L (n=190, 190, 181, 179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "3"}, {"groupId": "OG002", "value": "3"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Chloride > 120 mEq/L (n=190, 190, 181, 179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Albumin < 0.9 LLN (n=190, 190, 181, 179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Creatine Kinase > 5 x ULN (n=190, 190, 181, 179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "2"}, {"groupId": "OG002", "value": "3"}, {"groupId": "OG003", "value": "1"}]}]}, {"title": "Uric Acid > 1.5 x ULN (n=0, 0, 0, 0)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}, {"title": "Protein Urine, >=2-4 (n=187, 189, 180, 178)", "categories": [{"measurements": [{"groupId": "OG000", "value": "7"}, {"groupId": "OG001", "value": "9"}, {"groupId": "OG002", "value": "13"}, {"groupId": "OG003", "value": "12"}]}]}, {"title": "Blood Urine, >=2-4 (n=187, 189, 180, 178)", "categories": [{"measurements": [{"groupId": "OG000", "value": "17"}, {"groupId": "OG001", "value": "21"}, {"groupId": "OG002", "value": "18"}, {"groupId": "OG003", "value": "13"}]}]}, {"title": "Red Blood Cells Urine >=2-4 (n=175,176,162,166)", "categories": [{"measurements": [{"groupId": "OG000", "value": "28"}, {"groupId": "OG001", "value": "27"}, {"groupId": "OG002", "value": "22"}, {"groupId": "OG003", "value": "20"}]}]}, {"title": "White Blood Cells Urine >=2-4 (n=175,176,162,166)", "categories": [{"measurements": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "38"}, {"groupId": "OG002", "value": "26"}, {"groupId": "OG003", "value": "28"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Baseline and Changes From Baseline in Hemoglobin During the ST + LT Period", "populationDescription": "Treated participants; n=number of treated participants with measurement at time point", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "g/dL", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg + Metformin", "description": "Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg + Metformin", "description": "Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg + Metformin", "description": "Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo+ Metformin", "description": "Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "192"}, {"groupId": "OG001", "value": "191"}, {"groupId": "OG002", "value": "181"}, {"groupId": "OG003", "value": "179"}]}], "classes": [{"title": "Baseline (BL) (Week 0) (n=192, 191, 181, 179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "14.06", "spread": "0.098"}, {"groupId": "OG001", "value": "14.18", "spread": "0.094"}, {"groupId": "OG002", "value": "14.18", "spread": "0.103"}, {"groupId": "OG003", "value": "13.99", "spread": "0.096"}]}]}, {"title": "Change from BL at Week 2 (n=181, 177, 172, 169)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.08", "spread": "0.044"}, {"groupId": "OG001", "value": "-0.18", "spread": "0.052"}, {"groupId": "OG002", "value": "-0.18", "spread": "0.044"}, {"groupId": "OG003", "value": "-0.09", "spread": "0.046"}]}]}, {"title": "Change from BL at Week 4 (n=178, 178, 174, 166)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.07", "spread": "0.052"}, {"groupId": "OG001", "value": "-0.15", "spread": "0.047"}, {"groupId": "OG002", "value": "-0.09", "spread": "0.053"}, {"groupId": "OG003", "value": "0.03", "spread": "0.056"}]}]}, {"title": "Change from BL at Week 6 (n=176, 174, 166, 160)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.06", "spread": "0.052"}, {"groupId": "OG001", "value": "-0.15", "spread": "0.050"}, {"groupId": "OG002", "value": "-0.07", "spread": "0.050"}, {"groupId": "OG003", "value": "0.00", "spread": "0.055"}]}]}, {"title": "Change from BL at Week 8 (n=173, 176, 165, 157)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.07", "spread": "0.058"}, {"groupId": "OG001", "value": "-0.07", "spread": "0.051"}, {"groupId": "OG002", "value": "-0.02", "spread": "0.055"}, {"groupId": "OG003", "value": "0.01", "spread": "0.056"}]}]}, {"title": "Change from BL at Week 10 (n=149, 134, 137, 131)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.16", "spread": "0.061"}, {"groupId": "OG001", "value": "-0.17", "spread": "0.057"}, {"groupId": "OG002", "value": "-0.16", "spread": "0.067"}, {"groupId": "OG003", "value": "-0.16", "spread": "0.064"}]}]}, {"title": "Change from BL at Week 12 (n=170, 167, 160, 144)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.05", "spread": "0.059"}, {"groupId": "OG001", "value": "-0.11", "spread": "0.054"}, {"groupId": "OG002", "value": "0.03", "spread": "0.055"}, {"groupId": "OG003", "value": "-0.05", "spread": "0.065"}]}]}, {"title": "Change from BL at Week 14 (n=156, 154, 146, 139)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.15", "spread": "0.059"}, {"groupId": "OG001", "value": "-0.20", "spread": "0.055"}, {"groupId": "OG002", "value": "-0.10", "spread": "0.068"}, {"groupId": "OG003", "value": "-0.02", "spread": "0.066"}]}]}, {"title": "Change from BL at Week 16 (n=167, 166, 159, 140)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.12", "spread": "0.059"}, {"groupId": "OG001", "value": "-0.13", "spread": "0.052"}, {"groupId": "OG002", "value": "-0.10", "spread": "0.060"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.060"}]}]}, {"title": "Change from BL at Week 18 (n=155, 158, 149, 141)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.24", "spread": "0.069"}, {"groupId": "OG001", "value": "-0.28", "spread": "0.050"}, {"groupId": "OG002", "value": "-0.19", "spread": "0.059"}, {"groupId": "OG003", "value": "-0.09", "spread": "0.062"}]}]}, {"title": "Change from BL at Week 20 (n=162, 153, 154, 147)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.16", "spread": "0.059"}, {"groupId": "OG001", "value": "-0.23", "spread": "0.061"}, {"groupId": "OG002", "value": "-0.10", "spread": "0.060"}, {"groupId": "OG003", "value": "-0.12", "spread": "0.060"}]}]}, {"title": "Change from BL at Week 22 (n=157, 152, 143, 138)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.21", "spread": "0.064"}, {"groupId": "OG001", "value": "-0.33", "spread": "0.063"}, {"groupId": "OG002", "value": "-0.25", "spread": "0.062"}, {"groupId": "OG003", "value": "-0.23", "spread": "0.065"}]}]}, {"title": "Change from BL at Week 24 (n=164, 160, 159, 137)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.23", "spread": "0.064"}, {"groupId": "OG001", "value": "-0.30", "spread": "0.063"}, {"groupId": "OG002", "value": "-0.25", "spread": "0.057"}, {"groupId": "OG003", "value": "-0.24", "spread": "0.065"}]}]}, {"title": "Change from BL at Week 30 (n=161, 155, 154, 137)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.19", "spread": "0.059"}, {"groupId": "OG001", "value": "-0.29", "spread": "0.063"}, {"groupId": "OG002", "value": "-0.22", "spread": "0.071"}, {"groupId": "OG003", "value": "-0.18", "spread": "0.065"}]}]}, {"title": "Change from BL at Week 37 (n=152, 149, 146, 122)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.17", "spread": "0.068"}, {"groupId": "OG001", "value": "-0.29", "spread": "0.064"}, {"groupId": "OG002", "value": "-0.19", "spread": "0.067"}, {"groupId": "OG003", "value": "-0.17", "spread": "0.066"}]}]}, {"title": "Change from BL at Week 50 (n=151, 142, 146, 127)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.22", "spread": "0.061"}, {"groupId": "OG001", "value": "-0.22", "spread": "0.070"}, {"groupId": "OG002", "value": "-0.13", "spread": "0.066"}, {"groupId": "OG003", "value": "-0.12", "spread": "0.077"}]}]}, {"title": "Change from BL at Week 63 (n=148, 137, 142, 116)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.10", "spread": "0.068"}, {"groupId": "OG001", "value": "-0.28", "spread": "0.096"}, {"groupId": "OG002", "value": "-0.17", "spread": "0.067"}, {"groupId": "OG003", "value": "-0.07", "spread": "0.073"}]}]}, {"title": "Change from BL at Week 76 (n=134, 126, 130, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.27", "spread": "0.077"}, {"groupId": "OG001", "value": "-0.31", "spread": "0.080"}, {"groupId": "OG002", "value": "-0.26", "spread": "0.066"}, {"groupId": "OG003", "value": "-0.26", "spread": "0.083"}]}]}, {"title": "Change from BL at Week 89 (n=123, 114, 123, 85)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.22", "spread": "0.074"}, {"groupId": "OG001", "value": "-0.38", "spread": "0.075"}, {"groupId": "OG002", "value": "-0.32", "spread": "0.083"}, {"groupId": "OG003", "value": "-0.25", "spread": "0.088"}]}]}, {"title": "Change from BL at Week 102 (n=108, 104, 112, 70)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.36", "spread": "0.073"}, {"groupId": "OG001", "value": "-0.40", "spread": "0.085"}, {"groupId": "OG002", "value": "-0.27", "spread": "0.078"}, {"groupId": "OG003", "value": "-0.34", "spread": "0.100"}]}]}, {"title": "Change from BL at Week 115 (n=99, 94, 98, 58)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.26", "spread": "0.073"}, {"groupId": "OG001", "value": "-0.26", "spread": "0.082"}, {"groupId": "OG002", "value": "-0.36", "spread": "0.092"}, {"groupId": "OG003", "value": "-0.26", "spread": "0.106"}]}]}, {"title": "Change from BL at Week 128 (n=92, 88, 90, 52)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.40", "spread": "0.095"}, {"groupId": "OG001", "value": "-0.41", "spread": "0.097"}, {"groupId": "OG002", "value": "-0.39", "spread": "0.095"}, {"groupId": "OG003", "value": "-0.28", "spread": "0.105"}]}]}, {"title": "Change from BL at Week 141 (n=85, 79, 85, 48)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.49", "spread": "0.091"}, {"groupId": "OG001", "value": "-0.45", "spread": "0.093"}, {"groupId": "OG002", "value": "-0.42", "spread": "0.104"}, {"groupId": "OG003", "value": "-0.45", "spread": "0.132"}]}]}, {"title": "Change from BL at Week 154 (n=81, 74, 78, 45)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.59", "spread": "0.092"}, {"groupId": "OG001", "value": "-0.56", "spread": "0.105"}, {"groupId": "OG002", "value": "-0.47", "spread": "0.102"}, {"groupId": "OG003", "value": "-0.57", "spread": "0.107"}]}]}, {"title": "Change from BL at Week 167 (n=77, 67, 75, 42)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.49", "spread": "0.085"}, {"groupId": "OG001", "value": "-0.58", "spread": "0.127"}, {"groupId": "OG002", "value": "-0.53", "spread": "0.119"}, {"groupId": "OG003", "value": "-0.51", "spread": "0.137"}]}]}, {"title": "Change from BL at Week 180 (n=70, 61, 73, 41)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.62", "spread": "0.099"}, {"groupId": "OG001", "value": "-0.81", "spread": "0.154"}, {"groupId": "OG002", "value": "-0.46", "spread": "0.107"}, {"groupId": "OG003", "value": "-0.53", "spread": "0.129"}]}]}, {"title": "Change from BL at Week 193 (n=70, 60, 72, 40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.60", "spread": "0.103"}, {"groupId": "OG001", "value": "-0.82", "spread": "0.159"}, {"groupId": "OG002", "value": "-0.47", "spread": "0.101"}, {"groupId": "OG003", "value": "-0.53", "spread": "0.134"}]}]}, {"title": "Change from BL at Week 206 (n=61, 50, 64, 31)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.62", "spread": "0.108"}, {"groupId": "OG001", "value": "-0.87", "spread": "0.135"}, {"groupId": "OG002", "value": "-0.49", "spread": "0.101"}, {"groupId": "OG003", "value": "-0.75", "spread": "0.125"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Baseline and Changes From Baseline in Hematocrit During the ST + LT Period", "populationDescription": "Treated participants; n=number of treated participants with measurement at time point", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "percentage red blood cells", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg + Metformin", "description": "Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg + Metformin", "description": "Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg + Metformin", "description": "Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo+ Metformin", "description": "Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "192"}, {"groupId": "OG001", "value": "191"}, {"groupId": "OG002", "value": "181"}, {"groupId": "OG003", "value": "179"}]}], "classes": [{"title": "Baseline (Week 0) (n=192, 191, 181, 179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "41.9", "spread": "0.26"}, {"groupId": "OG001", "value": "42.3", "spread": "0.25"}, {"groupId": "OG002", "value": "42.2", "spread": "0.29"}, {"groupId": "OG003", "value": "41.8", "spread": "0.28"}]}]}, {"title": "Change from BL at Week 2 (n=181, 177, 172, 169)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.3", "spread": "0.15"}, {"groupId": "OG001", "value": "-0.5", "spread": "0.17"}, {"groupId": "OG002", "value": "-0.5", "spread": "0.15"}, {"groupId": "OG003", "value": "-0.4", "spread": "0.15"}]}]}, {"title": "Change from BL at Week 4 (n=178, 178, 174, 166)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.3", "spread": "0.17"}, {"groupId": "OG001", "value": "-0.4", "spread": "0.15"}, {"groupId": "OG002", "value": "-0.2", "spread": "0.18"}, {"groupId": "OG003", "value": "-0.0", "spread": "0.17"}]}]}, {"title": "Change from BL at Week 6 (n=176, 174, 166, 160)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.2", "spread": "0.17"}, {"groupId": "OG001", "value": "-0.3", "spread": "0.17"}, {"groupId": "OG002", "value": "-0.1", "spread": "0.18"}, {"groupId": "OG003", "value": "-0.0", "spread": "0.17"}]}]}, {"title": "Change from BL at Week 8 (n=173, 176, 165, 157)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.4", "spread": "0.18"}, {"groupId": "OG001", "value": "-0.1", "spread": "0.17"}, {"groupId": "OG002", "value": "-0.0", "spread": "0.19"}, {"groupId": "OG003", "value": "-0.0", "spread": "0.19"}]}]}, {"title": "Change from BL at Week 10 (n=149, 134, 137, 131)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.4", "spread": "0.19"}, {"groupId": "OG001", "value": "-0.4", "spread": "0.18"}, {"groupId": "OG002", "value": "-0.2", "spread": "0.21"}, {"groupId": "OG003", "value": "-0.1", "spread": "0.20"}]}]}, {"title": "Change from BL at Week 12 (n=170, 167, 160, 144)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.1", "spread": "0.18"}, {"groupId": "OG001", "value": "-0.1", "spread": "0.17"}, {"groupId": "OG002", "value": "0.4", "spread": "0.19"}, {"groupId": "OG003", "value": "0.0", "spread": "0.20"}]}]}, {"title": "Change from BL at Week 14 (n=156, 154, 146, 139)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.2", "spread": "0.18"}, {"groupId": "OG001", "value": "-0.2", "spread": "0.17"}, {"groupId": "OG002", "value": "-0.1", "spread": "0.23"}, {"groupId": "OG003", "value": "0.0", "spread": "0.20"}]}]}, {"title": "Change from BL at Week 16 (n=167, 166, 159, 140)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.1", "spread": "0.20"}, {"groupId": "OG001", "value": "0.0", "spread": "0.18"}, {"groupId": "OG002", "value": "-0.1", "spread": "0.21"}, {"groupId": "OG003", "value": "0.2", "spread": "0.19"}]}]}, {"title": "Change from BL at Week 18 (n=155, 158, 149, 141)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.3", "spread": "0.21"}, {"groupId": "OG001", "value": "-0.5", "spread": "0.17"}, {"groupId": "OG002", "value": "-0.3", "spread": "0.18"}, {"groupId": "OG003", "value": "-0.1", "spread": "0.21"}]}]}, {"title": "Change from BL at Week 20 (n=162, 153, 154, 147)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.1", "spread": "0.19"}, {"groupId": "OG001", "value": "-0.3", "spread": "0.19"}, {"groupId": "OG002", "value": "-0.2", "spread": "0.20"}, {"groupId": "OG003", "value": "-0.3", "spread": "0.20"}]}]}, {"title": "Change from BL at Week 22 (n=157, 152, 143, 138)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.2", "spread": "0.21"}, {"groupId": "OG001", "value": "-0.5", "spread": "0.21"}, {"groupId": "OG002", "value": "-0.5", "spread": "0.21"}, {"groupId": "OG003", "value": "-0.5", "spread": "0.23"}]}]}, {"title": "Change from BL at Week 24 (n=164, 160, 159, 137)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.3", "spread": "0.20"}, {"groupId": "OG001", "value": "-0.4", "spread": "0.21"}, {"groupId": "OG002", "value": "-0.3", "spread": "0.19"}, {"groupId": "OG003", "value": "-0.4", "spread": "0.22"}]}]}, {"title": "Change from BL at Week 30 (n=161, 155, 154, 137)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.2", "spread": "0.19"}, {"groupId": "OG001", "value": "-0.4", "spread": "0.23"}, {"groupId": "OG002", "value": "-0.0", "spread": "0.21"}, {"groupId": "OG003", "value": "-0.2", "spread": "0.23"}]}]}, {"title": "Change from BL at Week 37 (n=152, 149, 146, 122)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.1", "spread": "0.21"}, {"groupId": "OG001", "value": "-0.4", "spread": "0.21"}, {"groupId": "OG002", "value": "0.0", "spread": "0.23"}, {"groupId": "OG003", "value": "-0.1", "spread": "0.21"}]}]}, {"title": "Change from BL at Week 50 (n=151, 142, 146, 127)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.4", "spread": "0.21"}, {"groupId": "OG001", "value": "-0.5", "spread": "0.23"}, {"groupId": "OG002", "value": "-0.1", "spread": "0.22"}, {"groupId": "OG003", "value": "-0.0", "spread": "0.25"}]}]}, {"title": "Change from BL at Week 63 (n=148, 137, 142, 116)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.1", "spread": "0.22"}, {"groupId": "OG001", "value": "-0.5", "spread": "0.28"}, {"groupId": "OG002", "value": "-0.1", "spread": "0.22"}, {"groupId": "OG003", "value": "-0.0", "spread": "0.24"}]}]}, {"title": "Change from BL at Week 76 (n=134, 126, 130, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.2", "spread": "0.25"}, {"groupId": "OG001", "value": "-0.4", "spread": "0.23"}, {"groupId": "OG002", "value": "0.1", "spread": "0.22"}, {"groupId": "OG003", "value": "-0.4", "spread": "0.28"}]}]}, {"title": "Change from BL at Week 89 (n=123, 114, 123, 85)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.2", "spread": "0.27"}, {"groupId": "OG001", "value": "-0.5", "spread": "0.25"}, {"groupId": "OG002", "value": "-0.3", "spread": "0.27"}, {"groupId": "OG003", "value": "-0.3", "spread": "0.29"}]}]}, {"title": "Change from BL at Week 102 (n=108, 104, 112, 70)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.7", "spread": "0.21"}, {"groupId": "OG001", "value": "-0.9", "spread": "0.29"}, {"groupId": "OG002", "value": "-0.2", "spread": "0.25"}, {"groupId": "OG003", "value": "-0.7", "spread": "0.31"}]}]}, {"title": "Change from BL at Week 115 (n=99, 94, 98, 58)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.1", "spread": "0.22"}, {"groupId": "OG001", "value": "0.0", "spread": "0.29"}, {"groupId": "OG002", "value": "-0.4", "spread": "0.28"}, {"groupId": "OG003", "value": "-0.2", "spread": "0.33"}]}]}, {"title": "Change from BL at Week 128 (n=92, 88, 90, 52)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.6", "spread": "0.27"}, {"groupId": "OG001", "value": "-0.5", "spread": "0.32"}, {"groupId": "OG002", "value": "-0.5", "spread": "0.28"}, {"groupId": "OG003", "value": "-0.5", "spread": "0.34"}]}]}, {"title": "Change from BL at Week 141 (n=85, 79, 85, 48)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.6", "spread": "0.26"}, {"groupId": "OG001", "value": "-0.6", "spread": "0.28"}, {"groupId": "OG002", "value": "-0.3", "spread": "0.31"}, {"groupId": "OG003", "value": "-0.9", "spread": "0.37"}]}]}, {"title": "Change from BL at Week 154 (n=81, 74, 78, 45)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.5", "spread": "0.28"}, {"groupId": "OG001", "value": "-1.7", "spread": "0.30"}, {"groupId": "OG002", "value": "-1.2", "spread": "0.32"}, {"groupId": "OG003", "value": "-1.6", "spread": "0.34"}]}]}, {"title": "Change from BL at Week 167 (n=77, 67, 75, 42)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.0", "spread": "0.26"}, {"groupId": "OG001", "value": "-1.6", "spread": "0.34"}, {"groupId": "OG002", "value": "-1.2", "spread": "0.36"}, {"groupId": "OG003", "value": "-1.1", "spread": "0.41"}]}]}, {"title": "Change from BL at Week 180 (n=70, 61, 73, 41)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.1", "spread": "0.32"}, {"groupId": "OG001", "value": "-1.8", "spread": "0.46"}, {"groupId": "OG002", "value": "-0.7", "spread": "0.30"}, {"groupId": "OG003", "value": "-1.2", "spread": "0.34"}]}]}, {"title": "Change from BL at Week 193 (n=70, 60, 72, 40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.7", "spread": "0.33"}, {"groupId": "OG001", "value": "-1.7", "spread": "0.46"}, {"groupId": "OG002", "value": "-0.5", "spread": "0.33"}, {"groupId": "OG003", "value": "-0.7", "spread": "0.42"}]}]}, {"title": "Change from BL at Week 206 (n=61, 50, 64, 31)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.5", "spread": "0.35"}, {"groupId": "OG001", "value": "-2.3", "spread": "0.41"}, {"groupId": "OG002", "value": "-0.7", "spread": "0.32"}, {"groupId": "OG003", "value": "-1.3", "spread": "0.48"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Baseline and Changes From Baseline in Red Blood Cell Counts (x 10^6 c/\u00b5L) During the ST + LT Period", "populationDescription": "Treated participants; n=number of treated participants with measurement at time point", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "10^6 c/\u00b5L", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg + Metformin", "description": "Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg + Metformin", "description": "Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg + Metformin", "description": "Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo+ Metformin", "description": "Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "192"}, {"groupId": "OG001", "value": "191"}, {"groupId": "OG002", "value": "181"}, {"groupId": "OG003", "value": "179"}]}], "classes": [{"title": "Baseline (Week 0) (n=192, 191, 181, 179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.68", "spread": "0.031"}, {"groupId": "OG001", "value": "4.73", "spread": "0.029"}, {"groupId": "OG002", "value": "4.70", "spread": "0.034"}, {"groupId": "OG003", "value": "4.66", "spread": "0.033"}]}]}, {"title": "Change from BL at Week 2 (n=181, 177, 172, 169)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.04", "spread": "0.015"}, {"groupId": "OG001", "value": "-0.05", "spread": "0.016"}, {"groupId": "OG002", "value": "-0.05", "spread": "0.015"}, {"groupId": "OG003", "value": "-0.03", "spread": "0.015"}]}]}, {"title": "Change from BL at Week 4 (n=178, 178, 174, 166)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.02", "spread": "0.018"}, {"groupId": "OG001", "value": "-0.04", "spread": "0.016"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.019"}, {"groupId": "OG003", "value": "0.01", "spread": "0.018"}]}]}, {"title": "Change from BL at Week 6 (n=176, 174, 166, 160)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.01", "spread": "0.017"}, {"groupId": "OG001", "value": "-0.02", "spread": "0.016"}, {"groupId": "OG002", "value": "0.00", "spread": "0.018"}, {"groupId": "OG003", "value": "0.03", "spread": "0.017"}]}]}, {"title": "Change from BL at Week 8 (n=173, 176, 165, 157)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.019"}, {"groupId": "OG001", "value": "0.02", "spread": "0.017"}, {"groupId": "OG002", "value": "0.03", "spread": "0.019"}, {"groupId": "OG003", "value": "0.03", "spread": "0.019"}]}]}, {"title": "Change from BL at Week 10 (n=149, 134, 137, 131)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.03", "spread": "0.020"}, {"groupId": "OG001", "value": "-0.02", "spread": "0.019"}, {"groupId": "OG002", "value": "0.00", "spread": "0.021"}, {"groupId": "OG003", "value": "0.00", "spread": "0.022"}]}]}, {"title": "Change from BL at Week 12 (n=170, 167, 160, 144)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.03", "spread": "0.019"}, {"groupId": "OG001", "value": "0.03", "spread": "0.018"}, {"groupId": "OG002", "value": "0.09", "spread": "0.020"}, {"groupId": "OG003", "value": "0.04", "spread": "0.022"}]}]}, {"title": "Change from BL at Week 14 (n=156, 154, 146, 139)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.019"}, {"groupId": "OG001", "value": "0.01", "spread": "0.018"}, {"groupId": "OG002", "value": "0.04", "spread": "0.024"}, {"groupId": "OG003", "value": "0.04", "spread": "0.022"}]}]}, {"title": "Change from BL at Week 16 (n=167, 166, 159, 140)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.04", "spread": "0.020"}, {"groupId": "OG001", "value": "0.05", "spread": "0.017"}, {"groupId": "OG002", "value": "0.07", "spread": "0.021"}, {"groupId": "OG003", "value": "0.08", "spread": "0.020"}]}]}, {"title": "Change from BL at Week 18 (n=155, 158, 149, 141)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.024"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.018"}, {"groupId": "OG002", "value": "0.04", "spread": "0.018"}, {"groupId": "OG003", "value": "0.03", "spread": "0.021"}]}]}, {"title": "Change from BL at Week 20 (n=162, 153, 154, 147)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.02", "spread": "0.020"}, {"groupId": "OG001", "value": "0.02", "spread": "0.020"}, {"groupId": "OG002", "value": "0.06", "spread": "0.020"}, {"groupId": "OG003", "value": "0.03", "spread": "0.021"}]}]}, {"title": "Change from BL at Week 22 (n=157, 152, 143, 138)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.022"}, {"groupId": "OG001", "value": "-0.03", "spread": "0.020"}, {"groupId": "OG002", "value": "0.01", "spread": "0.020"}, {"groupId": "OG003", "value": "-0.02", "spread": "0.023"}]}]}, {"title": "Change from BL at Week 24 (n=164, 160, 159, 137)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.02", "spread": "0.022"}, {"groupId": "OG001", "value": "-0.02", "spread": "0.020"}, {"groupId": "OG002", "value": "0.01", "spread": "0.019"}, {"groupId": "OG003", "value": "-0.03", "spread": "0.024"}]}]}, {"title": "Change from BL at Week 30 (n=161, 155, 154, 137)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.01", "spread": "0.020"}, {"groupId": "OG001", "value": "-0.02", "spread": "0.021"}, {"groupId": "OG002", "value": "0.02", "spread": "0.022"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.021"}]}]}, {"title": "Change from BL at Week 37 (n=152, 149, 146, 122)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.00", "spread": "0.023"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.019"}, {"groupId": "OG002", "value": "0.02", "spread": "0.021"}, {"groupId": "OG003", "value": "0.00", "spread": "0.022"}]}]}, {"title": "Change from BL at Week 50 (n=151, 142, 146, 127)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.06", "spread": "0.022"}, {"groupId": "OG001", "value": "-0.04", "spread": "0.023"}, {"groupId": "OG002", "value": "0.00", "spread": "0.021"}, {"groupId": "OG003", "value": "-0.03", "spread": "0.024"}]}]}, {"title": "Change from BL at Week 63 (n=148, 137, 142, 116)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.01", "spread": "0.022"}, {"groupId": "OG001", "value": "-0.04", "spread": "0.031"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.023"}, {"groupId": "OG003", "value": "-0.02", "spread": "0.024"}]}]}, {"title": "Change from BL at Week 76 (n=134, 126, 130, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.08", "spread": "0.025"}, {"groupId": "OG001", "value": "-0.06", "spread": "0.024"}, {"groupId": "OG002", "value": "-0.02", "spread": "0.023"}, {"groupId": "OG003", "value": "-0.09", "spread": "0.029"}]}]}, {"title": "Change from BL at Week 89 (n=123, 114, 123, 85)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.09", "spread": "0.027"}, {"groupId": "OG001", "value": "-0.09", "spread": "0.024"}, {"groupId": "OG002", "value": "-0.07", "spread": "0.030"}, {"groupId": "OG003", "value": "-0.07", "spread": "0.028"}]}]}, {"title": "Change from BL at Week 102 (n=108, 104, 112, 70)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.13", "spread": "0.024"}, {"groupId": "OG001", "value": "-0.12", "spread": "0.027"}, {"groupId": "OG002", "value": "-0.07", "spread": "0.027"}, {"groupId": "OG003", "value": "-0.14", "spread": "0.031"}]}]}, {"title": "Change from BL at Week 115 (n=99, 94, 98, 58)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.08", "spread": "0.024"}, {"groupId": "OG001", "value": "-0.04", "spread": "0.026"}, {"groupId": "OG002", "value": "-0.06", "spread": "0.027"}, {"groupId": "OG003", "value": "-0.11", "spread": "0.034"}]}]}, {"title": "Change from BL at Week 128 (n=92, 88, 90, 52)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.10", "spread": "0.028"}, {"groupId": "OG001", "value": "-0.07", "spread": "0.030"}, {"groupId": "OG002", "value": "-0.06", "spread": "0.027"}, {"groupId": "OG003", "value": "-0.08", "spread": "0.031"}]}]}, {"title": "Change from BL at Week 141 (n=85, 79, 85, 48)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.13", "spread": "0.030"}, {"groupId": "OG001", "value": "-0.10", "spread": "0.027"}, {"groupId": "OG002", "value": "-0.06", "spread": "0.031"}, {"groupId": "OG003", "value": "-0.13", "spread": "0.041"}]}]}, {"title": "Change from BL at Week 154 (n=81, 74, 78, 45)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.19", "spread": "0.032"}, {"groupId": "OG001", "value": "-0.17", "spread": "0.029"}, {"groupId": "OG002", "value": "-0.11", "spread": "0.029"}, {"groupId": "OG003", "value": "-0.20", "spread": "0.035"}]}]}, {"title": "Change from BL at Week 167 (n=77, 67, 75, 42)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.14", "spread": "0.030"}, {"groupId": "OG001", "value": "-0.15", "spread": "0.032"}, {"groupId": "OG002", "value": "-0.12", "spread": "0.034"}, {"groupId": "OG003", "value": "-0.16", "spread": "0.041"}]}]}, {"title": "Change from BL at Week 180 (n=70, 61, 73, 41)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.16", "spread": "0.033"}, {"groupId": "OG001", "value": "-0.21", "spread": "0.038"}, {"groupId": "OG002", "value": "-0.09", "spread": "0.033"}, {"groupId": "OG003", "value": "-0.16", "spread": "0.037"}]}]}, {"title": "Change from BL at Week 193 (n=70, 60, 72, 40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.14", "spread": "0.035"}, {"groupId": "OG001", "value": "-0.22", "spread": "0.040"}, {"groupId": "OG002", "value": "-0.12", "spread": "0.032"}, {"groupId": "OG003", "value": "-0.13", "spread": "0.044"}]}]}, {"title": "Change from BL at Week 206 (n=61, 50, 64, 31)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.16", "spread": "0.040"}, {"groupId": "OG001", "value": "-0.25", "spread": "0.044"}, {"groupId": "OG002", "value": "-0.09", "spread": "0.032"}, {"groupId": "OG003", "value": "-0.15", "spread": "0.048"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Baseline and Changes From Baseline in Platelet Counts (x 10^9 c/L) During the ST + LT Period", "populationDescription": "Treated participants; n=number of treated participants with measurement at time point", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "10^9 c/L", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg + Metformin", "description": "Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg + Metformin", "description": "Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg + Metformin", "description": "Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo+ Metformin", "description": "Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "192"}, {"groupId": "OG001", "value": "191"}, {"groupId": "OG002", "value": "181"}, {"groupId": "OG003", "value": "179"}]}], "classes": [{"title": "Baseline (Week 0) (n=192, 189, 181, 178)", "categories": [{"measurements": [{"groupId": "OG000", "value": "265.5", "spread": "4.78"}, {"groupId": "OG001", "value": "256.2", "spread": "4.28"}, {"groupId": "OG002", "value": "258.7", "spread": "5.05"}, {"groupId": "OG003", "value": "261.0", "spread": "5.05"}]}]}, {"title": "Change from BL at Week 2 (n=179, 168, 167, 166)", "categories": [{"measurements": [{"groupId": "OG000", "value": "8.4", "spread": "2.32"}, {"groupId": "OG001", "value": "9.8", "spread": "2.77"}, {"groupId": "OG002", "value": "6.5", "spread": "2.57"}, {"groupId": "OG003", "value": "13.7", "spread": "2.99"}]}]}, {"title": "Change from BL at Week 4 (n=176, 172, 168, 164)", "categories": [{"measurements": [{"groupId": "OG000", "value": "11.3", "spread": "2.59"}, {"groupId": "OG001", "value": "11.8", "spread": "2.55"}, {"groupId": "OG002", "value": "5.1", "spread": "2.31"}, {"groupId": "OG003", "value": "11.1", "spread": "3.04"}]}]}, {"title": "Change from BL at Week 6 (n=171, 171, 164, 157)", "categories": [{"measurements": [{"groupId": "OG000", "value": "8.7", "spread": "2.46"}, {"groupId": "OG001", "value": "8.5", "spread": "2.78"}, {"groupId": "OG002", "value": "5.1", "spread": "4.16"}, {"groupId": "OG003", "value": "12.0", "spread": "2.99"}]}]}, {"title": "Change from BL at Week 8 (n=172, 170, 162, 151)", "categories": [{"measurements": [{"groupId": "OG000", "value": "6.7", "spread": "2.53"}, {"groupId": "OG001", "value": "7.5", "spread": "2.47"}, {"groupId": "OG002", "value": "4.9", "spread": "2.67"}, {"groupId": "OG003", "value": "8.5", "spread": "3.07"}]}]}, {"title": "Change from BL at Week 10 (n=147, 132, 137, 129)", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.7", "spread": "2.73"}, {"groupId": "OG001", "value": "8.5", "spread": "3.23"}, {"groupId": "OG002", "value": "0.5", "spread": "3.24"}, {"groupId": "OG003", "value": "11.5", "spread": "3.30"}]}]}, {"title": "Change from BL at Week 12 (n=170, 165, 157, 141)", "categories": [{"measurements": [{"groupId": "OG000", "value": "6.8", "spread": "2.49"}, {"groupId": "OG001", "value": "9.3", "spread": "3.26"}, {"groupId": "OG002", "value": "4.8", "spread": "3.24"}, {"groupId": "OG003", "value": "8.2", "spread": "2.83"}]}]}, {"title": "Change from BL at Week 14 (n=153, 149, 145, 133)", "categories": [{"measurements": [{"groupId": "OG000", "value": "6.1", "spread": "3.16"}, {"groupId": "OG001", "value": "7.4", "spread": "2.70"}, {"groupId": "OG002", "value": "2.5", "spread": "3.08"}, {"groupId": "OG003", "value": "7.5", "spread": "2.70"}]}]}, {"title": "Change from BL at Week 16 (n=166, 161, 156, 133)", "categories": [{"measurements": [{"groupId": "OG000", "value": "5.3", "spread": "2.71"}, {"groupId": "OG001", "value": "7.1", "spread": "2.76"}, {"groupId": "OG002", "value": "-0.0", "spread": "2.64"}, {"groupId": "OG003", "value": "7.4", "spread": "3.15"}]}]}, {"title": "Change from BL at Week 18 (n=152, 155, 147, 139)", "categories": [{"measurements": [{"groupId": "OG000", "value": "5.6", "spread": "2.95"}, {"groupId": "OG001", "value": "3.0", "spread": "2.66"}, {"groupId": "OG002", "value": "5.2", "spread": "2.82"}, {"groupId": "OG003", "value": "8.5", "spread": "3.59"}]}]}, {"title": "Change from BL at Week 20 (n=160, 151, 153, 144)", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.9", "spread": "3.00"}, {"groupId": "OG001", "value": "7.0", "spread": "3.07"}, {"groupId": "OG002", "value": "-1.7", "spread": "2.64"}, {"groupId": "OG003", "value": "6.8", "spread": "3.06"}]}]}, {"title": "Change from BL at Week 22 (n=151, 148, 142, 134)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.5", "spread": "2.50"}, {"groupId": "OG001", "value": "9.7", "spread": "2.98"}, {"groupId": "OG002", "value": "-1.7", "spread": "2.95"}, {"groupId": "OG003", "value": "4.1", "spread": "3.24"}]}]}, {"title": "Change from BL at Week 24 (n=158, 153, 156, 135)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.6", "spread": "2.97"}, {"groupId": "OG001", "value": "3.5", "spread": "2.77"}, {"groupId": "OG002", "value": "-2.0", "spread": "2.75"}, {"groupId": "OG003", "value": "-2.3", "spread": "2.95"}]}]}, {"title": "Change from BL at Week 30 (n=157, 153, 148, 130)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.1", "spread": "2.96"}, {"groupId": "OG001", "value": "3.6", "spread": "2.88"}, {"groupId": "OG002", "value": "-0.8", "spread": "3.18"}, {"groupId": "OG003", "value": "2.0", "spread": "3.65"}]}]}, {"title": "Change from BL at Week 37 (n=149, 142, 139, 120)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.6", "spread": "3.07"}, {"groupId": "OG001", "value": "-4.1", "spread": "3.16"}, {"groupId": "OG002", "value": "-11.9", "spread": "2.98"}, {"groupId": "OG003", "value": "-2.3", "spread": "3.84"}]}]}, {"title": "Change from BL at Week 50 (n=151, 141, 143, 120)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.2", "spread": "3.40"}, {"groupId": "OG001", "value": "-2.4", "spread": "3.44"}, {"groupId": "OG002", "value": "-9.0", "spread": "3.13"}, {"groupId": "OG003", "value": "-6.4", "spread": "3.70"}]}]}, {"title": "Change from BL at Week 63 (n=147, 132, 137, 115)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.6", "spread": "3.24"}, {"groupId": "OG001", "value": "3.5", "spread": "3.36"}, {"groupId": "OG002", "value": "0.1", "spread": "4.80"}, {"groupId": "OG003", "value": "-4.7", "spread": "4.15"}]}]}, {"title": "Change from BL at Week 76 (n=132, 124, 130, 92)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.1", "spread": "3.84"}, {"groupId": "OG001", "value": "4.0", "spread": "3.55"}, {"groupId": "OG002", "value": "-2.6", "spread": "3.09"}, {"groupId": "OG003", "value": "4.7", "spread": "3.98"}]}]}, {"title": "Change from BL at Week 89 (n=122, 111, 122, 84)", "categories": [{"measurements": [{"groupId": "OG000", "value": "9.1", "spread": "4.42"}, {"groupId": "OG001", "value": "8.6", "spread": "3.01"}, {"groupId": "OG002", "value": "1.4", "spread": "3.68"}, {"groupId": "OG003", "value": "13.6", "spread": "3.91"}]}]}, {"title": "Change from BL at Week 102 (n=107, 103, 110, 69)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.3", "spread": "3.96"}, {"groupId": "OG001", "value": "6.1", "spread": "3.47"}, {"groupId": "OG002", "value": "3.3", "spread": "3.74"}, {"groupId": "OG003", "value": "6.1", "spread": "5.20"}]}]}, {"title": "Change from BL at Week 115 (n=99, 93, 98, 57)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.1", "spread": "4.45"}, {"groupId": "OG001", "value": "4.2", "spread": "4.12"}, {"groupId": "OG002", "value": "1.2", "spread": "4.19"}, {"groupId": "OG003", "value": "7.0", "spread": "5.12"}]}]}, {"title": "Change from BL at Week 128 (n=91, 84, 88, 51)", "categories": [{"measurements": [{"groupId": "OG000", "value": "5.7", "spread": "5.27"}, {"groupId": "OG001", "value": "3.2", "spread": "3.89"}, {"groupId": "OG002", "value": "2.2", "spread": "4.41"}, {"groupId": "OG003", "value": "4.5", "spread": "4.73"}]}]}, {"title": "Change from BL at Week 141 (n=83, 77, 84, 47)", "categories": [{"measurements": [{"groupId": "OG000", "value": "9.2", "spread": "4.96"}, {"groupId": "OG001", "value": "6.5", "spread": "4.45"}, {"groupId": "OG002", "value": "1.1", "spread": "5.21"}, {"groupId": "OG003", "value": "12.0", "spread": "5.24"}]}]}, {"title": "Change from BL at Week 154 (n=79, 70, 77, 45)", "categories": [{"measurements": [{"groupId": "OG000", "value": "8.0", "spread": "5.65"}, {"groupId": "OG001", "value": "9.4", "spread": "4.55"}, {"groupId": "OG002", "value": "-1.8", "spread": "5.79"}, {"groupId": "OG003", "value": "12.5", "spread": "7.01"}]}]}, {"title": "Change from BL at Week 167 (n=75, 64, 74, 41)", "categories": [{"measurements": [{"groupId": "OG000", "value": "10.1", "spread": "5.39"}, {"groupId": "OG001", "value": "3.2", "spread": "4.39"}, {"groupId": "OG002", "value": "-1.9", "spread": "5.26"}, {"groupId": "OG003", "value": "13.8", "spread": "6.78"}]}]}, {"title": "Change from BL at Week 180 (n=68, 60, 71, 41)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.7", "spread": "6.19"}, {"groupId": "OG001", "value": "-1.2", "spread": "5.65"}, {"groupId": "OG002", "value": "-8.3", "spread": "5.07"}, {"groupId": "OG003", "value": "8.9", "spread": "5.80"}]}]}, {"title": "Change from BL at Week 193 (n=67, 57, 68, 40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.3", "spread": "6.40"}, {"groupId": "OG001", "value": "-2.9", "spread": "5.40"}, {"groupId": "OG002", "value": "-8.5", "spread": "5.19"}, {"groupId": "OG003", "value": "12.2", "spread": "6.79"}]}]}, {"title": "Change from BL at Week 206 (n=61, 49, 64, 31)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.7", "spread": "6.45"}, {"groupId": "OG001", "value": "1.5", "spread": "7.48"}, {"groupId": "OG002", "value": "-4.7", "spread": "5.62"}, {"groupId": "OG003", "value": "9.8", "spread": "7.45"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Baseline and Changes From Baseline in White Blood Cell Counts (x 10^3 c/\u00b5L) During the ST + LT Period", "populationDescription": "Treated participants; n=number of treated participants with measurement at time point", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "10^3 c/\u00b5L", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg + Metformin", "description": "Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg + Metformin", "description": "Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg + Metformin", "description": "Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo+ Metformin", "description": "Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "192"}, {"groupId": "OG001", "value": "191"}, {"groupId": "OG002", "value": "181"}, {"groupId": "OG003", "value": "179"}]}], "classes": [{"title": "Baseline (Week 0) (n=192, 191, 181, 179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "7.23", "spread": "0.136"}, {"groupId": "OG001", "value": "7.25", "spread": "0.167"}, {"groupId": "OG002", "value": "7.12", "spread": "0.136"}, {"groupId": "OG003", "value": "7.19", "spread": "0.136"}]}]}, {"title": "Change from BL at Week 2 (n=178, 175, 171, 169)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.10", "spread": "0.093"}, {"groupId": "OG001", "value": "-0.03", "spread": "0.116"}, {"groupId": "OG002", "value": "0.17", "spread": "0.102"}, {"groupId": "OG003", "value": "0.11", "spread": "0.113"}]}]}, {"title": "Change from BL at Week 4 (n=176, 176, 171, 166)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.19", "spread": "0.111"}, {"groupId": "OG001", "value": "0.04", "spread": "0.131"}, {"groupId": "OG002", "value": "-0.02", "spread": "0.100"}, {"groupId": "OG003", "value": "0.22", "spread": "0.117"}]}]}, {"title": "Change from BL at Week 6 (n=175, 172, 165, 158)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.11", "spread": "0.089"}, {"groupId": "OG001", "value": "0.02", "spread": "0.102"}, {"groupId": "OG002", "value": "0.07", "spread": "0.092"}, {"groupId": "OG003", "value": "0.07", "spread": "0.115"}]}]}, {"title": "Change from BL at Week 8 (n=172, 174, 163, 153)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.15", "spread": "0.104"}, {"groupId": "OG001", "value": "-0.03", "spread": "0.116"}, {"groupId": "OG002", "value": "0.19", "spread": "0.106"}, {"groupId": "OG003", "value": "0.03", "spread": "0.109"}]}]}, {"title": "Change from BL at Week 10 (n=148, 130, 137, 128)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.42", "spread": "0.108"}, {"groupId": "OG001", "value": "0.37", "spread": "0.126"}, {"groupId": "OG002", "value": "0.23", "spread": "0.105"}, {"groupId": "OG003", "value": "0.39", "spread": "0.115"}]}]}, {"title": "Change from BL at Week 12 (n=169, 166, 159, 142)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.18", "spread": "0.100"}, {"groupId": "OG001", "value": "0.08", "spread": "0.134"}, {"groupId": "OG002", "value": "0.26", "spread": "0.114"}, {"groupId": "OG003", "value": "0.37", "spread": "0.130"}]}]}, {"title": "Change from BL at Week 14 (n=156, 152, 145, 136)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.57", "spread": "0.142"}, {"groupId": "OG001", "value": "0.30", "spread": "0.148"}, {"groupId": "OG002", "value": "0.24", "spread": "0.121"}, {"groupId": "OG003", "value": "0.33", "spread": "0.132"}]}]}, {"title": "Change from BL at Week 16 (n=166, 166, 159, 137)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.28", "spread": "0.103"}, {"groupId": "OG001", "value": "0.07", "spread": "0.127"}, {"groupId": "OG002", "value": "0.16", "spread": "0.115"}, {"groupId": "OG003", "value": "0.42", "spread": "0.139"}]}]}, {"title": "Change from BL at Week 18 (n=155, 158, 149, 139)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.67", "spread": "0.121"}, {"groupId": "OG001", "value": "0.23", "spread": "0.135"}, {"groupId": "OG002", "value": "0.39", "spread": "0.114"}, {"groupId": "OG003", "value": "0.58", "spread": "0.135"}]}]}, {"title": "Change from BL at Week 20 (n=162, 153, 154, 146)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.23", "spread": "0.112"}, {"groupId": "OG001", "value": "-0.02", "spread": "0.130"}, {"groupId": "OG002", "value": "0.19", "spread": "0.111"}, {"groupId": "OG003", "value": "0.39", "spread": "0.142"}]}]}, {"title": "Change from BL at Week 22 (n=157, 152, 143, 138)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.45", "spread": "0.112"}, {"groupId": "OG001", "value": "0.36", "spread": "0.138"}, {"groupId": "OG002", "value": "0.24", "spread": "0.112"}, {"groupId": "OG003", "value": "0.50", "spread": "0.120"}]}]}, {"title": "Change from BL at Week 24 (n=162, 160, 157, 135)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.13", "spread": "0.103"}, {"groupId": "OG001", "value": "0.12", "spread": "0.161"}, {"groupId": "OG002", "value": "0.11", "spread": "0.097"}, {"groupId": "OG003", "value": "0.10", "spread": "0.135"}]}]}, {"title": "Change from BL at Week 30 (n=160, 155, 154, 136)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.27", "spread": "0.091"}, {"groupId": "OG001", "value": "0.05", "spread": "0.131"}, {"groupId": "OG002", "value": "0.21", "spread": "0.109"}, {"groupId": "OG003", "value": "0.14", "spread": "0.141"}]}]}, {"title": "Change from BL at Week 37 (n=150, 149, 146, 121)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.34", "spread": "0.130"}, {"groupId": "OG001", "value": "0.10", "spread": "0.137"}, {"groupId": "OG002", "value": "0.02", "spread": "0.105"}, {"groupId": "OG003", "value": "0.10", "spread": "0.135"}]}]}, {"title": "Change from BL at Week 50 (n=150, 142, 145, 125)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.14", "spread": "0.116"}, {"groupId": "OG001", "value": "-0.14", "spread": "0.160"}, {"groupId": "OG002", "value": "-0.20", "spread": "0.114"}, {"groupId": "OG003", "value": "-0.36", "spread": "0.120"}]}]}, {"title": "Change from BL at Week 63 (n=147, 136, 140, 115)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.10", "spread": "0.117"}, {"groupId": "OG001", "value": "-0.10", "spread": "0.123"}, {"groupId": "OG002", "value": "-0.02", "spread": "0.168"}, {"groupId": "OG003", "value": "-0.39", "spread": "0.148"}]}]}, {"title": "Change from BL at Week 76 (n=134, 126, 130, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.19", "spread": "0.122"}, {"groupId": "OG001", "value": "-0.18", "spread": "0.157"}, {"groupId": "OG002", "value": "-0.25", "spread": "0.105"}, {"groupId": "OG003", "value": "-0.30", "spread": "0.172"}]}]}, {"title": "Change from BL at Week 89 (n=122, 114, 123, 85)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.29", "spread": "0.141"}, {"groupId": "OG001", "value": "-0.34", "spread": "0.136"}, {"groupId": "OG002", "value": "-0.21", "spread": "0.153"}, {"groupId": "OG003", "value": "-0.38", "spread": "0.197"}]}]}, {"title": "Change from BL at Week 102 (n=105, 104, 111, 68)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.36", "spread": "0.140"}, {"groupId": "OG001", "value": "-0.11", "spread": "0.150"}, {"groupId": "OG002", "value": "-0.31", "spread": "0.102"}, {"groupId": "OG003", "value": "-0.54", "spread": "0.178"}]}]}, {"title": "Change from BL at Week 115 (n=98, 92, 95, 57)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.10", "spread": "0.142"}, {"groupId": "OG001", "value": "-0.26", "spread": "0.161"}, {"groupId": "OG002", "value": "-0.05", "spread": "0.183"}, {"groupId": "OG003", "value": "-0.15", "spread": "0.202"}]}]}, {"title": "Change from BL at Week 128 (n=90, 87, 88, 50)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.16", "spread": "0.162"}, {"groupId": "OG001", "value": "-0.27", "spread": "0.148"}, {"groupId": "OG002", "value": "-0.12", "spread": "0.155"}, {"groupId": "OG003", "value": "-0.32", "spread": "0.225"}]}]}, {"title": "Change from BL at Week 141 (n=85, 78, 85, 47)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.01", "spread": "0.156"}, {"groupId": "OG001", "value": "-0.42", "spread": "0.161"}, {"groupId": "OG002", "value": "0.13", "spread": "0.174"}, {"groupId": "OG003", "value": "-0.07", "spread": "0.235"}]}]}, {"title": "Change from BL at Week 154 (n=77, 72, 78, 45)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.19", "spread": "0.170"}, {"groupId": "OG001", "value": "-0.38", "spread": "0.226"}, {"groupId": "OG002", "value": "-0.55", "spread": "0.144"}, {"groupId": "OG003", "value": "-0.54", "spread": "0.180"}]}]}, {"title": "Change from BL at Week 167 (n=76, 67, 75, 42)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.15", "spread": "0.179"}, {"groupId": "OG001", "value": "-0.18", "spread": "0.178"}, {"groupId": "OG002", "value": "-0.18", "spread": "0.152"}, {"groupId": "OG003", "value": "-0.38", "spread": "0.177"}]}]}, {"title": "Change from BL at Week 180 (n=70, 60, 72, 41)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.40", "spread": "0.185"}, {"groupId": "OG001", "value": "-0.72", "spread": "0.212"}, {"groupId": "OG002", "value": "-0.38", "spread": "0.142"}, {"groupId": "OG003", "value": "-0.37", "spread": "0.190"}]}]}, {"title": "Change from BL at Week 193 (n=69, 60, 72, 40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.45", "spread": "0.160"}, {"groupId": "OG001", "value": "-0.34", "spread": "0.228"}, {"groupId": "OG002", "value": "-0.13", "spread": "0.143"}, {"groupId": "OG003", "value": "-0.35", "spread": "0.203"}]}]}, {"title": "Change from BL at Week 206 (n=61, 49, 63, 31)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.58", "spread": "0.175"}, {"groupId": "OG001", "value": "-0.80", "spread": "0.270"}, {"groupId": "OG002", "value": "-0.36", "spread": "0.170"}, {"groupId": "OG003", "value": "-0.71", "spread": "0.201"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Baseline and Changes From Baseline in Absolute Neutrophil Counts (x 10^3 c/\u00b5L) During the ST + LT Period", "populationDescription": "Treated participants; n=number of treated participants with measurement at time point", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "10^3 c/\u00b5L", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg + Metformin", "description": "Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg + Metformin", "description": "Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg + Metformin", "description": "Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo+ Metformin", "description": "Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "192"}, {"groupId": "OG001", "value": "191"}, {"groupId": "OG002", "value": "181"}, {"groupId": "OG003", "value": "179"}]}], "classes": [{"title": "Baseline (Week 0) (n=192, 191, 181, 179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.27", "spread": "0.101"}, {"groupId": "OG001", "value": "4.27", "spread": "0.127"}, {"groupId": "OG002", "value": "4.19", "spread": "0.105"}, {"groupId": "OG003", "value": "4.23", "spread": "0.102"}]}]}, {"title": "Change from BL at Week 2 (n=178, 175, 170, 169)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.15", "spread": "0.083"}, {"groupId": "OG001", "value": "0.05", "spread": "0.102"}, {"groupId": "OG002", "value": "0.21", "spread": "0.087"}, {"groupId": "OG003", "value": "0.12", "spread": "0.094"}]}]}, {"title": "Change from BL at Week 4 (n=176, 175, 170, 166)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.21", "spread": "0.097"}, {"groupId": "OG001", "value": "0.11", "spread": "0.116"}, {"groupId": "OG002", "value": "0.15", "spread": "0.090"}, {"groupId": "OG003", "value": "0.19", "spread": "0.098"}]}]}, {"title": "Change from BL at Week 6 (n=175, 172, 165, 158)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.15", "spread": "0.075"}, {"groupId": "OG001", "value": "0.10", "spread": "0.093"}, {"groupId": "OG002", "value": "0.22", "spread": "0.085"}, {"groupId": "OG003", "value": "0.07", "spread": "0.098"}]}]}, {"title": "Change from BL at Week 8 (n=172, 172, 163, 153)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.16", "spread": "0.087"}, {"groupId": "OG001", "value": "0.03", "spread": "0.103"}, {"groupId": "OG002", "value": "0.35", "spread": "0.096"}, {"groupId": "OG003", "value": "0.02", "spread": "0.097"}]}]}, {"title": "Change from BL at Week 10 (n=148, 130, 137, 128)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.27", "spread": "0.094"}, {"groupId": "OG001", "value": "0.28", "spread": "0.106"}, {"groupId": "OG002", "value": "0.26", "spread": "0.093"}, {"groupId": "OG003", "value": "0.19", "spread": "0.105"}]}]}, {"title": "Change from BL at Week 12 (n=168, 166, 159, 141)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.22", "spread": "0.085"}, {"groupId": "OG001", "value": "0.11", "spread": "0.110"}, {"groupId": "OG002", "value": "0.40", "spread": "0.102"}, {"groupId": "OG003", "value": "0.27", "spread": "0.111"}]}]}, {"title": "Change from BL at Week 14 (n=156, 152, 145, 136)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.38", "spread": "0.123"}, {"groupId": "OG001", "value": "0.24", "spread": "0.125"}, {"groupId": "OG002", "value": "0.32", "spread": "0.109"}, {"groupId": "OG003", "value": "0.17", "spread": "0.112"}]}]}, {"title": "Change from BL at Week 16 (n=166, 166, 157, 137)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.24", "spread": "0.093"}, {"groupId": "OG001", "value": "0.14", "spread": "0.113"}, {"groupId": "OG002", "value": "0.30", "spread": "0.107"}, {"groupId": "OG003", "value": "0.33", "spread": "0.113"}]}]}, {"title": "Change from BL at Week 18 (n=155, 157, 149, 139)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.41", "spread": "0.104"}, {"groupId": "OG001", "value": "0.16", "spread": "0.116"}, {"groupId": "OG002", "value": "0.41", "spread": "0.099"}, {"groupId": "OG003", "value": "0.34", "spread": "0.111"}]}]}, {"title": "Change from BL at Week 20 (n=162, 153, 154, 146)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.17", "spread": "0.096"}, {"groupId": "OG001", "value": "0.06", "spread": "0.109"}, {"groupId": "OG002", "value": "0.32", "spread": "0.099"}, {"groupId": "OG003", "value": "0.24", "spread": "0.122"}]}]}, {"title": "Change from BL at Week 22 (n=157, 151, 143, 138)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.24", "spread": "0.096"}, {"groupId": "OG001", "value": "0.24", "spread": "0.116"}, {"groupId": "OG002", "value": "0.30", "spread": "0.097"}, {"groupId": "OG003", "value": "0.24", "spread": "0.100"}]}]}, {"title": "Change from BL at Week 24 (n=162, 160, 157, 135)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.06", "spread": "0.088"}, {"groupId": "OG001", "value": "0.15", "spread": "0.150"}, {"groupId": "OG002", "value": "0.20", "spread": "0.091"}, {"groupId": "OG003", "value": "0.03", "spread": "0.111"}]}]}, {"title": "Change from BL at Week 30 (n=159, 155, 154, 136)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.21", "spread": "0.085"}, {"groupId": "OG001", "value": "0.03", "spread": "0.117"}, {"groupId": "OG002", "value": "0.26", "spread": "0.090"}, {"groupId": "OG003", "value": "0.04", "spread": "0.111"}]}]}, {"title": "Change from BL at Week 37 (n=150, 149, 146, 121)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.27", "spread": "0.110"}, {"groupId": "OG001", "value": "0.11", "spread": "0.122"}, {"groupId": "OG002", "value": "0.20", "spread": "0.096"}, {"groupId": "OG003", "value": "0.08", "spread": "0.105"}]}]}, {"title": "Change from BL at Week 50 (n=150, 142, 145, 124)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.03", "spread": "0.104"}, {"groupId": "OG001", "value": "0.02", "spread": "0.144"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.107"}, {"groupId": "OG003", "value": "-0.25", "spread": "0.105"}]}]}, {"title": "Change from BL at Week 63 (n=147, 136, 140, 115)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.05", "spread": "0.107"}, {"groupId": "OG001", "value": "0.03", "spread": "0.100"}, {"groupId": "OG002", "value": "0.23", "spread": "0.140"}, {"groupId": "OG003", "value": "-0.25", "spread": "0.119"}]}]}, {"title": "Change from BL at Week 76 (n=134, 126, 130, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.11", "spread": "0.108"}, {"groupId": "OG001", "value": "0.02", "spread": "0.133"}, {"groupId": "OG002", "value": "0.03", "spread": "0.101"}, {"groupId": "OG003", "value": "-0.13", "spread": "0.146"}]}]}, {"title": "Change from BL at Week 89 (n=122, 113, 123, 85)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.17", "spread": "0.121"}, {"groupId": "OG001", "value": "-0.08", "spread": "0.106"}, {"groupId": "OG002", "value": "0.08", "spread": "0.132"}, {"groupId": "OG003", "value": "-0.18", "spread": "0.163"}]}]}, {"title": "Change from BL at Week 102 (n=104, 104, 111, 68)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.16", "spread": "0.123"}, {"groupId": "OG001", "value": "-0.04", "spread": "0.119"}, {"groupId": "OG002", "value": "-0.05", "spread": "0.093"}, {"groupId": "OG003", "value": "-0.35", "spread": "0.142"}]}]}, {"title": "Change from BL at Week 115 (n=98, 92, 95, 57)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.113"}, {"groupId": "OG001", "value": "-0.13", "spread": "0.145"}, {"groupId": "OG002", "value": "0.11", "spread": "0.167"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.169"}]}]}, {"title": "Change from BL at Week 128 (n=90, 87, 88, 50)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.04", "spread": "0.147"}, {"groupId": "OG001", "value": "-0.04", "spread": "0.111"}, {"groupId": "OG002", "value": "0.11", "spread": "0.136"}, {"groupId": "OG003", "value": "-0.11", "spread": "0.185"}]}]}, {"title": "Change from BL at Week 141 (n=85, 78, 84, 47)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.128"}, {"groupId": "OG001", "value": "-0.23", "spread": "0.131"}, {"groupId": "OG002", "value": "0.32", "spread": "0.151"}, {"groupId": "OG003", "value": "0.07", "spread": "0.195"}]}]}, {"title": "Change from BL at Week 154 (n=77, 71, 78, 45)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.06", "spread": "0.167"}, {"groupId": "OG001", "value": "-0.10", "spread": "0.194"}, {"groupId": "OG002", "value": "-0.23", "spread": "0.117"}, {"groupId": "OG003", "value": "-0.34", "spread": "0.137"}]}]}, {"title": "Change from BL at Week 167 (n=76, 67, 75, 42)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.04", "spread": "0.161"}, {"groupId": "OG001", "value": "0.02", "spread": "0.160"}, {"groupId": "OG002", "value": "0.06", "spread": "0.130"}, {"groupId": "OG003", "value": "-0.22", "spread": "0.145"}]}]}, {"title": "Change from BL at Week 180 (n=69, 60, 72, 41)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.23", "spread": "0.159"}, {"groupId": "OG001", "value": "-0.35", "spread": "0.176"}, {"groupId": "OG002", "value": "-0.17", "spread": "0.114"}, {"groupId": "OG003", "value": "-0.20", "spread": "0.155"}]}]}, {"title": "Change from BL at Week 193 (n=69, 60, 71, 40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.25", "spread": "0.139"}, {"groupId": "OG001", "value": "-0.11", "spread": "0.178"}, {"groupId": "OG002", "value": "0.11", "spread": "0.118"}, {"groupId": "OG003", "value": "-0.19", "spread": "0.185"}]}]}, {"title": "Change from BL at Week 206 (n=61, 48, 63, 31)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.14", "spread": "0.146"}, {"groupId": "OG001", "value": "-0.40", "spread": "0.215"}, {"groupId": "OG002", "value": "-0.03", "spread": "0.124"}, {"groupId": "OG003", "value": "-0.29", "spread": "0.154"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Baseline and Changes From Baseline in Absolute Lymphocyte Counts (x 10^3 c/\u00b5L) During the ST + LT Period", "populationDescription": "Treated participants; n=number of treated participants with measurement at time point", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "10^3 c/\u00b5L", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg + Metformin", "description": "Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg + Metformin", "description": "Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg + Metformin", "description": "Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo+ Metformin", "description": "Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "192"}, {"groupId": "OG001", "value": "191"}, {"groupId": "OG002", "value": "181"}, {"groupId": "OG003", "value": "179"}]}], "classes": [{"title": "Baseline (Week 0) (n=192, 191, 181, 179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.29", "spread": "0.051"}, {"groupId": "OG001", "value": "2.29", "spread": "0.057"}, {"groupId": "OG002", "value": "2.23", "spread": "0.051"}, {"groupId": "OG003", "value": "2.31", "spread": "0.054"}]}]}, {"title": "Change from BL at Week 2 (n=178, 175, 170, 169)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.02", "spread": "0.037"}, {"groupId": "OG001", "value": "-0.07", "spread": "0.036"}, {"groupId": "OG002", "value": "-0.03", "spread": "0.038"}, {"groupId": "OG003", "value": "-0.02", "spread": "0.038"}]}]}, {"title": "Change from BL at Week 4 (n=176, 175, 170, 166)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.02", "spread": "0.035"}, {"groupId": "OG001", "value": "-0.04", "spread": "0.037"}, {"groupId": "OG002", "value": "-0.13", "spread": "0.035"}, {"groupId": "OG003", "value": "0.00", "spread": "0.037"}]}]}, {"title": "Change from BL at Week 6 (n=175, 172, 165, 158)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.03", "spread": "0.040"}, {"groupId": "OG001", "value": "-0.06", "spread": "0.033"}, {"groupId": "OG002", "value": "-0.12", "spread": "0.037"}, {"groupId": "OG003", "value": "-0.03", "spread": "0.038"}]}]}, {"title": "Change from BL at Week 8 (n=172, 172, 163, 153)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.01", "spread": "0.038"}, {"groupId": "OG001", "value": "-0.04", "spread": "0.039"}, {"groupId": "OG002", "value": "-0.13", "spread": "0.038"}, {"groupId": "OG003", "value": "0.00", "spread": "0.044"}]}]}, {"title": "Change from BL at Week 10 (n=148, 130, 137, 128)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.12", "spread": "0.046"}, {"groupId": "OG001", "value": "0.07", "spread": "0.049"}, {"groupId": "OG002", "value": "-0.03", "spread": "0.051"}, {"groupId": "OG003", "value": "0.15", "spread": "0.046"}]}]}, {"title": "Change from BL at Week 12 (n=168, 166, 159, 141)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.02", "spread": "0.041"}, {"groupId": "OG001", "value": "-0.02", "spread": "0.044"}, {"groupId": "OG002", "value": "-0.11", "spread": "0.043"}, {"groupId": "OG003", "value": "0.07", "spread": "0.045"}]}]}, {"title": "Change from BL at Week 14 (n=156, 152, 145, 136)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.13", "spread": "0.045"}, {"groupId": "OG001", "value": "0.04", "spread": "0.039"}, {"groupId": "OG002", "value": "-0.08", "spread": "0.044"}, {"groupId": "OG003", "value": "0.11", "spread": "0.048"}]}]}, {"title": "Change from BL at Week 16 (n=166, 166, 157, 137)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.04", "spread": "0.045"}, {"groupId": "OG001", "value": "-0.08", "spread": "0.038"}, {"groupId": "OG002", "value": "-0.12", "spread": "0.047"}, {"groupId": "OG003", "value": "0.04", "spread": "0.051"}]}]}, {"title": "Change from BL at Week 18 (n=155, 157, 149, 139)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.22", "spread": "0.049"}, {"groupId": "OG001", "value": "0.04", "spread": "0.044"}, {"groupId": "OG002", "value": "-0.06", "spread": "0.048"}, {"groupId": "OG003", "value": "0.14", "spread": "0.050"}]}]}, {"title": "Change from BL at Week 20 (n=162, 153, 154, 146)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.08", "spread": "0.040"}, {"groupId": "OG001", "value": "-0.07", "spread": "0.043"}, {"groupId": "OG002", "value": "-0.12", "spread": "0.039"}, {"groupId": "OG003", "value": "0.10", "spread": "0.052"}]}]}, {"title": "Change from BL at Week 22 (n=157, 151, 143, 138)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.16", "spread": "0.044"}, {"groupId": "OG001", "value": "0.05", "spread": "0.043"}, {"groupId": "OG002", "value": "-0.09", "spread": "0.044"}, {"groupId": "OG003", "value": "0.18", "spread": "0.047"}]}]}, {"title": "Change from BL at Week 24 (n=162, 160, 157, 135)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.07", "spread": "0.045"}, {"groupId": "OG001", "value": "-0.02", "spread": "0.041"}, {"groupId": "OG002", "value": "-0.09", "spread": "0.039"}, {"groupId": "OG003", "value": "0.02", "spread": "0.051"}]}]}, {"title": "Change from BL at Week 30 (n=159, 155, 154, 136)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.06", "spread": "0.040"}, {"groupId": "OG001", "value": "0.03", "spread": "0.045"}, {"groupId": "OG002", "value": "-0.07", "spread": "0.048"}, {"groupId": "OG003", "value": "0.04", "spread": "0.051"}]}]}, {"title": "Change from BL at Week 37 (n=150, 149, 146, 121)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.04", "spread": "0.045"}, {"groupId": "OG001", "value": "0.00", "spread": "0.041"}, {"groupId": "OG002", "value": "-0.17", "spread": "0.048"}, {"groupId": "OG003", "value": "0.00", "spread": "0.051"}]}]}, {"title": "Change from BL at Week 50 (n=150, 142, 145, 124)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.12", "spread": "0.038"}, {"groupId": "OG001", "value": "-0.17", "spread": "0.040"}, {"groupId": "OG002", "value": "-0.25", "spread": "0.044"}, {"groupId": "OG003", "value": "-0.10", "spread": "0.042"}]}]}, {"title": "Change from BL at Week 63 (n=147, 136, 140, 115)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.12", "spread": "0.042"}, {"groupId": "OG001", "value": "-0.17", "spread": "0.043"}, {"groupId": "OG002", "value": "-0.30", "spread": "0.042"}, {"groupId": "OG003", "value": "-0.16", "spread": "0.051"}]}]}, {"title": "Change from BL at Week 76 (n=134, 126, 130, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.11", "spread": "0.047"}, {"groupId": "OG001", "value": "-0.23", "spread": "0.044"}, {"groupId": "OG002", "value": "-0.30", "spread": "0.046"}, {"groupId": "OG003", "value": "-0.17", "spread": "0.054"}]}]}, {"title": "Change from BL at Week 89 (n=122, 114, 123, 85)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.14", "spread": "0.053"}, {"groupId": "OG001", "value": "-0.23", "spread": "0.062"}, {"groupId": "OG002", "value": "-0.33", "spread": "0.047"}, {"groupId": "OG003", "value": "-0.21", "spread": "0.061"}]}]}, {"title": "Change from BL at Week 102 (n=104, 104, 111, 68)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.20", "spread": "0.050"}, {"groupId": "OG001", "value": "-0.14", "spread": "0.058"}, {"groupId": "OG002", "value": "-0.30", "spread": "0.044"}, {"groupId": "OG003", "value": "-0.20", "spread": "0.063"}]}]}, {"title": "Change from BL at Week 115 (n=98, 92, 95, 58)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.13", "spread": "0.057"}, {"groupId": "OG001", "value": "-0.15", "spread": "0.056"}, {"groupId": "OG002", "value": "-0.23", "spread": "0.057"}, {"groupId": "OG003", "value": "-0.12", "spread": "0.065"}]}]}, {"title": "Change from BL at Week 128 (n=91, 88, 88, 50)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.15", "spread": "0.061"}, {"groupId": "OG001", "value": "-0.24", "spread": "0.057"}, {"groupId": "OG002", "value": "-0.28", "spread": "0.053"}, {"groupId": "OG003", "value": "-0.21", "spread": "0.075"}]}]}, {"title": "Change from BL at Week 141 (n=85, 78, 84, 48)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.04", "spread": "0.067"}, {"groupId": "OG001", "value": "-0.20", "spread": "0.058"}, {"groupId": "OG002", "value": "-0.22", "spread": "0.060"}, {"groupId": "OG003", "value": "-0.17", "spread": "0.080"}]}]}, {"title": "Change from BL at Week 154 (n=78, 71, 78, 45)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.23", "spread": "0.058"}, {"groupId": "OG001", "value": "-0.28", "spread": "0.079"}, {"groupId": "OG002", "value": "-0.35", "spread": "0.075"}, {"groupId": "OG003", "value": "-0.19", "spread": "0.065"}]}]}, {"title": "Change from BL at Week 167 (n=77, 67, 75, 42)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.11", "spread": "0.065"}, {"groupId": "OG001", "value": "-0.25", "spread": "0.081"}, {"groupId": "OG002", "value": "-0.24", "spread": "0.058"}, {"groupId": "OG003", "value": "-0.13", "spread": "0.072"}]}]}, {"title": "Change from BL at Week 180 (n=69, 60, 72, 41)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.21", "spread": "0.059"}, {"groupId": "OG001", "value": "-0.35", "spread": "0.072"}, {"groupId": "OG002", "value": "-0.26", "spread": "0.074"}, {"groupId": "OG003", "value": "-0.14", "spread": "0.081"}]}]}, {"title": "Change from BL at Week 193 (n=69, 60, 71, 40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.18", "spread": "0.069"}, {"groupId": "OG001", "value": "-0.31", "spread": "0.081"}, {"groupId": "OG002", "value": "-0.30", "spread": "0.071"}, {"groupId": "OG003", "value": "-0.14", "spread": "0.079"}]}]}, {"title": "Change from BL at Week 206 (n=61, 48, 63, 31)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.40", "spread": "0.070"}, {"groupId": "OG001", "value": "-0.39", "spread": "0.085"}, {"groupId": "OG002", "value": "-0.36", "spread": "0.067"}, {"groupId": "OG003", "value": "-0.32", "spread": "0.077"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Baseline and Changes From Baseline in Absolute Monocyte Counts (x 10^3 c/\u00b5L) During the ST + LT Period", "populationDescription": "Treated participants; n=number of treated participants with measurement at time point", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "10^3 c/\u00b5L", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg + Metformin", "description": "Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg + Metformin", "description": "Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg + Metformin", "description": "Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo+ Metformin", "description": "Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "192"}, {"groupId": "OG001", "value": "191"}, {"groupId": "OG002", "value": "181"}, {"groupId": "OG003", "value": "179"}]}], "classes": [{"title": "Baseline (Week 0) (n=192, 191, 181, 179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.40", "spread": "0.015"}, {"groupId": "OG001", "value": "0.41", "spread": "0.015"}, {"groupId": "OG002", "value": "0.42", "spread": "0.014"}, {"groupId": "OG003", "value": "0.40", "spread": "0.014"}]}]}, {"title": "Change from BL at Week 2 (n=178, 175, 170, 169)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.01", "spread": "0.015"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.012"}, {"groupId": "OG002", "value": "-0.00", "spread": "0.011"}, {"groupId": "OG003", "value": "0.01", "spread": "0.011"}]}]}, {"title": "Change from BL at Week 4 (n=176, 175, 170, 166)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.014"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.014"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.013"}, {"groupId": "OG003", "value": "0.03", "spread": "0.012"}]}]}, {"title": "Change from BL at Week 6 (n=175, 172, 165, 158)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.013"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.013"}, {"groupId": "OG002", "value": "0.01", "spread": "0.011"}, {"groupId": "OG003", "value": "0.02", "spread": "0.015"}]}]}, {"title": "Change from BL at Week 8 (n=172, 172, 163, 153)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.016"}, {"groupId": "OG001", "value": "-0.00", "spread": "0.013"}, {"groupId": "OG002", "value": "-0.02", "spread": "0.012"}, {"groupId": "OG003", "value": "0.01", "spread": "0.013"}]}]}, {"title": "Change from BL at Week 10 (n=148, 130, 137, 128)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.05", "spread": "0.016"}, {"groupId": "OG001", "value": "0.02", "spread": "0.015"}, {"groupId": "OG002", "value": "0.03", "spread": "0.012"}, {"groupId": "OG003", "value": "0.05", "spread": "0.014"}]}]}, {"title": "Change from BL at Week 12 (n=168, 166, 159, 141)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.02", "spread": "0.011"}, {"groupId": "OG001", "value": "0.01", "spread": "0.013"}, {"groupId": "OG002", "value": "0.01", "spread": "0.012"}, {"groupId": "OG003", "value": "0.03", "spread": "0.014"}]}]}, {"title": "Change from BL at Week 14 (n=156, 152, 145, 136)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.04", "spread": "0.015"}, {"groupId": "OG001", "value": "0.03", "spread": "0.015"}, {"groupId": "OG002", "value": "0.03", "spread": "0.014"}, {"groupId": "OG003", "value": "0.05", "spread": "0.013"}]}]}, {"title": "Change from BL at Week 16 (n=166, 166, 157, 137)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.02", "spread": "0.015"}, {"groupId": "OG001", "value": "0.02", "spread": "0.014"}, {"groupId": "OG002", "value": "0.02", "spread": "0.012"}, {"groupId": "OG003", "value": "0.03", "spread": "0.014"}]}]}, {"title": "Change from BL at Week 18 (n=155, 157, 149, 139)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.06", "spread": "0.015"}, {"groupId": "OG001", "value": "0.04", "spread": "0.016"}, {"groupId": "OG002", "value": "0.05", "spread": "0.014"}, {"groupId": "OG003", "value": "0.06", "spread": "0.014"}]}]}, {"title": "Change from BL at Week 20 (n=162, 153, 154, 146)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.02", "spread": "0.014"}, {"groupId": "OG001", "value": "0.02", "spread": "0.014"}, {"groupId": "OG002", "value": "0.02", "spread": "0.011"}, {"groupId": "OG003", "value": "0.04", "spread": "0.012"}]}]}, {"title": "Change from BL at Week 22 (n=157, 151, 143, 138)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.06", "spread": "0.015"}, {"groupId": "OG001", "value": "0.04", "spread": "0.015"}, {"groupId": "OG002", "value": "0.03", "spread": "0.012"}, {"groupId": "OG003", "value": "0.07", "spread": "0.013"}]}]}, {"title": "Change from BL at Week 24 (n=162, 160, 157, 135)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.03", "spread": "0.015"}, {"groupId": "OG001", "value": "0.02", "spread": "0.015"}, {"groupId": "OG002", "value": "0.02", "spread": "0.012"}, {"groupId": "OG003", "value": "0.04", "spread": "0.013"}]}]}, {"title": "Change from BL at Week 30 (n=159, 155, 154, 136)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.02", "spread": "0.013"}, {"groupId": "OG001", "value": "0.02", "spread": "0.015"}, {"groupId": "OG002", "value": "0.02", "spread": "0.011"}, {"groupId": "OG003", "value": "0.05", "spread": "0.018"}]}]}, {"title": "Change from BL at Week 37 (n=150, 149, 146, 121)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.03", "spread": "0.015"}, {"groupId": "OG001", "value": "0.03", "spread": "0.017"}, {"groupId": "OG002", "value": "0.02", "spread": "0.011"}, {"groupId": "OG003", "value": "0.03", "spread": "0.016"}]}]}, {"title": "Change from BL at Week 50 (n=150, 142, 145, 124)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.04", "spread": "0.014"}, {"groupId": "OG001", "value": "0.04", "spread": "0.014"}, {"groupId": "OG002", "value": "0.04", "spread": "0.011"}, {"groupId": "OG003", "value": "0.03", "spread": "0.013"}]}]}, {"title": "Change from BL at Week 63 (n=147, 136, 140, 115)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.06", "spread": "0.014"}, {"groupId": "OG001", "value": "0.06", "spread": "0.016"}, {"groupId": "OG002", "value": "0.06", "spread": "0.019"}, {"groupId": "OG003", "value": "0.04", "spread": "0.015"}]}]}, {"title": "Change from BL at Week 76 (n=134, 126, 130, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.03", "spread": "0.015"}, {"groupId": "OG001", "value": "0.05", "spread": "0.017"}, {"groupId": "OG002", "value": "0.04", "spread": "0.012"}, {"groupId": "OG003", "value": "0.05", "spread": "0.015"}]}]}, {"title": "Change from BL at Week 89 (n=122, 113, 123, 85)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.04", "spread": "0.018"}, {"groupId": "OG001", "value": "0.04", "spread": "0.019"}, {"groupId": "OG002", "value": "0.06", "spread": "0.016"}, {"groupId": "OG003", "value": "0.06", "spread": "0.017"}]}]}, {"title": "Change from BL at Week 102 (n=104, 104, 111, 68)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.02", "spread": "0.018"}, {"groupId": "OG001", "value": "0.07", "spread": "0.023"}, {"groupId": "OG002", "value": "0.03", "spread": "0.015"}, {"groupId": "OG003", "value": "0.06", "spread": "0.018"}]}]}, {"title": "Change from BL at Week 115 (n=98, 92, 95, 57)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.04", "spread": "0.018"}, {"groupId": "OG001", "value": "0.05", "spread": "0.023"}, {"groupId": "OG002", "value": "0.08", "spread": "0.017"}, {"groupId": "OG003", "value": "0.04", "spread": "0.019"}]}]}, {"title": "Change from BL at Week 128 (n=90, 87, 88, 50)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.04", "spread": "0.021"}, {"groupId": "OG001", "value": "0.05", "spread": "0.024"}, {"groupId": "OG002", "value": "0.04", "spread": "0.014"}, {"groupId": "OG003", "value": "0.04", "spread": "0.020"}]}]}, {"title": "Change from BL at Week 141 (n=85, 78, 84, 47)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.05", "spread": "0.021"}, {"groupId": "OG001", "value": "0.06", "spread": "0.021"}, {"groupId": "OG002", "value": "0.07", "spread": "0.018"}, {"groupId": "OG003", "value": "0.07", "spread": "0.019"}]}]}, {"title": "Change from BL at Week 154 (n=77, 71, 78, 45)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.021"}, {"groupId": "OG001", "value": "0.07", "spread": "0.025"}, {"groupId": "OG002", "value": "0.03", "spread": "0.019"}, {"groupId": "OG003", "value": "0.05", "spread": "0.019"}]}]}, {"title": "Change from BL at Week 167 (n=76, 67, 75, 42)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.024"}, {"groupId": "OG001", "value": "0.07", "spread": "0.024"}, {"groupId": "OG002", "value": "0.03", "spread": "0.017"}, {"groupId": "OG003", "value": "0.05", "spread": "0.017"}]}]}, {"title": "Change from BL at Week 180 (n=69, 60, 72, 41)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.02", "spread": "0.024"}, {"groupId": "OG001", "value": "0.04", "spread": "0.024"}, {"groupId": "OG002", "value": "0.06", "spread": "0.017"}, {"groupId": "OG003", "value": "0.04", "spread": "0.016"}]}]}, {"title": "Change from BL at Week 193 (n=69, 60, 71, 40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.024"}, {"groupId": "OG001", "value": "0.08", "spread": "0.027"}, {"groupId": "OG002", "value": "0.06", "spread": "0.017"}, {"groupId": "OG003", "value": "0.04", "spread": "0.014"}]}]}, {"title": "Change from BL at Week 206 (n=61, 48, 63, 31)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.018"}, {"groupId": "OG001", "value": "0.04", "spread": "0.021"}, {"groupId": "OG002", "value": "0.02", "spread": "0.019"}, {"groupId": "OG003", "value": "0.01", "spread": "0.016"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Baseline and Changes From Baseline in Absolute Basophil Counts (x 10^3 c/\u00b5L) During the ST + LT Period", "populationDescription": "Treated participants; n=number of treated participants with measurement at time point", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "10^3 c/\u00b5L", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg + Metformin", "description": "Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg + Metformin", "description": "Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg + Metformin", "description": "Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo+ Metformin", "description": "Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "192"}, {"groupId": "OG001", "value": "191"}, {"groupId": "OG002", "value": "181"}, {"groupId": "OG003", "value": "179"}]}], "classes": [{"title": "Baseline (Week 0) (n=192, 191, 181, 179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.02", "spread": "0.003"}, {"groupId": "OG001", "value": "0.02", "spread": "0.003"}, {"groupId": "OG002", "value": "0.02", "spread": "0.003"}, {"groupId": "OG003", "value": "0.02", "spread": "0.003"}]}]}, {"title": "Change from BL at Week 2 (n=178, 175, 170, 169)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.00", "spread": "0.002"}, {"groupId": "OG001", "value": "-0.00", "spread": "0.003"}, {"groupId": "OG002", "value": "0.00", "spread": "0.003"}, {"groupId": "OG003", "value": "-0.00", "spread": "0.003"}]}]}, {"title": "Change from BL at Week 4 (n=176, 175, 170, 166)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.003"}, {"groupId": "OG001", "value": "-0.00", "spread": "0.003"}, {"groupId": "OG002", "value": "0.00", "spread": "0.004"}, {"groupId": "OG003", "value": "-0.00", "spread": "0.003"}]}]}, {"title": "Change from BL at Week 6 (n=175, 172, 165, 158)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.00", "spread": "0.003"}, {"groupId": "OG001", "value": "-0.00", "spread": "0.003"}, {"groupId": "OG002", "value": "-0.00", "spread": "0.003"}, {"groupId": "OG003", "value": "0.00", "spread": "0.004"}]}]}, {"title": "Change from BL at Week 8 (n=172, 172, 163, 153)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.00", "spread": "0.003"}, {"groupId": "OG001", "value": "-0.00", "spread": "0.003"}, {"groupId": "OG002", "value": "0.00", "spread": "0.003"}, {"groupId": "OG003", "value": "-0.00", "spread": "0.003"}]}]}, {"title": "Change from BL at Week 10 (n=148, 130, 137, 128)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.00", "spread": "0.003"}, {"groupId": "OG001", "value": "-0.00", "spread": "0.003"}, {"groupId": "OG002", "value": "-0.00", "spread": "0.003"}, {"groupId": "OG003", "value": "-0.00", "spread": "0.004"}]}]}, {"title": "Change from BL at Week 12 (n=168, 166, 159, 141)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.004"}, {"groupId": "OG001", "value": "0.00", "spread": "0.004"}, {"groupId": "OG002", "value": "-0.00", "spread": "0.003"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.003"}]}]}, {"title": "Change from BL at Week 14 (n=156, 152, 145, 136)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.00", "spread": "0.003"}, {"groupId": "OG001", "value": "0.00", "spread": "0.003"}, {"groupId": "OG002", "value": "-0.00", "spread": "0.003"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.003"}]}]}, {"title": "Change from BL at Week 16 (n=166, 166, 157, 137)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.00", "spread": "0.003"}, {"groupId": "OG001", "value": "0.00", "spread": "0.003"}, {"groupId": "OG002", "value": "0.00", "spread": "0.003"}, {"groupId": "OG003", "value": "-0.00", "spread": "0.003"}]}]}, {"title": "Change from BL at Week 18 (n=155, 157, 149, 139)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.004"}, {"groupId": "OG001", "value": "0.00", "spread": "0.004"}, {"groupId": "OG002", "value": "0.00", "spread": "0.003"}, {"groupId": "OG003", "value": "-0.00", "spread": "0.003"}]}]}, {"title": "Change from BL at Week 20 (n=162, 153, 154, 146)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.003"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.003"}, {"groupId": "OG002", "value": "0.00", "spread": "0.003"}, {"groupId": "OG003", "value": "-0.00", "spread": "0.004"}]}]}, {"title": "Change from BL at Week 22 (n=157, 151, 143, 138)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.003"}, {"groupId": "OG001", "value": "0.00", "spread": "0.004"}, {"groupId": "OG002", "value": "-0.00", "spread": "0.003"}, {"groupId": "OG003", "value": "-0.00", "spread": "0.005"}]}]}, {"title": "Change from BL at Week 24 (n=162, 160, 157, 135)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.004"}, {"groupId": "OG001", "value": "0.00", "spread": "0.003"}, {"groupId": "OG002", "value": "0.00", "spread": "0.003"}, {"groupId": "OG003", "value": "-0.00", "spread": "0.004"}]}]}, {"title": "Change from BL at Week 30 (n=159, 155, 154, 136)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.003"}, {"groupId": "OG001", "value": "0.00", "spread": "0.003"}, {"groupId": "OG002", "value": "0.00", "spread": "0.004"}, {"groupId": "OG003", "value": "0.00", "spread": "0.003"}]}]}, {"title": "Change from BL at Week 37 (n=150, 149, 146, 121)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.003"}, {"groupId": "OG001", "value": "0.00", "spread": "0.003"}, {"groupId": "OG002", "value": "0.01", "spread": "0.003"}, {"groupId": "OG003", "value": "-0.00", "spread": "0.004"}]}]}, {"title": "Change from BL at Week 50 (n=150, 142, 145, 124)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.003"}, {"groupId": "OG001", "value": "0.01", "spread": "0.004"}, {"groupId": "OG002", "value": "0.01", "spread": "0.003"}, {"groupId": "OG003", "value": "0.00", "spread": "0.004"}]}]}, {"title": "Change from BL at Week 63 (n=147, 136, 140, 115)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.004"}, {"groupId": "OG001", "value": "0.01", "spread": "0.004"}, {"groupId": "OG002", "value": "0.01", "spread": "0.005"}, {"groupId": "OG003", "value": "0.00", "spread": "0.004"}]}]}, {"title": "Change from BL at Week 76 (n=134, 126, 130, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.02", "spread": "0.005"}, {"groupId": "OG001", "value": "0.01", "spread": "0.004"}, {"groupId": "OG002", "value": "0.02", "spread": "0.005"}, {"groupId": "OG003", "value": "0.00", "spread": "0.005"}]}]}, {"title": "Change from BL at Week 89 (n=122, 113, 123, 85)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.004"}, {"groupId": "OG001", "value": "0.01", "spread": "0.004"}, {"groupId": "OG002", "value": "0.01", "spread": "0.003"}, {"groupId": "OG003", "value": "0.00", "spread": "0.005"}]}]}, {"title": "Change from BL at Week 102 (n=104, 104, 111, 68)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.005"}, {"groupId": "OG001", "value": "0.01", "spread": "0.005"}, {"groupId": "OG002", "value": "0.02", "spread": "0.005"}, {"groupId": "OG003", "value": "-0.00", "spread": "0.006"}]}]}, {"title": "Change from BL at Week 115 (n=98, 92, 95, 57)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.004"}, {"groupId": "OG001", "value": "0.01", "spread": "0.006"}, {"groupId": "OG002", "value": "0.01", "spread": "0.004"}, {"groupId": "OG003", "value": "0.00", "spread": "0.007"}]}]}, {"title": "Change from BL at Week 128 (n=90, 87, 88, 50)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.005"}, {"groupId": "OG001", "value": "0.01", "spread": "0.005"}, {"groupId": "OG002", "value": "0.02", "spread": "0.005"}, {"groupId": "OG003", "value": "-0.00", "spread": "0.008"}]}]}, {"title": "Change from BL at Week 141 (n=85, 78, 84, 47)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.005"}, {"groupId": "OG001", "value": "0.01", "spread": "0.004"}, {"groupId": "OG002", "value": "0.01", "spread": "0.003"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.008"}]}]}, {"title": "Change from BL at Week 154 (n=77, 71, 78, 45)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.005"}, {"groupId": "OG001", "value": "0.01", "spread": "0.005"}, {"groupId": "OG002", "value": "0.00", "spread": "0.005"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.007"}]}]}, {"title": "Change from BL at Week 167 (n=76, 67, 75, 42)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.005"}, {"groupId": "OG001", "value": "0.01", "spread": "0.006"}, {"groupId": "OG002", "value": "0.01", "spread": "0.005"}, {"groupId": "OG003", "value": "-0.00", "spread": "0.008"}]}]}, {"title": "Change from BL at Week 180 (n=69, 60, 72, 41)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.00", "spread": "0.005"}, {"groupId": "OG001", "value": "-0.00", "spread": "0.006"}, {"groupId": "OG002", "value": "0.01", "spread": "0.004"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.006"}]}]}, {"title": "Change from BL at Week 193 (n=69, 60, 71, 40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.006"}, {"groupId": "OG001", "value": "0.00", "spread": "0.006"}, {"groupId": "OG002", "value": "0.00", "spread": "0.004"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.008"}]}]}, {"title": "Change from BL at Week 206 (n=61, 48, 63, 31)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.005"}, {"groupId": "OG001", "value": "0.01", "spread": "0.006"}, {"groupId": "OG002", "value": "0.01", "spread": "0.005"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.008"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Baseline and Changes From Baseline in Absolute Eosinophil Counts (x 10^3 c/\u00b5L) During the ST + LT Period", "populationDescription": "Treated participants; n=number of treated participants with measurement at time point", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "10^3 c/\u00b5L", "timeFrame": "Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg + Metformin", "description": "Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg + Metformin", "description": "Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg + Metformin", "description": "Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo+ Metformin", "description": "Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "192"}, {"groupId": "OG001", "value": "191"}, {"groupId": "OG002", "value": "181"}, {"groupId": "OG003", "value": "179"}]}], "classes": [{"title": "Baseline (Week 0) (n=192, 191, 181, 179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.24", "spread": "0.018"}, {"groupId": "OG001", "value": "0.23", "spread": "0.016"}, {"groupId": "OG002", "value": "0.24", "spread": "0.024"}, {"groupId": "OG003", "value": "0.21", "spread": "0.013"}]}]}, {"title": "Change from BL at Week 2 (n=178, 175, 170, 169)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.02", "spread": "0.014"}, {"groupId": "OG001", "value": "0.01", "spread": "0.010"}, {"groupId": "OG002", "value": "-0.00", "spread": "0.013"}, {"groupId": "OG003", "value": "0.00", "spread": "0.007"}]}]}, {"title": "Change from BL at Week 4 (n=176, 175, 170, 166)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.01", "spread": "0.023"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.011"}, {"groupId": "OG002", "value": "-0.02", "spread": "0.016"}, {"groupId": "OG003", "value": "0.00", "spread": "0.007"}]}]}, {"title": "Change from BL at Week 6 (n=175, 172, 165, 158)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.02", "spread": "0.017"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.012"}, {"groupId": "OG002", "value": "-0.03", "spread": "0.012"}, {"groupId": "OG003", "value": "0.01", "spread": "0.009"}]}]}, {"title": "Change from BL at Week 8 (n=172, 172, 163, 153)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.00", "spread": "0.019"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.011"}, {"groupId": "OG002", "value": "-0.02", "spread": "0.011"}, {"groupId": "OG003", "value": "0.00", "spread": "0.010"}]}]}, {"title": "Change from BL at Week 10 (n=148, 130, 137, 128)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.02", "spread": "0.012"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.019"}, {"groupId": "OG002", "value": "-0.02", "spread": "0.015"}, {"groupId": "OG003", "value": "0.01", "spread": "0.011"}]}]}, {"title": "Change from BL at Week 12 (n=168, 166, 159, 141)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.02", "spread": "0.019"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.013"}, {"groupId": "OG002", "value": "-0.03", "spread": "0.013"}, {"groupId": "OG003", "value": "0.00", "spread": "0.009"}]}]}, {"title": "Change from BL at Week 14 (n=156, 152, 145, 136)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.022"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.014"}, {"groupId": "OG002", "value": "-0.02", "spread": "0.016"}, {"groupId": "OG003", "value": "0.02", "spread": "0.013"}]}]}, {"title": "Change from BL at Week 16 (n=166, 166, 157, 137)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.02", "spread": "0.023"}, {"groupId": "OG001", "value": "0.00", "spread": "0.012"}, {"groupId": "OG002", "value": "-0.02", "spread": "0.014"}, {"groupId": "OG003", "value": "0.04", "spread": "0.016"}]}]}, {"title": "Change from BL at Week 18 (n=155, 157, 149, 139)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.01", "spread": "0.015"}, {"groupId": "OG001", "value": "-0.00", "spread": "0.017"}, {"groupId": "OG002", "value": "-0.00", "spread": "0.013"}, {"groupId": "OG003", "value": "0.04", "spread": "0.015"}]}]}, {"title": "Change from BL at Week 20 (n=162, 153, 154, 146)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.04", "spread": "0.016"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.014"}, {"groupId": "OG002", "value": "-0.02", "spread": "0.021"}, {"groupId": "OG003", "value": "0.02", "spread": "0.013"}]}]}, {"title": "Change from BL at Week 22 (n=157, 151, 143, 138)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.01", "spread": "0.017"}, {"groupId": "OG001", "value": "-0.00", "spread": "0.016"}, {"groupId": "OG002", "value": "0.00", "spread": "0.011"}, {"groupId": "OG003", "value": "0.03", "spread": "0.014"}]}]}, {"title": "Change from BL at Week 24 (n=162, 160, 157, 135)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.03", "spread": "0.022"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.021"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.013"}, {"groupId": "OG003", "value": "0.01", "spread": "0.011"}]}]}, {"title": "Change from BL at Week 30 (n=159, 155, 154, 136)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.02", "spread": "0.017"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.018"}, {"groupId": "OG002", "value": "0.00", "spread": "0.012"}, {"groupId": "OG003", "value": "0.00", "spread": "0.012"}]}]}, {"title": "Change from BL at Week 37 (n=150, 149, 146, 121)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.00", "spread": "0.037"}, {"groupId": "OG001", "value": "-0.02", "spread": "0.016"}, {"groupId": "OG002", "value": "-0.03", "spread": "0.011"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.011"}]}]}, {"title": "Change from BL at Week 50 (n=150, 142, 145, 124)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.03", "spread": "0.021"}, {"groupId": "OG001", "value": "-0.02", "spread": "0.017"}, {"groupId": "OG002", "value": "0.02", "spread": "0.030"}, {"groupId": "OG003", "value": "-0.02", "spread": "0.011"}]}]}, {"title": "Change from BL at Week 63 (n=147, 136, 140, 115)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.00", "spread": "0.026"}, {"groupId": "OG001", "value": "-0.02", "spread": "0.018"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.018"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.015"}]}]}, {"title": "Change from BL at Week 76 (n=134, 126, 130, 94)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.01", "spread": "0.031"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.020"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.014"}, {"groupId": "OG003", "value": "-0.03", "spread": "0.015"}]}]}, {"title": "Change from BL at Week 89 (n=122, 113, 123, 85)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.02", "spread": "0.028"}, {"groupId": "OG001", "value": "-0.05", "spread": "0.023"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.018"}, {"groupId": "OG003", "value": "-0.03", "spread": "0.015"}]}]}, {"title": "Change from BL at Week 102 (n=104, 104, 111, 68)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.01", "spread": "0.052"}, {"groupId": "OG001", "value": "0.00", "spread": "0.018"}, {"groupId": "OG002", "value": "0.01", "spread": "0.015"}, {"groupId": "OG003", "value": "-0.03", "spread": "0.018"}]}]}, {"title": "Change from BL at Week 115 (n=98, 92, 95, 57)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0.049"}, {"groupId": "OG001", "value": "-0.02", "spread": "0.025"}, {"groupId": "OG002", "value": "0.00", "spread": "0.013"}, {"groupId": "OG003", "value": "-0.03", "spread": "0.022"}]}]}, {"title": "Change from BL at Week 128 (n=90, 87, 88, 50)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.01", "spread": "0.051"}, {"groupId": "OG001", "value": "-0.02", "spread": "0.027"}, {"groupId": "OG002", "value": "0.01", "spread": "0.015"}, {"groupId": "OG003", "value": "-0.03", "spread": "0.021"}]}]}, {"title": "Change from BL at Week 141 (n=85, 78, 84, 47)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.01", "spread": "0.032"}, {"groupId": "OG001", "value": "-0.03", "spread": "0.024"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.015"}, {"groupId": "OG003", "value": "-0.01", "spread": "0.032"}]}]}, {"title": "Change from BL at Week 154 (n=77, 71, 78, 45)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.01", "spread": "0.051"}, {"groupId": "OG001", "value": "-0.02", "spread": "0.017"}, {"groupId": "OG002", "value": "-0.00", "spread": "0.018"}, {"groupId": "OG003", "value": "-0.03", "spread": "0.020"}]}]}, {"title": "Change from BL at Week 167 (n=76, 67, 75, 42)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01", "spread": "0.044"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.014"}, {"groupId": "OG002", "value": "0.00", "spread": "0.020"}, {"groupId": "OG003", "value": "-0.05", "spread": "0.019"}]}]}, {"title": "Change from BL at Week 180 (n=69, 60, 72, 41)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.03", "spread": "0.044"}, {"groupId": "OG001", "value": "-0.03", "spread": "0.014"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.017"}, {"groupId": "OG003", "value": "-0.04", "spread": "0.023"}]}]}, {"title": "Change from BL at Week 193 (n=69, 60, 71, 40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.02", "spread": "0.020"}, {"groupId": "OG001", "value": "-0.00", "spread": "0.021"}, {"groupId": "OG002", "value": "-0.00", "spread": "0.023"}, {"groupId": "OG003", "value": "-0.04", "spread": "0.025"}]}]}, {"title": "Change from BL at Week 206 (n=61, 48, 63, 31)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.03", "spread": "0.019"}, {"groupId": "OG001", "value": "-0.03", "spread": "0.020"}, {"groupId": "OG002", "value": "0.03", "spread": "0.031"}, {"groupId": "OG003", "value": "-0.09", "spread": "0.028"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Changes From Baseline in Systolic Blood Pressure During the ST + LT Period", "populationDescription": "Treated participants; n=number of treated participants with measurement at time point", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "mmHg", "timeFrame": "Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg + Metformin", "description": "Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg + Metformin", "description": "Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg + Metformin", "description": "Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo+ Metformin", "description": "Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "192"}, {"groupId": "OG001", "value": "191"}, {"groupId": "OG002", "value": "181"}, {"groupId": "OG003", "value": "179"}]}], "classes": [{"title": "Change from BL at Week 2 (n=182, 181, 176, 170)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.6", "spread": "1.0"}, {"groupId": "OG001", "value": "-2.5", "spread": "1.0"}, {"groupId": "OG002", "value": "-1.6", "spread": "0.9"}, {"groupId": "OG003", "value": "-3.3", "spread": "1.1"}]}]}, {"title": "Change from BL at Week 4 (n=178, 179, 175, 164)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.0", "spread": "1.0"}, {"groupId": "OG001", "value": "-2.3", "spread": "1.1"}, {"groupId": "OG002", "value": "-3.3", "spread": "0.9"}, {"groupId": "OG003", "value": "-2.9", "spread": "1.1"}]}]}, {"title": "Change from BL at Week 6 (n=178, 176, 171, 162)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.8", "spread": "1.1"}, {"groupId": "OG001", "value": "-4.1", "spread": "1.0"}, {"groupId": "OG002", "value": "-2.8", "spread": "1.1"}, {"groupId": "OG003", "value": "-2.8", "spread": "1.1"}]}]}, {"title": "Change from BL at Week 8 (n=175, 176, 170, 152)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.9", "spread": "1.1"}, {"groupId": "OG001", "value": "-4.2", "spread": "1.1"}, {"groupId": "OG002", "value": "-4.2", "spread": "1.1"}, {"groupId": "OG003", "value": "-3.7", "spread": "1.2"}]}]}, {"title": "Change from BL at Week 10 (n=116, 108, 101, 101)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.1", "spread": "1.4"}, {"groupId": "OG001", "value": "-3.3", "spread": "1.2"}, {"groupId": "OG002", "value": "-2.8", "spread": "1.4"}, {"groupId": "OG003", "value": "-6.8", "spread": "1.5"}]}]}, {"title": "Change from BL at Week 12 (n=170, 166, 161, 138)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.2", "spread": "1.1"}, {"groupId": "OG001", "value": "-2.8", "spread": "1.1"}, {"groupId": "OG002", "value": "-4.3", "spread": "1.0"}, {"groupId": "OG003", "value": "-4.3", "spread": "1.3"}]}]}, {"title": "Change from BL at Week 14 (n=132, 129, 124, 116)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.7", "spread": "1.3"}, {"groupId": "OG001", "value": "-2.3", "spread": "1.1"}, {"groupId": "OG002", "value": "-3.4", "spread": "1.1"}, {"groupId": "OG003", "value": "-2.6", "spread": "1.4"}]}]}, {"title": "Change from BL at Week 16 (n=166, 164, 156, 140)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.7", "spread": "1.1"}, {"groupId": "OG001", "value": "-3.5", "spread": "1.1"}, {"groupId": "OG002", "value": "-4.4", "spread": "1.0"}, {"groupId": "OG003", "value": "-2.6", "spread": "1.2"}]}]}, {"title": "Change from BL at Week 18 (n=144, 141, 132, 123)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.9", "spread": "1.2"}, {"groupId": "OG001", "value": "-2.2", "spread": "1.2"}, {"groupId": "OG002", "value": "-4.2", "spread": "1.1"}, {"groupId": "OG003", "value": "-4.1", "spread": "1.4"}]}]}, {"title": "Change from BL at Week 20 (n=163, 155, 153, 147)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.9", "spread": "1.2"}, {"groupId": "OG001", "value": "-2.2", "spread": "1.1"}, {"groupId": "OG002", "value": "-4.9", "spread": "1.2"}, {"groupId": "OG003", "value": "-4.3", "spread": "1.3"}]}]}, {"title": "Change from BL at Week 22 (n=146, 140, 136, 126)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.0", "spread": "1.2"}, {"groupId": "OG001", "value": "-3.1", "spread": "1.2"}, {"groupId": "OG002", "value": "-3.1", "spread": "1.2"}, {"groupId": "OG003", "value": "-4.7", "spread": "1.3"}]}]}, {"title": "Change from BL at Week 24 (n=165, 160, 161, 140)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-4.3", "spread": "1.2"}, {"groupId": "OG001", "value": "-3.6", "spread": "1.2"}, {"groupId": "OG002", "value": "-3.8", "spread": "1.2"}, {"groupId": "OG003", "value": "-4.5", "spread": "1.3"}]}]}, {"title": "Change from BL at Week 30 (n=162, 156, 155, 138)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.6", "spread": "1.2"}, {"groupId": "OG001", "value": "-1.1", "spread": "1.3"}, {"groupId": "OG002", "value": "-2.5", "spread": "1.2"}, {"groupId": "OG003", "value": "-3.4", "spread": "1.4"}]}]}, {"title": "Change from BL at Week 37 (n=154, 151, 149, 123)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.6", "spread": "1.2"}, {"groupId": "OG001", "value": "-1.8", "spread": "1.3"}, {"groupId": "OG002", "value": "-3.3", "spread": "1.3"}, {"groupId": "OG003", "value": "-2.3", "spread": "1.2"}]}]}, {"title": "Change from BL at Week 50 (n=155, 147, 151, 130)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.6", "spread": "1.3"}, {"groupId": "OG001", "value": "-1.7", "spread": "1.2"}, {"groupId": "OG002", "value": "-1.9", "spread": "1.2"}, {"groupId": "OG003", "value": "-2.9", "spread": "1.5"}]}]}, {"title": "Change from BL at Week 63 (n=151, 138, 145, 117)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.6", "spread": "1.3"}, {"groupId": "OG001", "value": "0.9", "spread": "1.2"}, {"groupId": "OG002", "value": "-0.6", "spread": "1.3"}, {"groupId": "OG003", "value": "-0.0", "spread": "1.3"}]}]}, {"title": "Change from BL at Week 76 (n=134, 126, 133, 98)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.1", "spread": "1.5"}, {"groupId": "OG001", "value": "-0.6", "spread": "1.4"}, {"groupId": "OG002", "value": "-0.7", "spread": "1.3"}, {"groupId": "OG003", "value": "-1.7", "spread": "1.6"}]}]}, {"title": "Change from BL at Week 89 (n=124, 117, 125, 86)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.7", "spread": "1.3"}, {"groupId": "OG001", "value": "0.3", "spread": "1.4"}, {"groupId": "OG002", "value": "-1.7", "spread": "1.4"}, {"groupId": "OG003", "value": "0.3", "spread": "1.6"}]}]}, {"title": "Change from BL at Week 102 (n=111, 107, 113, 73)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.2", "spread": "1.5"}, {"groupId": "OG001", "value": "0.6", "spread": "1.5"}, {"groupId": "OG002", "value": "-2.8", "spread": "1.4"}, {"groupId": "OG003", "value": "-2.0", "spread": "2.0"}]}]}, {"title": "Change from BL at Week 115 (n=100, 94, 98, 58)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.4", "spread": "1.8"}, {"groupId": "OG001", "value": "2.0", "spread": "1.8"}, {"groupId": "OG002", "value": "-1.3", "spread": "1.6"}, {"groupId": "OG003", "value": "-2.8", "spread": "1.9"}]}]}, {"title": "Change from BL at Week 128 (n=94, 88, 90, 52)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.4", "spread": "1.7"}, {"groupId": "OG001", "value": "2.9", "spread": "2.0"}, {"groupId": "OG002", "value": "1.5", "spread": "1.7"}, {"groupId": "OG003", "value": "-2.5", "spread": "2.0"}]}]}, {"title": "Change from BL at Week 141 (n=87, 82, 85, 49)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.7", "spread": "1.8"}, {"groupId": "OG001", "value": "2.0", "spread": "1.6"}, {"groupId": "OG002", "value": "-1.5", "spread": "1.7"}, {"groupId": "OG003", "value": "0.3", "spread": "2.3"}]}]}, {"title": "Change from BL at Week 154 (n=84, 75, 79, 45)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.3", "spread": "1.7"}, {"groupId": "OG001", "value": "-0.0", "spread": "1.8"}, {"groupId": "OG002", "value": "1.5", "spread": "1.8"}, {"groupId": "OG003", "value": "-2.8", "spread": "2.3"}]}]}, {"title": "Change from BL at Week 167 (n=78, 67, 75, 42)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.8", "spread": "1.7"}, {"groupId": "OG001", "value": "-0.4", "spread": "2.1"}, {"groupId": "OG002", "value": "0.7", "spread": "1.7"}, {"groupId": "OG003", "value": "-1.8", "spread": "2.5"}]}]}, {"title": "Change from BL at Week 180 (n=71, 63, 74, 41)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.0", "spread": "2.0"}, {"groupId": "OG001", "value": "3.1", "spread": "2.1"}, {"groupId": "OG002", "value": "3.5", "spread": "1.7"}, {"groupId": "OG003", "value": "2.7", "spread": "2.5"}]}]}, {"title": "Change from BL at Week 193 (n=70, 60, 72, 40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.1", "spread": "2.0"}, {"groupId": "OG001", "value": "0.9", "spread": "2.3"}, {"groupId": "OG002", "value": "0.2", "spread": "1.8"}, {"groupId": "OG003", "value": "-1.4", "spread": "2.4"}]}]}, {"title": "Change from BL at Week 206 (n=61, 53, 64, 33)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.6", "spread": "2.1"}, {"groupId": "OG001", "value": "2.2", "spread": "2.3"}, {"groupId": "OG002", "value": "1.7", "spread": "1.9"}, {"groupId": "OG003", "value": "-0.4", "spread": "2.2"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Changes From Baseline in Diastolic Blood Pressure During the ST + LT Period", "populationDescription": "Treated participants; n=number of treated participants with measurement at time point", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "mmHg", "timeFrame": "Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg + Metformin", "description": "Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg + Metformin", "description": "Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg + Metformin", "description": "Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo+ Metformin", "description": "Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "192"}, {"groupId": "OG001", "value": "191"}, {"groupId": "OG002", "value": "181"}, {"groupId": "OG003", "value": "179"}]}], "classes": [{"title": "Change from BL at Week 2 (n=182, 181, 176, 170)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.0", "spread": "0.6"}, {"groupId": "OG001", "value": "-1.1", "spread": "0.7"}, {"groupId": "OG002", "value": "-0.9", "spread": "0.6"}, {"groupId": "OG003", "value": "-1.5", "spread": "0.7"}]}]}, {"title": "Change from BL at Week 4 (n=178, 179, 175, 164)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.3", "spread": "0.7"}, {"groupId": "OG001", "value": "-0.9", "spread": "0.7"}, {"groupId": "OG002", "value": "-1.3", "spread": "0.6"}, {"groupId": "OG003", "value": "-1.4", "spread": "0.7"}]}]}, {"title": "Change from BL at Week 6 (n=178, 176, 171, 162)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.1", "spread": "0.7"}, {"groupId": "OG001", "value": "-1.6", "spread": "0.7"}, {"groupId": "OG002", "value": "-0.5", "spread": "0.6"}, {"groupId": "OG003", "value": "-1.4", "spread": "0.7"}]}]}, {"title": "Change from BL at Week 8 (n=175, 176, 170, 152)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.1", "spread": "0.7"}, {"groupId": "OG001", "value": "-1.9", "spread": "0.7"}, {"groupId": "OG002", "value": "-1.5", "spread": "0.6"}, {"groupId": "OG003", "value": "-2.2", "spread": "0.7"}]}]}, {"title": "Change from BL at Week 10 (n=116, 108, 101, 101)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.3", "spread": "0.8"}, {"groupId": "OG001", "value": "-0.5", "spread": "0.8"}, {"groupId": "OG002", "value": "-1.6", "spread": "0.8"}, {"groupId": "OG003", "value": "-3.4", "spread": "0.9"}]}]}, {"title": "Change from BL at Week 12 (n=170, 166, 161, 138)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.6", "spread": "0.7"}, {"groupId": "OG001", "value": "-1.0", "spread": "0.7"}, {"groupId": "OG002", "value": "-2.1", "spread": "0.6"}, {"groupId": "OG003", "value": "-1.7", "spread": "0.8"}]}]}, {"title": "Change from BL at Week 14 (n=132, 129, 124, 116)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.2", "spread": "0.8"}, {"groupId": "OG001", "value": "-0.4", "spread": "0.7"}, {"groupId": "OG002", "value": "-2.2", "spread": "0.7"}, {"groupId": "OG003", "value": "-2.1", "spread": "0.9"}]}]}, {"title": "Change from BL at Week 16 (n=166, 164, 156, 140)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.7", "spread": "0.7"}, {"groupId": "OG001", "value": "-1.0", "spread": "0.6"}, {"groupId": "OG002", "value": "-1.7", "spread": "0.6"}, {"groupId": "OG003", "value": "-1.0", "spread": "0.8"}]}]}, {"title": "Change from BL at Week 18 (n=144, 141, 132, 123)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.4", "spread": "0.8"}, {"groupId": "OG001", "value": "-0.7", "spread": "0.8"}, {"groupId": "OG002", "value": "-2.3", "spread": "0.7"}, {"groupId": "OG003", "value": "-1.8", "spread": "0.8"}]}]}, {"title": "Change from BL at Week 20 (n=163, 155, 153, 147)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.2", "spread": "0.7"}, {"groupId": "OG001", "value": "-1.0", "spread": "0.7"}, {"groupId": "OG002", "value": "-2.1", "spread": "0.7"}, {"groupId": "OG003", "value": "-1.9", "spread": "0.7"}]}]}, {"title": "Change from BL at Week 22 (n=146, 140, 136, 126)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.7", "spread": "0.8"}, {"groupId": "OG001", "value": "-1.2", "spread": "0.8"}, {"groupId": "OG002", "value": "-1.6", "spread": "0.8"}, {"groupId": "OG003", "value": "-1.6", "spread": "0.8"}]}]}, {"title": "Change from BL at Week 24 (n=165, 160, 161, 140)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.3", "spread": "0.7"}, {"groupId": "OG001", "value": "-1.3", "spread": "0.8"}, {"groupId": "OG002", "value": "-2.5", "spread": "0.7"}, {"groupId": "OG003", "value": "-2.4", "spread": "0.7"}]}]}, {"title": "Change from BL at Week 30 (n=162, 156, 155, 138)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.9", "spread": "0.8"}, {"groupId": "OG001", "value": "-0.5", "spread": "0.8"}, {"groupId": "OG002", "value": "-1.6", "spread": "0.7"}, {"groupId": "OG003", "value": "-1.6", "spread": "0.8"}]}]}, {"title": "Change from BL at Week 37 (n=154, 151, 149, 123)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.9", "spread": "0.7"}, {"groupId": "OG001", "value": "-1.1", "spread": "0.8"}, {"groupId": "OG002", "value": "-1.9", "spread": "0.8"}, {"groupId": "OG003", "value": "-1.6", "spread": "0.8"}]}]}, {"title": "Change from BL at Week 50 (n=155, 147, 151, 130)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.1", "spread": "0.8"}, {"groupId": "OG001", "value": "-1.7", "spread": "0.8"}, {"groupId": "OG002", "value": "-1.5", "spread": "0.7"}, {"groupId": "OG003", "value": "-1.4", "spread": "0.8"}]}]}, {"title": "Change from BL at Week 63 (n=151, 138, 145, 117)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.8", "spread": "0.8"}, {"groupId": "OG001", "value": "-0.3", "spread": "0.7"}, {"groupId": "OG002", "value": "-0.9", "spread": "0.7"}, {"groupId": "OG003", "value": "-0.7", "spread": "0.8"}]}]}, {"title": "Change from BL at Week 76 (n=134, 126, 133, 98)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.2", "spread": "0.9"}, {"groupId": "OG001", "value": "-1.2", "spread": "0.8"}, {"groupId": "OG002", "value": "-1.6", "spread": "0.8"}, {"groupId": "OG003", "value": "-1.8", "spread": "1.0"}]}]}, {"title": "Change from BL at Week 89 (n=124, 117, 125, 86)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.2", "spread": "0.8"}, {"groupId": "OG001", "value": "-0.8", "spread": "0.8"}, {"groupId": "OG002", "value": "-1.9", "spread": "0.8"}, {"groupId": "OG003", "value": "-2.1", "spread": "1.0"}]}]}, {"title": "Change from BL at Week 102 (n=111, 107, 113, 73)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.2", "spread": "0.9"}, {"groupId": "OG001", "value": "-0.4", "spread": "1.0"}, {"groupId": "OG002", "value": "-2.3", "spread": "0.9"}, {"groupId": "OG003", "value": "-3.6", "spread": "1.2"}]}]}, {"title": "Change from BL at Week 115 (n=100, 94, 98, 58)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.1", "spread": "1.0"}, {"groupId": "OG001", "value": "0.7", "spread": "1.1"}, {"groupId": "OG002", "value": "-1.1", "spread": "1.1"}, {"groupId": "OG003", "value": "-3.6", "spread": "1.2"}]}]}, {"title": "Change from BL at Week 128 (n=94, 88, 90, 52)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.6", "spread": "1.1"}, {"groupId": "OG001", "value": "0.0", "spread": "1.1"}, {"groupId": "OG002", "value": "-1.2", "spread": "1.0"}, {"groupId": "OG003", "value": "-3.1", "spread": "1.3"}]}]}, {"title": "Change from BL at Week 141 (n=87, 82, 85, 49)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.7", "spread": "1.1"}, {"groupId": "OG001", "value": "0.3", "spread": "1.1"}, {"groupId": "OG002", "value": "-3.0", "spread": "1.1"}, {"groupId": "OG003", "value": "-2.7", "spread": "1.5"}]}]}, {"title": "Change from BL at Week 154 (n=84, 75, 79, 45)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.7", "spread": "1.0"}, {"groupId": "OG001", "value": "-1.8", "spread": "1.1"}, {"groupId": "OG002", "value": "-2.7", "spread": "1.1"}, {"groupId": "OG003", "value": "-4.6", "spread": "1.2"}]}]}, {"title": "Change from BL at Week 167 (n=78, 67, 75, 42)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.1", "spread": "1.0"}, {"groupId": "OG001", "value": "-1.4", "spread": "1.3"}, {"groupId": "OG002", "value": "-1.6", "spread": "1.2"}, {"groupId": "OG003", "value": "-2.0", "spread": "1.7"}]}]}, {"title": "Change from BL at Week 180 (n=71, 63, 74, 41)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.3", "spread": "0.9"}, {"groupId": "OG001", "value": "-1.4", "spread": "1.2"}, {"groupId": "OG002", "value": "-0.9", "spread": "1.2"}, {"groupId": "OG003", "value": "-1.6", "spread": "1.7"}]}]}, {"title": "Change from BL at Week 193 (n=70, 60, 72, 40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.4", "spread": "1.2"}, {"groupId": "OG001", "value": "-2.6", "spread": "1.3"}, {"groupId": "OG002", "value": "-1.7", "spread": "1.2"}, {"groupId": "OG003", "value": "-2.6", "spread": "1.6"}]}]}, {"title": "Change from BL at Week 206 (n=61, 53, 64, 33)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.8", "spread": "1.0"}, {"groupId": "OG001", "value": "-0.6", "spread": "1.4"}, {"groupId": "OG002", "value": "-2.3", "spread": "1.3"}, {"groupId": "OG003", "value": "-2.8", "spread": "1.6"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Changes From Baseline in Heart Rate During the ST + LT Period", "populationDescription": "Treated participants; n=number of treated participants with measurement at time point", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "beats/min", "timeFrame": "Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg + Metformin", "description": "Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg + Metformin", "description": "Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg + Metformin", "description": "Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo+ Metformin", "description": "Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "192"}, {"groupId": "OG001", "value": "191"}, {"groupId": "OG002", "value": "181"}, {"groupId": "OG003", "value": "179"}]}], "classes": [{"title": "Change from BL at Week 2 (n=182, 181, 176, 170)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.3", "spread": "0.7"}, {"groupId": "OG001", "value": "1.0", "spread": "0.7"}, {"groupId": "OG002", "value": "-0.4", "spread": "0.8"}, {"groupId": "OG003", "value": "0.7", "spread": "0.7"}]}]}, {"title": "Change from BL at Week 4 (n=178, 179, 175, 164)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.1", "spread": "0.8"}, {"groupId": "OG001", "value": "1.3", "spread": "0.6"}, {"groupId": "OG002", "value": "-0.0", "spread": "0.7"}, {"groupId": "OG003", "value": "0.1", "spread": "0.6"}]}]}, {"title": "Change from BL at Week 6 (n=178, 176, 171, 162)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.2", "spread": "0.7"}, {"groupId": "OG001", "value": "1.0", "spread": "0.6"}, {"groupId": "OG002", "value": "-0.2", "spread": "0.7"}, {"groupId": "OG003", "value": "-0.5", "spread": "0.7"}]}]}, {"title": "Change from BL at Week 8 (n=175, 176, 170, 152)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.5", "spread": "0.7"}, {"groupId": "OG001", "value": "0.8", "spread": "0.6"}, {"groupId": "OG002", "value": "0.6", "spread": "0.7"}, {"groupId": "OG003", "value": "-0.6", "spread": "0.7"}]}]}, {"title": "Change from BL at Week 10 (n=116, 106, 100, 101)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.5", "spread": "0.8"}, {"groupId": "OG001", "value": "0.9", "spread": "0.8"}, {"groupId": "OG002", "value": "0.2", "spread": "1.0"}, {"groupId": "OG003", "value": "-1.5", "spread": "0.9"}]}]}, {"title": "Change from BL at Week 12 (n=170, 166, 161, 138)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.2", "spread": "0.7"}, {"groupId": "OG001", "value": "0.7", "spread": "0.6"}, {"groupId": "OG002", "value": "0.1", "spread": "0.7"}, {"groupId": "OG003", "value": "-1.5", "spread": "0.8"}]}]}, {"title": "Change from BL at Week 14 (n=132, 129, 124, 116)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.1", "spread": "0.8"}, {"groupId": "OG001", "value": "1.4", "spread": "0.8"}, {"groupId": "OG002", "value": "1.0", "spread": "0.9"}, {"groupId": "OG003", "value": "-1.5", "spread": "0.9"}]}]}, {"title": "Change from BL at Week 16 (n=166, 164, 156, 140)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.6", "spread": "0.7"}, {"groupId": "OG001", "value": "0.4", "spread": "0.7"}, {"groupId": "OG002", "value": "-0.5", "spread": "0.8"}, {"groupId": "OG003", "value": "-0.5", "spread": "0.8"}]}]}, {"title": "Change from BL at Week 18 (n=144, 141, 132, 123)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.0", "spread": "0.8"}, {"groupId": "OG001", "value": "1.6", "spread": "0.8"}, {"groupId": "OG002", "value": "0.3", "spread": "0.8"}, {"groupId": "OG003", "value": "-0.5", "spread": "0.9"}]}]}, {"title": "Change from BL at Week 20 (n=163, 155, 153, 147)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.0", "spread": "0.7"}, {"groupId": "OG001", "value": "0.9", "spread": "0.7"}, {"groupId": "OG002", "value": "-0.3", "spread": "0.8"}, {"groupId": "OG003", "value": "-0.8", "spread": "0.8"}]}]}, {"title": "Change from BL at Week 22 (n=146, 140, 136, 126)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.4", "spread": "0.9"}, {"groupId": "OG001", "value": "2.4", "spread": "0.8"}, {"groupId": "OG002", "value": "0.3", "spread": "0.8"}, {"groupId": "OG003", "value": "-1.6", "spread": "0.9"}]}]}, {"title": "Change from BL at Week 24 (n=165, 160, 161, 140)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.6", "spread": "0.8"}, {"groupId": "OG001", "value": "0.2", "spread": "0.7"}, {"groupId": "OG002", "value": "0.4", "spread": "0.7"}, {"groupId": "OG003", "value": "-0.7", "spread": "0.7"}]}]}, {"title": "Change from BL at Week 30 (n=162, 156, 154, 138)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.7", "spread": "0.8"}, {"groupId": "OG001", "value": "0.5", "spread": "0.7"}, {"groupId": "OG002", "value": "-0.3", "spread": "0.8"}, {"groupId": "OG003", "value": "-0.1", "spread": "0.8"}]}]}, {"title": "Change from BL at Week 37 (n=154, 151, 149, 123)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.2", "spread": "0.8"}, {"groupId": "OG001", "value": "0.6", "spread": "0.7"}, {"groupId": "OG002", "value": "-0.3", "spread": "0.8"}, {"groupId": "OG003", "value": "-0.6", "spread": "0.8"}]}]}, {"title": "Change from BL at Week 50 (n=154, 147, 151, 130)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.0", "spread": "0.8"}, {"groupId": "OG001", "value": "0.8", "spread": "0.8"}, {"groupId": "OG002", "value": "0.1", "spread": "0.8"}, {"groupId": "OG003", "value": "-1.0", "spread": "0.8"}]}]}, {"title": "Change from BL at Week 63 (n=151, 138, 145, 117)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.8", "spread": "0.8"}, {"groupId": "OG001", "value": "0.4", "spread": "0.8"}, {"groupId": "OG002", "value": "-0.8", "spread": "0.7"}, {"groupId": "OG003", "value": "-0.5", "spread": "0.9"}]}]}, {"title": "Change from BL at Week 76 (n=134, 126, 133, 98)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.3", "spread": "0.8"}, {"groupId": "OG001", "value": "-0.0", "spread": "0.9"}, {"groupId": "OG002", "value": "-0.5", "spread": "0.9"}, {"groupId": "OG003", "value": "-1.4", "spread": "0.9"}]}]}, {"title": "Change from BL at Week 89 (n=124, 116, 125, 86)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.5", "spread": "0.8"}, {"groupId": "OG001", "value": "-0.3", "spread": "0.9"}, {"groupId": "OG002", "value": "-0.2", "spread": "0.8"}, {"groupId": "OG003", "value": "-1.6", "spread": "1.0"}]}]}, {"title": "Change from BL at Week 102 (n=111, 107, 113, 73)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.6", "spread": "0.9"}, {"groupId": "OG001", "value": "0.5", "spread": "0.9"}, {"groupId": "OG002", "value": "0.6", "spread": "0.8"}, {"groupId": "OG003", "value": "-1.8", "spread": "1.2"}]}]}, {"title": "Change from BL at Week 115 (n=100, 94, 98, 58)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.5", "spread": "0.9"}, {"groupId": "OG001", "value": "-0.3", "spread": "1.1"}, {"groupId": "OG002", "value": "-0.8", "spread": "1.0"}, {"groupId": "OG003", "value": "-2.4", "spread": "1.2"}]}]}, {"title": "Change from BL at Week 128 (n=94, 88, 90, 52)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.2", "spread": "0.9"}, {"groupId": "OG001", "value": "-0.7", "spread": "1.2"}, {"groupId": "OG002", "value": "-0.9", "spread": "1.1"}, {"groupId": "OG003", "value": "-0.9", "spread": "1.3"}]}]}, {"title": "Change from BL at Week 141 (n=87, 82, 85, 49)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.7", "spread": "1.0"}, {"groupId": "OG001", "value": "-1.7", "spread": "1.2"}, {"groupId": "OG002", "value": "-0.6", "spread": "1.2"}, {"groupId": "OG003", "value": "-1.2", "spread": "1.3"}]}]}, {"title": "Change from BL at Week 154 (n=84, 75, 79, 45)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.6", "spread": "0.9"}, {"groupId": "OG001", "value": "-0.9", "spread": "1.4"}, {"groupId": "OG002", "value": "-0.0", "spread": "1.2"}, {"groupId": "OG003", "value": "-2.8", "spread": "1.4"}]}]}, {"title": "Change from BL at Week 167 (n=78, 67, 75, 42)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.3", "spread": "1.0"}, {"groupId": "OG001", "value": "-0.0", "spread": "1.3"}, {"groupId": "OG002", "value": "-1.2", "spread": "1.2"}, {"groupId": "OG003", "value": "-0.9", "spread": "1.4"}]}]}, {"title": "Change from BL at Week 180 (n=71, 63, 74, 41)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.8", "spread": "1.1"}, {"groupId": "OG001", "value": "-2.8", "spread": "1.3"}, {"groupId": "OG002", "value": "0.2", "spread": "1.6"}, {"groupId": "OG003", "value": "-2.7", "spread": "1.3"}]}]}, {"title": "Change from BL at Week 193 (n=70, 60, 72, 40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.3", "spread": "1.1"}, {"groupId": "OG001", "value": "-2.2", "spread": "1.3"}, {"groupId": "OG002", "value": "-1.1", "spread": "1.1"}, {"groupId": "OG003", "value": "-1.8", "spread": "1.5"}]}]}, {"title": "Change from BL at Week 206 (n=61, 53, 64, 33)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.1", "spread": "1.2"}, {"groupId": "OG001", "value": "-0.9", "spread": "1.2"}, {"groupId": "OG002", "value": "-1.2", "spread": "1.2"}, {"groupId": "OG003", "value": "-1.1", "spread": "1.6"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Electrocardiogram (ECG) Tracings - Shift Table From Baseline (BL) to Selected Visits During ST + LT Treatment Period", "description": "The normality/abnormality of the ECG tracing was determined by the investigator.", "populationDescription": "Number of Participants Analyzed=Treated Participants; BL n=normal or abnormal ECG status at baseline of the cohort of participants with measure at given time point", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "Baseline, Weeks 12, 24, 76, 102, 154, 206,", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg + Metformin", "description": "Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg + Metformin", "description": "Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg + Metformin", "description": "Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo+ Metformin", "description": "Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "192"}, {"groupId": "OG001", "value": "191"}, {"groupId": "OG002", "value": "181"}, {"groupId": "OG003", "value": "179"}]}], "classes": [{"title": "Normal BL, Normal Week 12(BL n=108, 109, 104, 104)", "categories": [{"measurements": [{"groupId": "OG000", "value": "97"}, {"groupId": "OG001", "value": "98"}, {"groupId": "OG002", "value": "94"}, {"groupId": "OG003", "value": "82"}]}]}, {"title": "Normal BL, Abnormal Week 12 (BL n=108,109,104,104)", "categories": [{"measurements": [{"groupId": "OG000", "value": "11"}, {"groupId": "OG001", "value": "11"}, {"groupId": "OG002", "value": "10"}, {"groupId": "OG003", "value": "22"}]}]}, {"title": "Abnormal BL, Normal Week 12 (BL n=69, 66, 70, 58)", "categories": [{"measurements": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "22"}, {"groupId": "OG002", "value": "22"}, {"groupId": "OG003", "value": "12"}]}]}, {"title": "Abnormal BL, Abnormal Week 12(BL n=69, 66, 70, 58)", "categories": [{"measurements": [{"groupId": "OG000", "value": "55"}, {"groupId": "OG001", "value": "44"}, {"groupId": "OG002", "value": "48"}, {"groupId": "OG003", "value": "46"}]}]}, {"title": "Normal BL, Normal Week 24 (BL n=96, 87, 83, 77)", "categories": [{"measurements": [{"groupId": "OG000", "value": "82"}, {"groupId": "OG001", "value": "79"}, {"groupId": "OG002", "value": "70"}, {"groupId": "OG003", "value": "61"}]}]}, {"title": "Normal BL, Abnormal Week 24 (BL n=96, 87, 83, 77)", "categories": [{"measurements": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "8"}, {"groupId": "OG002", "value": "13"}, {"groupId": "OG003", "value": "16"}]}]}, {"title": "Abnormal BL, Normal Week 24 (BL n=58, 58, 56, 41)", "categories": [{"measurements": [{"groupId": "OG000", "value": "16"}, {"groupId": "OG001", "value": "22"}, {"groupId": "OG002", "value": "15"}, {"groupId": "OG003", "value": "14"}]}]}, {"title": "Abnormal BL, Abnormal Week 24(BL n=58, 58, 56, 41)", "categories": [{"measurements": [{"groupId": "OG000", "value": "42"}, {"groupId": "OG001", "value": "36"}, {"groupId": "OG002", "value": "41"}, {"groupId": "OG003", "value": "27"}]}]}, {"title": "Normal BL, Normal Week 76 (BL n=94, 89, 92, 81)", "categories": [{"measurements": [{"groupId": "OG000", "value": "75"}, {"groupId": "OG001", "value": "74"}, {"groupId": "OG002", "value": "73"}, {"groupId": "OG003", "value": "60"}]}]}, {"title": "Normal BL, Abnormal Week 76 (BL n=94, 89, 92, 81)", "categories": [{"measurements": [{"groupId": "OG000", "value": "19"}, {"groupId": "OG001", "value": "15"}, {"groupId": "OG002", "value": "19"}, {"groupId": "OG003", "value": "21"}]}]}, {"title": "Abnormal BL, Normal Week 76 (BL n=51, 52, 59, 44)", "categories": [{"measurements": [{"groupId": "OG000", "value": "13"}, {"groupId": "OG001", "value": "18"}, {"groupId": "OG002", "value": "18"}, {"groupId": "OG003", "value": "13"}]}]}, {"title": "Abnormal BL, Abnormal Week 76 (BL n=51,52,59,44)", "categories": [{"measurements": [{"groupId": "OG000", "value": "38"}, {"groupId": "OG001", "value": "34"}, {"groupId": "OG002", "value": "41"}, {"groupId": "OG003", "value": "31"}]}]}, {"title": "Normal BL, Normal Week 102 (BL n=80, 66, 65, 50)", "categories": [{"measurements": [{"groupId": "OG000", "value": "63"}, {"groupId": "OG001", "value": "55"}, {"groupId": "OG002", "value": "48"}, {"groupId": "OG003", "value": "41"}]}]}, {"title": "Normal BL, Abnormal Week 102 (BL n=80, 66, 65, 50)", "categories": [{"measurements": [{"groupId": "OG000", "value": "17"}, {"groupId": "OG001", "value": "11"}, {"groupId": "OG002", "value": "17"}, {"groupId": "OG003", "value": "9"}]}]}, {"title": "Abnormal BL, Normal Week 102 (BL n=43,45,49, 21)", "categories": [{"measurements": [{"groupId": "OG000", "value": "11"}, {"groupId": "OG001", "value": "14"}, {"groupId": "OG002", "value": "14"}, {"groupId": "OG003", "value": "6"}]}]}, {"title": "Abnormal BL, Abnormal Week 102 (BL n=43,45,49, 21)", "categories": [{"measurements": [{"groupId": "OG000", "value": "32"}, {"groupId": "OG001", "value": "31"}, {"groupId": "OG002", "value": "35"}, {"groupId": "OG003", "value": "15"}]}]}, {"title": "Normal BL, Normal Week 154 (BL n=60, 46, 53, 34)", "categories": [{"measurements": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "36"}, {"groupId": "OG002", "value": "37"}, {"groupId": "OG003", "value": "26"}]}]}, {"title": "Normal BL, Abnormal Week 154 (BL n=60, 46, 53, 34)", "categories": [{"measurements": [{"groupId": "OG000", "value": "12"}, {"groupId": "OG001", "value": "10"}, {"groupId": "OG002", "value": "16"}, {"groupId": "OG003", "value": "8"}]}]}, {"title": "Abnormal BL, Normal Week 154 (BL n=26, 34, 34, 16)", "categories": [{"measurements": [{"groupId": "OG000", "value": "10"}, {"groupId": "OG001", "value": "13"}, {"groupId": "OG002", "value": "12"}, {"groupId": "OG003", "value": "7"}]}]}, {"title": "Abnormal BL, Abnormal Week 154 (BL n=26,34,34,16)", "categories": [{"measurements": [{"groupId": "OG000", "value": "16"}, {"groupId": "OG001", "value": "21"}, {"groupId": "OG002", "value": "22"}, {"groupId": "OG003", "value": "9"}]}]}, {"title": "Normal BL, Normal Week 206 (BL n=48, 31, 42, 24)", "categories": [{"measurements": [{"groupId": "OG000", "value": "39"}, {"groupId": "OG001", "value": "27"}, {"groupId": "OG002", "value": "32"}, {"groupId": "OG003", "value": "16"}]}]}, {"title": "Normal BL, Abnormal Week 206 (BL n=48, 31, 42, 24)", "categories": [{"measurements": [{"groupId": "OG000", "value": "9"}, {"groupId": "OG001", "value": "4"}, {"groupId": "OG002", "value": "10"}, {"groupId": "OG003", "value": "8"}]}]}, {"title": "Abnormal BL, Normal Week 206 (BL n=20, 25, 28, 13)", "categories": [{"measurements": [{"groupId": "OG000", "value": "9"}, {"groupId": "OG001", "value": "9"}, {"groupId": "OG002", "value": "11"}, {"groupId": "OG003", "value": "7"}]}]}, {"title": "Abnormal BL, Abnormal Week 206 (BL n=20,25,28,13)", "categories": [{"measurements": [{"groupId": "OG000", "value": "11"}, {"groupId": "OG001", "value": "16"}, {"groupId": "OG002", "value": "17"}, {"groupId": "OG003", "value": "6"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "All Reported Hypoglycemic Adverse Events During the ST + LT Treatment Period", "description": "Hypoglycemic Events are based upon the Saxagliptin Predefined List of Events, which are hypoglycemia, blood glucose decreased, and hypoglycemic unconsciousness.", "populationDescription": "Treated participants", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "AEs: up to last treatment day + 1 day or last visit day in the ST+LT period; SAEs: up to last treatment day + 30 days or last visit day + 30 days in the LT+ST period. Mean duration of exposure: 124, 118, 130, 95 wks respectively for 2.5mg, 5mg, 10 mg, pla", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg + Metformin", "description": "Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg + Metformin", "description": "Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg + Metformin", "description": "Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo+ Metformin", "description": "Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "192"}, {"groupId": "OG001", "value": "191"}, {"groupId": "OG002", "value": "181"}, {"groupId": "OG003", "value": "179"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "23"}, {"groupId": "OG001", "value": "20"}, {"groupId": "OG002", "value": "21"}, {"groupId": "OG003", "value": "20"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Confirmed Hypoglycemia During the ST + LT Treatment Period", "description": "'Confirmed' = recorded on the hypoglycemia AE case report form with a fingerstick glucose \\<= 50 mg/dL and associated symptoms.", "populationDescription": "Treated participants", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "AEs: up to last treatment day + 1 day or last visit day in the ST+LT period; SAEs: up to last treatment day + 30 days or last visit day + 30 days in the LT+ST period. Mean duration of exposure: 124, 118, 130, 95 wks respectively for 2.5mg, 5mg, 10 mg, pla", "groups": [{"id": "OG000", "title": "Saxagliptin 2.5 mg + Metformin", "description": "Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG001", "title": "Saxagliptin 5 mg + Metformin", "description": "Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG002", "title": "Saxagliptin 10 mg + Metformin", "description": "Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}, {"id": "OG003", "title": "Placebo+ Metformin", "description": "Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue)."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "192"}, {"groupId": "OG001", "value": "191"}, {"groupId": "OG002", "value": "181"}, {"groupId": "OG003", "value": "179"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "2"}, {"groupId": "OG002", "value": "3"}, {"groupId": "OG003", "value": "1"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "eventGroups": [{"id": "EG000", "title": "Placebo+ Metformin", "description": "Tablets, Oral, 0 mg, Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).", "seriousNumAffected": 15, "seriousNumAtRisk": 179, "otherNumAffected": 129, "otherNumAtRisk": 179}, {"id": "EG001", "title": "Saxagliptin 10 mg + Metformin", "description": "Tablets, Oral, 10 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).", "seriousNumAffected": 22, "seriousNumAtRisk": 181, "otherNumAffected": 133, "otherNumAtRisk": 181}, {"id": "EG002", "title": "Saxagliptin 2.5 mg + Metformin", "description": "Tablets, Oral, 2.5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).", "seriousNumAffected": 23, "seriousNumAtRisk": 192, "otherNumAffected": 139, "otherNumAtRisk": 192}, {"id": "EG003", "title": "Saxagliptin 5 mg + Metformin", "description": "Tablets, Oral, 5 mg Saxagliptin (plus flexible metformin dose), Once daily (24 weeks ST, 42 months LT); Pioglitazone 15-45 mg (as needed for rescue).", "seriousNumAffected": 27, "seriousNumAtRisk": 191, "otherNumAffected": 133, "otherNumAtRisk": 191}], "seriousEvents": [{"term": "ANGINA PECTORIS", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "ANGINA UNSTABLE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "CARDIOGENIC SHOCK", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "MYOCARDIAL ISCHAEMIA", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "MYOCARDIAL INFARCTION", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "CORONARY ARTERY DISEASE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 4, "numAtRisk": 191}]}, {"term": "CARDIAC FAILURE CONGESTIVE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 3, "numAtRisk": 191}]}, {"term": "SUPRAVENTRICULAR TACHYCARDIA", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "CORONARY ARTERY INSUFFICIENCY", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "VARICOSE VEIN", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "HYPERTENSIVE CRISIS", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "DEPRESSION", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "MAJOR DEPRESSION", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "PSYCHIATRIC SYMPTOM", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "BILIARY COLIC", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "CHOLECYSTITIS", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "CHOLELITHIASIS", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "CHOLECYSTITIS ACUTE", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "SARCOIDOSIS", "organSystem": "Immune system disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "DRUG HYPERSENSITIVITY", "organSystem": "Immune system disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "HEADACHE", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "DIZZINESS", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "SOMNOLENCE", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "CEREBROVASCULAR ACCIDENT", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "TRANSIENT ISCHAEMIC ATTACK", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "ALTERED STATE OF CONSCIOUSNESS", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "VOMITING", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "DIARRHOEA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "ABDOMINAL PAIN", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "FOOD POISONING", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "ABDOMINAL HERNIA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "STOMACH GRANULOMA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "INTESTINAL OBSTRUCTION", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "GASTROINTESTINAL HAEMORRHAGE", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "PNEUMONIA", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "SINUSITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "UROSEPSIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "CELLULITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "ERYSIPELAS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "APPENDICITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "BREAST ABSCESS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "DIVERTICULITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "PYELONEPHRITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "SCROTAL ABSCESS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "SINUSITIS BACTERIAL", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "PERIUMBILICAL ABSCESS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "MENINGITIS TUBERCULOUS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "APPENDICITIS PERFORATED", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "URINARY TRACT INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "CLOSTRIDIUM DIFFICILE COLITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "NEPHROLITHIASIS", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "CALCULUS URINARY", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "CALCULUS URETERIC", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "RENAL FAILURE ACUTE", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "STERILISATION", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "DEHYDRATION", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "ANAEMIA", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "CYSTOCELE", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "RECTOCELE", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "PROSTATITIS", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "DYSFUNCTIONAL UTERINE BLEEDING", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "FALL", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "LIMB INJURY", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "HIP FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "ANKLE FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "SKIN LACERATION", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "INCISIONAL HERNIA", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "UPPER LIMB FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "ROAD TRAFFIC ACCIDENT", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "EXOSTOSIS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "ARTHRALGIA", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "OSTEOARTHRITIS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "MUSCULOSKELETAL PAIN", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "RHEUMATOID ARTHRITIS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "INTERVERTEBRAL DISC PROTRUSION", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "ASTHMA", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "PULMONARY EMBOLISM", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "HERNIA", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "CHEST PAIN", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "PELVIC MASS", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "NEURILEMMOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "BREAST CANCER", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "LUNG NEOPLASM", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "UTERINE CANCER", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "PROSTATE CANCER", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "MULTIPLE MYELOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 191}]}, {"term": "BASAL CELL CARCINOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "NON-HODGKIN'S LYMPHOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "BREAST CANCER RECURRENT", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}, {"term": "GASTROINTESTINAL CARCINOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 191}]}], "otherEvents": [{"term": "HYPERTENSION", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 13, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 16, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 21, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 14, "numAtRisk": 191}]}, {"term": "HEADACHE", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 22, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 24, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 27, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 18, "numAtRisk": 191}]}, {"term": "DIZZINESS", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 10, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 8, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 9, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 8, "numAtRisk": 191}]}, {"term": "NAUSEA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 8, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 14, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 11, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 7, "numAtRisk": 191}]}, {"term": "VOMITING", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 8, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 7, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 12, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 9, "numAtRisk": 191}]}, {"term": "DIARRHOEA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 23, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 19, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 29, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 19, "numAtRisk": 191}]}, {"term": "DYSPEPSIA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 8, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 6, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 9, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 12, "numAtRisk": 191}]}, {"term": "GASTRITIS", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 10, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 3, "numAtRisk": 191}]}, {"term": "TOOTHACHE", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 11, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 6, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 10, "numAtRisk": 191}]}, {"term": "ABDOMINAL PAIN", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 13, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 8, "numAtRisk": 191}]}, {"term": "ABDOMINAL PAIN UPPER", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 5, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 6, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 6, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 10, "numAtRisk": 191}]}, {"term": "INFLUENZA", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 27, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 28, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 27, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 31, "numAtRisk": 191}]}, {"term": "SINUSITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 8, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 15, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 9, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 14, "numAtRisk": 191}]}, {"term": "BRONCHITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 13, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 12, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 15, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 19, "numAtRisk": 191}]}, {"term": "GASTROENTERITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 10, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 6, "numAtRisk": 191}]}, {"term": "NASOPHARYNGITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 25, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 28, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 28, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 28, "numAtRisk": 191}]}, {"term": "URINARY TRACT INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 15, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 22, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 26, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 16, "numAtRisk": 191}]}, {"term": "UPPER RESPIRATORY TRACT INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 17, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 21, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 25, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 19, "numAtRisk": 191}]}, {"term": "ANAEMIA", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 7, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 15, "numAtRisk": 191}]}, {"term": "RASH", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 5, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 12, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 6, "numAtRisk": 191}]}, {"term": "MYALGIA", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 8, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 10, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 7, "numAtRisk": 191}]}, {"term": "BACK PAIN", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 19, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 14, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 19, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 16, "numAtRisk": 191}]}, {"term": "ARTHRALGIA", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 12, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 23, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 22, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 20, "numAtRisk": 191}]}, {"term": "PAIN IN EXTREMITY", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 17, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 15, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 14, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 10, "numAtRisk": 191}]}, {"term": "MUSCULOSKELETAL PAIN", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 9, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 10, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 5, "numAtRisk": 191}]}, {"term": "COUGH", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 11, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 9, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 15, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 9, "numAtRisk": 191}]}, {"term": "OEDEMA PERIPHERAL", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 12, "numAtRisk": 179}, {"groupId": "EG001", "numAffected": 16, "numAtRisk": 181}, {"groupId": "EG002", "numAffected": 16, "numAtRisk": 192}, {"groupId": "EG003", "numAffected": 15, "numAtRisk": 191}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication."}, "pointOfContact": {"title": "Boaz Hirschberg", "organization": "AstraZeneca Pharmaceuticals", "email": "ClinicalTrialTransparency@astrazeneca.com"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000003924", "term": "Diabetes Mellitus, Type 2"}], "ancestors": [{"id": "D000003920", "term": "Diabetes Mellitus"}, {"id": "D000044882", "term": "Glucose Metabolism Disorders"}, {"id": "D000008659", "term": "Metabolic Diseases"}, {"id": "D000004700", "term": "Endocrine System Diseases"}], "browseLeaves": [{"id": "M7115", "name": "Diabetes Mellitus", "relevance": "LOW"}, {"id": "M7119", "name": "Diabetes Mellitus, Type 2", "asFound": "Diabetes Mellitus, Type 2", "relevance": "HIGH"}, {"id": "M11639", "name": "Metabolic Diseases", "relevance": "LOW"}, {"id": "M25403", "name": "Glucose Metabolism Disorders", "relevance": "LOW"}, {"id": "M7862", "name": "Endocrine System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC18", "name": "Nutritional and Metabolic Diseases"}, {"abbrev": "BC19", "name": "Gland and Hormone Related Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000008687", "term": "Metformin"}, {"id": "D000077205", "term": "Pioglitazone"}, {"id": "C000502994", "term": "Saxagliptin"}], "ancestors": [{"id": "D000007004", "term": "Hypoglycemic Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000054795", "term": "Incretins"}, {"id": "D000006728", "term": "Hormones"}, {"id": "D000006730", "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"id": "D000054873", "term": "Dipeptidyl-Peptidase IV Inhibitors"}, {"id": "D000011480", "term": "Protease Inhibitors"}, {"id": "D000004791", "term": "Enzyme Inhibitors"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}], "browseLeaves": [{"id": "M11667", "name": "Metformin", "asFound": "Assessment", "relevance": "HIGH"}, {"id": "M1693", "name": "Pioglitazone", "asFound": "Registry", "relevance": "HIGH"}, {"id": "M228152", "name": "Saxagliptin", "asFound": "Manufacturer", "relevance": "HIGH"}, {"id": "M10054", "name": "Hypoglycemic Agents", "relevance": "LOW"}, {"id": "M27905", "name": "Incretins", "relevance": "LOW"}, {"id": "M9789", "name": "Hormones", "relevance": "LOW"}, {"id": "M9788", "name": "Hormone Antagonists", "relevance": "LOW"}, {"id": "M27957", "name": "Dipeptidyl-Peptidase IV Inhibitors", "relevance": "LOW"}, {"id": "M19609", "name": "HIV Protease Inhibitors", "relevance": "LOW"}, {"id": "M14343", "name": "Protease Inhibitors", "relevance": "LOW"}, {"id": "M7951", "name": "Enzyme Inhibitors", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Hypo", "name": "Hypoglycemic Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "Infe", "name": "Anti-Infective Agents"}]}}, "hasResults": true}